https://timmermanreport.com/2019/04/blazing-a-new-trail-in-psychiatry-womens-health-jeff-jonas-on-the-long-run/jeff-jonas-1/2019-04-24T02:17:45+00:00https://timmermanreport.com/wp-content/uploads/2019/04/jeff-jonas-1.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/rivervest-logo-jpeg/2019-04-24T22:27:45+00:00https://timmermanreport.com/wp-content/uploads/2019/04/RiverVest-Logo-JPEG-e1556144883919.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/toftgroup/2019-04-24T22:31:03+00:00https://timmermanreport.com/wp-content/uploads/2019/04/toftgroup-e1556145081964.jpghttps://timmermanreport.com/2019/04/membraneless-organelles-offer-new-drug-discovery-opportunities/tonyhyman/2019-04-26T22:37:04+00:00https://timmermanreport.com/wp-content/uploads/2019/04/tonyhyman.jpghttps://timmermanreport.com/2019/04/membraneless-organelles-offer-new-drug-discovery-opportunities/amir-nashat\_2017\_polaris/2019-04-26T22:38:32+00:00https://timmermanreport.com/wp-content/uploads/2019/04/amir-nashat\_2017\_polaris.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/print/2019-04-26T23:47:50+00:00https://timmermanreport.com/wp-content/uploads/2019/04/JPM-Logo.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/antibodysolutions/2019-05-07T20:10:35+00:00https://timmermanreport.com/wp-content/uploads/2019/05/antibodysolutions-e1557259856305.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/\_mva-logo-black/2019-05-07T20:13:06+00:00https://timmermanreport.com/wp-content/uploads/2019/05/MVA-logo-black-e1557260006823.jpghttps://timmermanreport.com/2019/05/thank-you-biotech-kili-climb-to-fight-has-crushed-its-1m-goal-for-cancer-research/1m-video/2019-05-08T17:25:45+00:00https://timmermanreport.com/2019/05/an-elephant-for-immunology-drug-development-sheila-gujrathi-on-the-long-run/shelia-gujrathi/2019-05-09T00:34:58+00:00https://timmermanreport.com/wp-content/uploads/2019/05/shelia-gujrathi.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/akcea\_logo\_cmyk/2019-05-13T16:33:55+00:00https://timmermanreport.com/wp-content/uploads/2019/05/Akcea\_Logo\_CMYK-e1557765254366.jpghttps://timmermanreport.com/2019/05/amgen-swings-for-the-ras-fence-gileads-grilling-on-price-agios-enlarges-the-pie/miller/2019-05-16T23:17:32+00:00https://timmermanreport.com/wp-content/uploads/2019/05/miller.pnghttps://timmermanreport.com/2019/05/amgen-swings-for-the-ras-fence-gileads-grilling-on-price-agios-enlarges-the-pie/sachs-2/2019-05-16T23:22:12+00:00https://timmermanreport.com/wp-content/uploads/2019/05/sachs.jpghttps://timmermanreport.com/2019/05/pain-drug-development-flounders-in-the-opioid-crisis-but-novel-mechanisms-emerging/ericelenko/2019-05-20T16:23:43+00:00https://timmermanreport.com/wp-content/uploads/2019/05/ericelenko.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/altalogotwitter\_all-text-1/2019-05-20T18:13:01+00:00https://timmermanreport.com/wp-content/uploads/2019/05/altaLogoTwitter\_all-text-1-e1558376000873.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/altalogotwitter\_all-text-1-2/2019-05-20T18:16:15+00:00https://timmermanreport.com/wp-content/uploads/2019/05/altaLogoTwitter\_all-text-1-1-e1558376240557.jpghttps://timmermanreport.com/2019/05/organs-on-a-chip-organoids-start-to-deliver-results-as-an-alternative-preclinical-route/doningber/2019-05-25T00:35:44+00:00https://timmermanreport.com/wp-content/uploads/2019/05/doningber.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/geraldine/2019-05-25T00:36:25+00:00https://timmermanreport.com/wp-content/uploads/2018/12/geraldine.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/glaukos-charitable-foundation-logo-cmyk/2019-06-01T14:41:23+00:00https://timmermanreport.com/wp-content/uploads/2019/06/Glaukos-Charitable-Foundation-Logo-CMYK.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/altapartners/2019-06-06T21:01:45+00:00https://timmermanreport.com/wp-content/uploads/2019/06/altapartners-e1559854930129.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/skadden\_logo\_cmyk\_big/2019-06-06T22:53:10+00:00https://timmermanreport.com/wp-content/uploads/2019/06/SKADDEN\_LOGO\_CMYK\_big-e1559861618943.jpghttps://timmermanreport.com/2019/06/predicting-who-will-benefit-from-cancer-drugs-liz-oday-on-the-long-run/eoday/2019-06-10T17:13:15+00:00https://timmermanreport.com/wp-content/uploads/2019/06/eoday.jpghttps://timmermanreport.com/2019/06/who-will-be-the-next-celgene-of-dealmaking-vcs-entrepreneurs-size-up-partners/biopharma2019/2019-06-13T05:01:37+00:00https://timmermanreport.com/wp-content/uploads/2019/06/biopharma2019.pnghttps://timmermanreport.com/2019/06/who-will-be-the-next-celgene-of-dealmaking-vcs-entrepreneurs-size-up-partners/bpa19/2019-06-16T17:14:51+00:00https://timmermanreport.com/wp-content/uploads/2019/06/bpa19.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/finsbury-logo\_high-res/2019-06-24T21:37:41+00:00https://timmermanreport.com/wp-content/uploads/2019/06/Finsbury-Logo\_high-res-e1561412237794.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/proskauer-2cu-electric/2019-06-24T21:38:12+00:00https://timmermanreport.com/wp-content/uploads/2019/06/Proskauer-2CU-electric-e1561412346920.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/atlasventure/2019-06-26T20:13:39+00:00https://timmermanreport.com/wp-content/uploads/2019/06/atlasventure-e1561580035913.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/catenion/2019-06-26T20:14:32+00:00https://timmermanreport.com/wp-content/uploads/2019/06/catenion-e1561580087776.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/clarion/2019-06-26T20:18:15+00:00https://timmermanreport.com/wp-content/uploads/2019/06/clarion-e1561580290315.pnghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/cooley-logo-red-rgb/2019-06-26T20:18:41+00:00https://timmermanreport.com/wp-content/uploads/2019/06/cooley-logo-red-rgb.gifhttps://timmermanreport.com/2019/07/cancer-survivor-and-cancer-drug-developer-laura-shawver-on-the-long-run/laura-shawver/2019-07-02T21:36:51+00:00https://timmermanreport.com/wp-content/uploads/2019/07/laura-shawver.jpghttps://timmermanreport.com/in-the-news/seattletimes/2019-07-10T13:48:46+00:00https://timmermanreport.com/wp-content/uploads/2019/07/seattletimes.pnghttps://timmermanreport.com/2019/07/biontech-snags-320m-roche-spark-delay-summer-job-switches/midyearhikes/2019-07-11T20:54:35+00:00https://timmermanreport.com/wp-content/uploads/2019/07/midyearhikes.pnghttps://timmermanreport.com/2019/07/better-cancer-treatment-through-better-information-cindy-perettie-on-the-long-run/cperettie/2019-07-11T21:10:57+00:00https://timmermanreport.com/wp-content/uploads/2019/07/cperettie.jpghttps://timmermanreport.com/2019/07/as-cancer-immunotherapy-booms-biomarkers-re-emerge-to-guide-treatment/lavallee\_theresa\_2x2\_web/2019-07-11T21:50:25+00:00https://timmermanreport.com/wp-content/uploads/2019/07/LaVallee\_Theresa\_2x2\_web.pnghttps://timmermanreport.com/2019/07/as-cancer-immunotherapy-booms-biomarkers-re-emerge-to-guide-treatment/johnwherry/2019-07-11T21:52:33+00:00https://timmermanreport.com/wp-content/uploads/2019/07/johnwherry.pnghttps://timmermanreport.com/2019/07/crispr-boosts-animal-models-making-preclinical-research-more-efficient/kalinichenko-vladimir/2019-07-13T16:32:05+00:00https://timmermanreport.com/wp-content/uploads/2019/07/kalinichenko-vladimir.jpghttps://timmermanreport.com/2019/07/crispr-boosts-animal-models-making-preclinical-research-more-efficient/kevin-holden-1/2019-07-13T16:34:10+00:00https://timmermanreport.com/wp-content/uploads/2019/07/Kevin-Holden-1.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/lek/2019-08-05T17:14:49+00:00https://timmermanreport.com/wp-content/uploads/2019/08/lek.jpghttps://timmermanreport.com/2019/08/from-pharma-vc-to-cell-therapy-startup-janelle-anderson-on-the-long-run/janelle/2019-08-08T16:08:34+00:00https://timmermanreport.com/wp-content/uploads/2019/08/janelle.jpghttps://timmermanreport.com/2019/08/novartis-no-no-bayer-buys-bluerock-and-job-switches-galore/sharpless1/2019-08-09T00:00:19+00:00https://timmermanreport.com/wp-content/uploads/2019/08/sharpless1.pnghttps://timmermanreport.com/2019/08/novartis-no-no-bayer-buys-bluerock-and-job-switches-galore/sharpless2/2019-08-09T00:00:22+00:00https://timmermanreport.com/wp-content/uploads/2019/08/sharpless2.pnghttps://timmermanreport.com/2019/08/novartis-no-no-bayer-buys-bluerock-and-job-switches-galore/brad1/2019-08-09T00:02:08+00:00https://timmermanreport.com/wp-content/uploads/2019/08/brad1.pnghttps://timmermanreport.com/2019/08/novartis-no-no-bayer-buys-bluerock-and-job-switches-galore/jacob-2/2019-08-09T00:02:41+00:00https://timmermanreport.com/wp-content/uploads/2019/08/jacob.pnghttps://timmermanreport.com/2019/08/executive-shortages-pose-challenge-to-biotech-growth-prospects/asherfig1/2019-08-09T18:59:20+00:00https://timmermanreport.com/wp-content/uploads/2019/08/asherfig1.jpghttps://timmermanreport.com/2019/08/executive-shortages-pose-challenge-to-biotech-growth-prospects/asherfig2/2019-08-09T19:00:44+00:00https://timmermanreport.com/wp-content/uploads/2019/08/asherfig2.jpghttps://timmermanreport.com/2019/08/executive-shortages-pose-challenge-to-biotech-growth-prospects/toft\_robin-18tg245fxhi-1030x687/2019-08-09T19:06:41+00:00https://timmermanreport.com/wp-content/uploads/2019/08/toft\_robin-18TG245fxHi-1030x687.jpghttps://timmermanreport.com/2019/08/executive-shortages-pose-challenge-to-biotech-growth-prospects/formela\_wb640x536/2019-08-09T19:08:14+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Formela\_WB640x536.jpghttps://timmermanreport.com/timmerman-traverse/1\_-0zioslhoa-u3\_ktaki8gw/2019-08-13T14:45:59+00:00https://timmermanreport.com/wp-content/uploads/2019/08/1\_-0ziOsLhoa-u3\_kTaki8gw.jpghttps://timmermanreport.com/2019/08/as-car-t-ranks-expand-industry-scrambles-to-solve-long-standing-manufacturing-challenges/mitchfinal2large-v5-retinex-v1/2019-08-14T17:20:55+00:00https://timmermanreport.com/wp-content/uploads/2019/08/MitchFinal2large-v5-retinex-v1.jpghttps://timmermanreport.com/2019/08/as-car-t-ranks-expand-industry-scrambles-to-solve-long-standing-manufacturing-challenges/tim-moore-768x815/2019-08-14T17:22:07+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Tim-Moore-768x815.jpghttps://timmermanreport.com/2019/08/roche-genentechs-clever-ntkr-strategy-regenerons-ebola-win-pcr-pioneer-passes/collins/2019-08-16T02:06:24+00:00https://timmermanreport.com/wp-content/uploads/2019/08/collins.jpghttps://timmermanreport.com/2019/08/autoimmunity-research-paves-the-way-for-new-ideas-in-halting-preventing-type-1-diabetes/jessicadunne/2019-08-19T18:02:31+00:00https://timmermanreport.com/wp-content/uploads/2019/08/jessicadunne.jpghttps://timmermanreport.com/2019/08/getting-in-on-the-ground-floor-of-the-biotech-boom-joel-marcus-on-the-long-run/joelmarcus/2019-08-20T20:01:42+00:00https://timmermanreport.com/wp-content/uploads/2019/08/JoelMarcus.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/komoonkristin/2019-08-20T20:54:12+00:00https://timmermanreport.com/wp-content/uploads/2019/08/KOMOonKristin.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/nina-kjellson-2/2019-08-20T21:34:32+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Nina-Kjellson.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/katrine-bosley-2/2019-08-20T21:35:13+00:00https://timmermanreport.com/wp-content/uploads/2019/08/KBosley-headshot-2.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/kenbrunt/2019-08-20T21:35:46+00:00https://timmermanreport.com/wp-content/uploads/2019/08/kenbrunt.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/neuhouser-studies/2019-08-20T21:37:47+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Kristin-Anderson-1.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/\_dsc2175/2019-08-20T21:39:04+00:00https://timmermanreport.com/wp-content/uploads/2019/08/DSC2175.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/nancymillerrich-2/2019-08-20T21:40:49+00:00https://timmermanreport.com/wp-content/uploads/2019/08/nancymillerrich.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/sanford-zweifach-2/2019-08-20T21:45:46+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Sanford-Zweifach.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/\_dsc2557/2019-08-20T22:32:52+00:00https://timmermanreport.com/wp-content/uploads/2019/08/DSC2557.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/team-climb-to-fight-kili/2019-08-20T22:48:28+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Team-Climb-to-Fight-Kili.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/lt14/2019-08-20T23:17:32+00:00https://timmermanreport.com/wp-content/uploads/2019/08/LT14.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/anderson-summit-i-climb-for/2019-08-20T23:20:28+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Anderson-summit-I-climb-for.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/photo-jul-24-1-23-03-am/2019-08-20T23:21:23+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Photo-Jul-24-1-23-03-AM.jpghttps://timmermanreport.com/2019/08/bio-leaders-defend-immigrants-sareptas-smackdown-pfizer-bets-500m-on-nc/chandra/2019-08-22T22:10:27+00:00https://timmermanreport.com/wp-content/uploads/2019/08/chandra.pnghttps://timmermanreport.com/2019/08/amgen-antes-up-for-otezla-abbvie-does-the-obvious-an-sirna-nails-pcsk9/sek1/2019-08-29T21:52:46+00:00https://timmermanreport.com/wp-content/uploads/2019/08/sek1.pnghttps://timmermanreport.com/2019/08/amgen-antes-up-for-otezla-abbvie-does-the-obvious-an-sirna-nails-pcsk9/sek2/2019-08-29T21:53:21+00:00https://timmermanreport.com/wp-content/uploads/2019/08/sek2.pnghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/erinlanciati/2019-08-30T19:21:34+00:00https://timmermanreport.com/wp-content/uploads/2019/08/erinlanciati.jpghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/tomcarey/2019-08-30T19:25:58+00:00https://timmermanreport.com/wp-content/uploads/2019/08/tomcarey.jpghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/ginger/2019-08-30T19:27:53+00:00https://timmermanreport.com/wp-content/uploads/2019/08/ginger.jpghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/robsurdel/2019-08-30T19:29:38+00:00https://timmermanreport.com/wp-content/uploads/2019/08/robsurdel.jpghttps://timmermanreport.com/2019/09/making-a-difference-for-sickle-cell-disease-ted-love-on-the-long-run/ted-w-love\_headshot-2/2019-09-03T17:22:52+00:00https://timmermanreport.com/wp-content/uploads/2019/09/Ted-W.-Love\_Headshot-2-e1567531311772.jpghttps://timmermanreport.com/2019/09/making-a-difference-for-sickle-cell-disease-ted-love-on-the-long-run/tedlove/2019-09-03T17:25:04+00:00https://timmermanreport.com/wp-content/uploads/2019/09/tedlove-e1567531583823.jpghttps://timmermanreport.com/2019/09/vertexs-bet-on-type-1-diabetes-azs-type-2-diabetes-cv-outcomes-win-fda-commish-speculation/billn/2019-09-05T23:30:07+00:00https://timmermanreport.com/wp-content/uploads/2019/09/billn.pnghttps://timmermanreport.com/2019/09/vertexs-bet-on-type-1-diabetes-azs-type-2-diabetes-cv-outcomes-win-fda-commish-speculation/charley/2019-09-05T23:31:50+00:00https://timmermanreport.com/wp-content/uploads/2019/09/charley.pnghttps://timmermanreport.com/2019/09/speaker-pelosis-envisioned-drug-price-clampdown-lundbecks-move-into-migraine-diabetes-drug-device-pairings/boothtweet/2019-09-19T23:19:34+00:00https://timmermanreport.com/wp-content/uploads/2019/09/boothtweet.pnghttps://timmermanreport.com/2019/09/big-ipo-week-on-deck-amazon-walmart-health-moves-akcea-exec-shakeup/lisatweet/2019-09-27T00:03:21+00:00https://timmermanreport.com/wp-content/uploads/2019/09/lisatweet.pnghttps://timmermanreport.com/the-long-run/ppd-biotech-logo-2/2019-09-27T21:27:38+00:00https://timmermanreport.com/wp-content/uploads/2019/09/PPD-Biotech-Logo.pnghttps://timmermanreport.com/2019/10/from-farm-field-to-mit-lab-phil-sharp-on-the-long-run/philsharp/2019-10-01T19:18:57+00:00https://timmermanreport.com/wp-content/uploads/2019/10/PhilSharp.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/1-3/2019-10-04T21:28:34+00:00https://timmermanreport.com/wp-content/uploads/2019/10/1.3.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/attachment/20/2019-10-04T23:07:39+00:00https://timmermanreport.com/wp-content/uploads/2019/10/20.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/attachment/39/2019-10-04T23:08:59+00:00https://timmermanreport.com/wp-content/uploads/2019/10/39.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/p1000501/2019-10-04T23:13:46+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000501.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/attachment/35/2019-10-04T23:16:36+00:00https://timmermanreport.com/wp-content/uploads/2019/10/35.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/g25/2019-10-04T23:19:28+00:00https://timmermanreport.com/wp-content/uploads/2019/10/g25.jpghttps://timmermanreport.com/2019/10/join-me-and-20-biotech-pros-on-the-trek-of-a-lifetime-for-cancer-research/g43/2019-10-04T23:20:30+00:00https://timmermanreport.com/wp-content/uploads/2019/10/g43.jpghttps://timmermanreport.com/2019/10/12-vcs-who-matter-but-you-hardly-ever-read-about/biotech-showcase-january-13-15-2020-2/2019-10-09T20:04:30+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Biotech-Showcase-January-13-15-2020-2.jpghttps://timmermanreport.com/2019/10/turning-synthetic-biology-into-living-drugs-synlogics-aoife-brennan-on-the-long-run/aoifebrennan/2019-10-15T20:03:49+00:00https://timmermanreport.com/wp-content/uploads/2019/10/aoifebrennan.jpghttps://timmermanreport.com/everest-base-camp-2021/kilimanjaroclimbjuly2019/2019-10-16T14:42:46+00:00https://timmermanreport.com/wp-content/uploads/2019/10/kilimanjaroclimbjuly2019.pnghttps://timmermanreport.com/everest-base-camp-2021/screen-shot-2019-10-16-at-10-01-31-am/2019-10-16T14:42:58+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Screen-Shot-2019-10-16-at-10.01.31-AM.pnghttps://timmermanreport.com/everest-base-camp-2021/https\_\_\_www-royalmountaintrekking-com\_img\_posts\_1513660477everestbasecamptrek/2019-10-16T14:51:10+00:00https://timmermanreport.com/wp-content/uploads/2019/10/https\_\_\_www.royalmountaintrekking.com\_img\_posts\_1513660477everest20base20camp20trek.jpghttps://timmermanreport.com/everest-base-camp-2021/everest-sign/2019-10-16T15:19:19+00:00https://timmermanreport.com/wp-content/uploads/2019/10/everest-sign.jpghttps://timmermanreport.com/everest-base-camp-2021/everest-top-bg/2019-10-16T15:23:20+00:00https://timmermanreport.com/wp-content/uploads/2019/10/everest-top-bg.jpghttps://timmermanreport.com/everest-base-camp-2021/eric-guide/2019-10-16T15:28:22+00:00https://timmermanreport.com/wp-content/uploads/2019/10/eric-guide.pnghttps://timmermanreport.com/everest-base-camp-2021/everest-top/2019-10-16T17:28:25+00:00https://timmermanreport.com/wp-content/uploads/2019/10/everest-top.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek9-bj/2019-10-16T17:33:21+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek9-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/2everesttrek/2019-10-16T17:33:24+00:00https://timmermanreport.com/wp-content/uploads/2019/10/2everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/20everesttrek/2019-10-16T17:33:27+00:00https://timmermanreport.com/wp-content/uploads/2019/10/20everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/21everesttrek/2019-10-16T17:33:30+00:00https://timmermanreport.com/wp-content/uploads/2019/10/21everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/23everesttrek/2019-10-16T17:33:33+00:00https://timmermanreport.com/wp-content/uploads/2019/10/23everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/25everesttrek/2019-10-16T17:33:36+00:00https://timmermanreport.com/wp-content/uploads/2019/10/25everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/34everesttrek/2019-10-16T17:33:39+00:00https://timmermanreport.com/wp-content/uploads/2019/10/34everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/35everesttrek/2019-10-16T17:33:43+00:00https://timmermanreport.com/wp-content/uploads/2019/10/35everesttrek.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek1-bj/2019-10-16T17:33:46+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek1-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek3-bj/2019-10-16T17:33:48+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek3-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek4-bj/2019-10-16T17:33:51+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek4-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek5-bj/2019-10-16T17:33:53+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek5-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek6-bj/2019-10-16T17:33:56+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek6-bj.jpghttps://timmermanreport.com/everest-base-camp-2021/etrek7-bj/2019-10-16T17:33:59+00:00https://timmermanreport.com/wp-content/uploads/2019/10/etrek7-bj.jpghttps://timmermanreport.com/2019/10/reata-booms-alexion-buys-achillion-teva-drops-the-ball-big-time/reatashares/2019-10-18T00:23:31+00:00https://timmermanreport.com/wp-content/uploads/2019/10/reatashares.jpghttps://timmermanreport.com/2019/10/reata-booms-alexion-buys-achillion-teva-drops-the-ball-big-time/mnk/2019-10-18T01:58:45+00:00https://timmermanreport.com/wp-content/uploads/2019/10/mnk.jpghttps://timmermanreport.com/everest-base-camp-2021/11-2/2019-10-18T23:54:45+00:00https://timmermanreport.com/wp-content/uploads/2019/10/11.jpghttps://timmermanreport.com/everest-base-camp-2021/attachment/25/2019-10-18T23:54:50+00:00https://timmermanreport.com/wp-content/uploads/2019/10/25.jpghttps://timmermanreport.com/everest-base-camp-2021/alpine-ascents-logo/2019-10-22T16:31:42+00:00https://timmermanreport.com/wp-content/uploads/2017/10/alpine-ascents-logo.pnghttps://timmermanreport.com/2019/10/vertexs-watershed-for-cf-biogens-head-scratcher-and-seattle-genetics-nails-her2climb/coughlin/2019-10-24T23:52:09+00:00https://timmermanreport.com/wp-content/uploads/2019/10/coughlin.pnghttps://timmermanreport.com/2019/10/vertexs-watershed-for-cf-biogens-head-scratcher-and-seattle-genetics-nails-her2climb/brad2/2019-10-24T23:52:59+00:00https://timmermanreport.com/wp-content/uploads/2019/10/brad2.pnghttps://timmermanreport.com/2019/10/early-cancer-screening-is-proving-itself-in-the-clinic-but-what-will-it-mean-for-drug-developers/helmy/2019-10-25T20:46:56+00:00https://timmermanreport.com/wp-content/uploads/2019/10/helmy.jpghttps://timmermanreport.com/2019/10/early-cancer-screening-is-proving-itself-in-the-clinic-but-what-will-it-mean-for-drug-developers/paul\_600x600\_0/2019-10-25T20:52:10+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Paul\_600x600\_0.jpghttps://timmermanreport.com/2019/10/the-story-of-henri-termeer-john-hawkins-and-jim-geraghty-on-the-long-run/john-hawkins-final/2019-10-29T20:54:15+00:00https://timmermanreport.com/wp-content/uploads/2019/10/John-Hawkins-final.jpghttps://timmermanreport.com/2019/10/the-story-of-henri-termeer-john-hawkins-and-jim-geraghty-on-the-long-run/jimgeraghty/2019-10-29T20:56:14+00:00https://timmermanreport.com/wp-content/uploads/2019/10/jimgeraghty.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000592/2019-10-30T16:04:13+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000592.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000593/2019-10-30T16:04:16+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000593.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000575/2019-10-30T16:04:18+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000575.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000578/2019-10-30T16:04:20+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000578.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000581/2019-10-30T16:04:22+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000581.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000588/2019-10-30T16:04:23+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000588.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000552/2019-10-30T16:04:25+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000552.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000558/2019-10-30T16:04:27+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000558.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000559/2019-10-30T16:04:30+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000559.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000561/2019-10-30T16:04:31+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000561.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000534/2019-10-30T16:04:33+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000534.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000537/2019-10-30T16:04:35+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000537.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000539/2019-10-30T16:04:36+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000539.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000531/2019-10-30T16:04:37+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000531.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000510/2019-10-30T16:04:39+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000510.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000526/2019-10-30T16:04:40+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000526.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000528/2019-10-30T16:04:42+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000528.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000489/2019-10-30T16:04:43+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000489.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000497/2019-10-30T16:04:45+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000497.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000499/2019-10-30T16:04:46+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000499.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000479/2019-10-30T16:04:48+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000479.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000482/2019-10-30T16:04:49+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000482.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000485/2019-10-30T16:04:50+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000485.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000488/2019-10-30T16:04:52+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000488.jpghttps://timmermanreport.com/everest-base-camp-2021/namchehelipad/2019-10-30T16:04:54+00:00https://timmermanreport.com/wp-content/uploads/2019/10/namchehelipad.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000441/2019-10-30T16:04:56+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000441.jpghttps://timmermanreport.com/everest-base-camp-2021/p1000444/2019-10-30T16:04:59+00:00https://timmermanreport.com/wp-content/uploads/2019/10/P1000444.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-86-of-194/2019-10-30T16:05:00+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-86-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-94-of-194/2019-10-30T16:05:04+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-94-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-25-of-194/2019-10-30T16:05:06+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-25-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-67-of-194/2019-10-30T16:05:08+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-67-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-23-of-194/2019-10-30T16:05:09+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-23-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-20-of-194/2019-10-30T16:05:11+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-20-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-12-of-194/2019-10-30T16:05:12+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-12-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-13-of-194/2019-10-30T16:05:14+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-13-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-19-of-194/2019-10-30T16:05:17+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-19-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-9-of-194/2019-10-30T16:05:18+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-9-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-6-of-194/2019-10-30T16:05:20+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-6-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-8-of-194/2019-10-30T16:05:22+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-8-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-3-of-194/2019-10-30T16:05:24+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-3-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-5-of-194/2019-10-30T16:05:26+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-5-of-194.jpghttps://timmermanreport.com/everest-base-camp-2021/everest\_2018-2-of-194/2019-10-30T16:05:29+00:00https://timmermanreport.com/wp-content/uploads/2019/10/Everest\_2018-2-of-194.jpghttps://timmermanreport.com/2019/10/amgens-bet-on-beigene-david-hungs-megaround-zolgensma-speed-bump/ali/2019-11-01T03:22:47+00:00https://timmermanreport.com/wp-content/uploads/2019/10/ali.pnghttps://timmermanreport.com/2019/10/amgens-bet-on-beigene-david-hungs-megaround-zolgensma-speed-bump/bradkey/2019-11-01T03:23:16+00:00https://timmermanreport.com/wp-content/uploads/2019/10/bradkey.pnghttps://timmermanreport.com/2019/10/amgens-bet-on-beigene-david-hungs-megaround-zolgensma-speed-bump/mrtx/2019-11-01T03:24:30+00:00https://timmermanreport.com/wp-content/uploads/2019/10/mrtx.pnghttps://timmermanreport.com/2019/11/newer-gene-editing-candidates-target-blood-disorders-as-gene-therapies-start-to-hit-the-market/samkulkarni/2019-11-01T19:52:01+00:00https://timmermanreport.com/wp-content/uploads/2019/11/samkulkarni.jpghttps://timmermanreport.com/2019/11/newer-gene-editing-candidates-target-blood-disorders-as-gene-therapies-start-to-hit-the-market/jason-fontenot/2019-11-01T19:55:08+00:00https://timmermanreport.com/wp-content/uploads/2019/11/jason-fontenot.jpghttps://timmermanreport.com/about-luke-timmerman/breakthroughprize2020/2019-11-05T22:46:52+00:00https://timmermanreport.com/wp-content/uploads/2019/11/breakthroughprize2020.jpghttps://timmermanreport.com/team/david-shaywitz/davidshaywitz/2019-11-05T22:54:40+00:00https://timmermanreport.com/wp-content/uploads/2019/11/davidshaywitz.jpghttps://timmermanreport.com/2019/11/tech-vcs-and-biotech-vcs-talking-past-each-other-on-ai-drug-discovery/davidweitz/2019-11-05T23:30:51+00:00https://timmermanreport.com/wp-content/uploads/2019/11/davidweitz.jpghttps://timmermanreport.com/2019/11/takedas-busy-week-halozymes-stumble-and-new-fda-commish-on-deck/regn/2019-11-08T01:28:31+00:00https://timmermanreport.com/wp-content/uploads/2019/11/regn.pnghttps://timmermanreport.com/2019/11/takedas-busy-week-halozymes-stumble-and-new-fda-commish-on-deck/andyp/2019-11-08T01:29:09+00:00https://timmermanreport.com/wp-content/uploads/2019/11/andyp.pnghttps://timmermanreport.com/2019/11/takedas-busy-week-halozymes-stumble-and-new-fda-commish-on-deck/bobc/2019-11-08T01:29:38+00:00https://timmermanreport.com/wp-content/uploads/2019/11/bobc.pnghttps://timmermanreport.com/2019/11/disruption-fast-and-slow/astounding-banner-2-1/2019-11-08T19:13:41+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner-2-1.jpghttps://timmermanreport.com/2019/11/disruption-fast-and-slow/bkocher\_detail/2019-11-09T17:59:36+00:00https://timmermanreport.com/wp-content/uploads/2019/11/bkocher\_detail.jpghttps://timmermanreport.com/about-luke-timmerman/2020-breakthrough-prize-red-carpet/2019-11-10T19:02:53+00:00https://timmermanreport.com/wp-content/uploads/2019/11/DSC\_4529\_2019110363532582.jpghttps://timmermanreport.com/about-luke-timmerman/2020-breakthrough-prize-red-carpet-2/2019-11-10T19:03:52+00:00https://timmermanreport.com/wp-content/uploads/2019/11/DSC\_4528\_2019110363532582.jpghttps://timmermanreport.com/about-luke-timmerman/2020-breakthrough-prize-red-carpet-3/2019-11-10T19:05:09+00:00https://timmermanreport.com/wp-content/uploads/2019/11/DSC\_4529\_2019110363532582-1.jpghttps://timmermanreport.com/about-luke-timmerman/2020-breakthrough-prize-red-carpet-4/2019-11-10T19:07:17+00:00https://timmermanreport.com/wp-content/uploads/2019/11/BreakthroughGalaLuke.jpghttps://timmermanreport.com/about-luke-timmerman/breakthroughprizegalasmall/2019-11-10T19:09:17+00:00https://timmermanreport.com/wp-content/uploads/2019/11/breakthroughprizegalasmall.jpghttps://timmermanreport.com/2019/11/disruption-fast-and-slow/astounding-banner/2019-11-11T00:49:07+00:00https://timmermanreport.com/wp-content/uploads/2019/11/astounding-banner.jpghttps://timmermanreport.com/about-luke-timmerman/\_e8a1652/2019-11-11T01:21:47+00:00https://timmermanreport.com/wp-content/uploads/2019/11/E8A1652.jpghttps://timmermanreport.com/about-luke-timmerman/breakthroughwithweinberg/2019-11-11T01:26:24+00:00https://timmermanreport.com/wp-content/uploads/2019/11/breakthroughwithweinberg.jpghttps://timmermanreport.com/about-luke-timmerman/\_e8a1664/2019-11-11T01:30:20+00:00https://timmermanreport.com/wp-content/uploads/2019/11/E8A1664.jpghttps://timmermanreport.com/2019/11/scientist-entrepreneur-rock-collector-tim-springer-on-the-long-run/springer\_img\_0956a6x6/2019-11-13T00:04:30+00:00https://timmermanreport.com/wp-content/uploads/2019/11/Springer\_IMG\_0956a6x6.jpghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/tevastatement/2019-11-15T00:46:52+00:00https://timmermanreport.com/wp-content/uploads/2019/11/tevastatement.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/andyamarin/2019-11-15T00:47:24+00:00https://timmermanreport.com/wp-content/uploads/2019/11/andyamarin.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/andyamarin2/2019-11-15T00:47:25+00:00https://timmermanreport.com/wp-content/uploads/2019/11/andyamarin2.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/davidnektar/2019-11-15T00:48:03+00:00https://timmermanreport.com/wp-content/uploads/2019/11/davidnektar.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/daphnetweet/2019-11-15T00:48:37+00:00https://timmermanreport.com/wp-content/uploads/2019/11/daphnetweet.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/solidstock/2019-11-15T00:55:15+00:00https://timmermanreport.com/wp-content/uploads/2019/11/solidstock.pnghttps://timmermanreport.com/2019/11/mercks-ebola-vaccine-triumph-weills-106m-neurohub-tevas-reversal/sldbchart/2019-11-15T00:57:21+00:00https://timmermanreport.com/wp-content/uploads/2019/11/sldbchart.jpghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/claythorp/2019-11-17T20:00:35+00:00https://timmermanreport.com/wp-content/uploads/2019/11/claythorp.jpghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay1/2019-11-17T20:05:31+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay1.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay2/2019-11-17T20:06:35+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay2.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay3/2019-11-17T20:07:33+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay3.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay4/2019-11-17T20:08:03+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay4.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay5/2019-11-17T20:09:09+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay5.pnghttps://timmermanreport.com/2019/11/feeding-frenzy-the-ecosystem-is-growing-stronger/clay6/2019-11-17T20:09:51+00:00https://timmermanreport.com/wp-content/uploads/2019/11/clay6.pnghttps://timmermanreport.com/2019/11/running-the-kras-marathon-with-wellspring-and-visualizing-a-second-half-kick/kevanshokat/2019-11-18T20:24:06+00:00https://timmermanreport.com/wp-content/uploads/2019/11/kevanshokat.jpghttps://timmermanreport.com/2019/11/ai-can-help-with-repeatable-processes-but-dont-expect-thunderbolts-for-drug-discovery/manzi\_hires-white-background/2019-11-22T01:17:32+00:00https://timmermanreport.com/wp-content/uploads/2019/11/manzi\_hires-white-background.jpghttps://timmermanreport.com/2019/11/ai-can-help-with-repeatable-processes-but-dont-expect-thunderbolts-for-drug-discovery/david-shaywitz-at-srk-headshot-day/2019-11-28T02:32:26+00:00https://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Headshot\_19P6473\_SQ1\_Web.jpghttps://timmermanreport.com/2019/11/ai-can-help-with-repeatable-processes-but-dont-expect-thunderbolts-for-drug-discovery/david-shaywitz-at-srk-headshot-day-2/2019-11-28T18:09:19+00:00https://timmermanreport.com/wp-content/uploads/2019/11/David\_Shaywitz\_Notie-e1578510915488.jpghttps://timmermanreport.com/2019/04/ifm-nails-second-big-deal-selling-nlrp3-inhibitors-to-novartis-for-310m-upfront/garyglick/2019-12-01T19:07:57+00:00https://timmermanreport.com/wp-content/uploads/2019/03/garyglick.jpghttps://timmermanreport.com/2019/12/ifm-staying-small-raises-merely-55-5m-promotes-former-novartis-exec-to-ceo/martinsiedel/2019-12-01T19:10:33+00:00https://timmermanreport.com/wp-content/uploads/2019/12/martinsiedel.jpghttps://timmermanreport.com/the-long-run/precisionnanosystems/2019-12-02T20:01:15+00:00https://timmermanreport.com/wp-content/uploads/2019/12/precisionnanosystems.jpghttps://timmermanreport.com/2019/12/biotechs-build-on-single-cell-analytics-for-drug-rd-as-human-cell-atlas-is-mapped/ben-hindson-1/2019-12-05T19:16:04+00:00https://timmermanreport.com/wp-content/uploads/2019/12/ben-hindson-1.jpghttps://timmermanreport.com/2020/01/hbv-curative-treatments-gear-up-in-the-clinic-as-hcv-combos-help-to-guide-the-way/james-merson/2019-12-23T23:44:49+00:00https://timmermanreport.com/wp-content/uploads/2019/12/james-merson.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/clarion\_navy-gray-logotag\_stacked\_hi-res-transparent/2019-12-23T23:45:21+00:00https://timmermanreport.com/wp-content/uploads/2019/06/clarion\_navy-gray-logotag\_stacked\_hi-res-transparent.pnghttps://timmermanreport.com/2020/01/hbv-curative-treatments-gear-up-in-the-clinic-as-hcv-combos-help-to-guide-the-way/jamesmerson/2019-12-23T23:46:53+00:00https://timmermanreport.com/wp-content/uploads/2019/12/jamesmerson.jpghttps://timmermanreport.com/2020/01/hbv-curative-treatments-gear-up-in-the-clinic-as-hcv-combos-help-to-guide-the-way/philpang/2019-12-23T23:48:46+00:00https://timmermanreport.com/wp-content/uploads/2019/12/PhilPang.jpghttps://timmermanreport.com/2020/01/hbv-curative-treatments-gear-up-in-the-clinic-as-hcv-combos-help-to-guide-the-way/zhihong/2019-12-23T23:50:30+00:00https://timmermanreport.com/wp-content/uploads/2019/12/zhihong.jpghttps://timmermanreport.com/2019/12/losing-80-lbs-was-hard-keeping-it-off-was-so-much-harder/weightloss/2019-12-26T23:34:10+00:00https://timmermanreport.com/wp-content/uploads/2019/12/weightloss.jpghttps://timmermanreport.com/2019/12/losing-80-lbs-was-hard-keeping-it-off-was-so-much-harder/ketones/2019-12-27T15:24:46+00:00https://timmermanreport.com/wp-content/uploads/2019/12/ketones.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/juliakilisummit/2020-01-06T01:27:30+00:00https://timmermanreport.com/wp-content/uploads/2020/01/juliakilisummit.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/\_dsc2204-2/2020-01-06T01:29:11+00:00https://timmermanreport.com/wp-content/uploads/2020/01/DSC2204.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/\_dsc2182/2020-01-06T01:32:44+00:00https://timmermanreport.com/wp-content/uploads/2020/01/DSC2182.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/selfcare/2020-01-06T01:35:52+00:00https://timmermanreport.com/wp-content/uploads/2020/01/selfcare.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/juliakili1/2020-01-06T01:39:42+00:00https://timmermanreport.com/wp-content/uploads/2020/01/juliakili1.jpghttps://timmermanreport.com/2019/12/biotechs-build-on-single-cell-analytics-for-drug-rd-as-human-cell-atlas-is-mapped/bio\_liangschweizer/2020-01-08T16:26:55+00:00https://timmermanreport.com/wp-content/uploads/2019/12/bio\_liangschweizer.jpghttps://timmermanreport.com/2020/01/sanofis-new-ceo-captures-pharmas-grounded-view-of-health-tech/paulhudson/2020-01-08T20:14:26+00:00https://timmermanreport.com/wp-content/uploads/2020/01/paulhudson-e1578514452262.jpghttps://timmermanreport.com/2020/01/mrna-vaccines-impress-blueprint-wins-first-fda-ok-calif-gov-stares-down-biotech-on-the-eve-of-jpm20/gopr0032/2020-01-10T03:34:12+00:00https://timmermanreport.com/wp-content/uploads/2020/01/GOPR0032-scaled.jpghttps://timmermanreport.com/2020/01/mrna-vaccines-impress-blueprint-wins-first-fda-ok-calif-gov-stares-down-biotech-on-the-eve-of-jpm20/gopr0038/2020-01-10T03:35:36+00:00https://timmermanreport.com/wp-content/uploads/2020/01/GOPR0038-scaled.jpghttps://timmermanreport.com/2020/01/mrna-vaccines-impress-blueprint-wins-first-fda-ok-calif-gov-stares-down-biotech-on-the-eve-of-jpm20/gopr0084/2020-01-10T03:37:58+00:00https://timmermanreport.com/wp-content/uploads/2020/01/GOPR0084-scaled.jpghttps://timmermanreport.com/2020/01/eqrx-taps-zeitgeist-raises-200m-for-innovative-drugs-at-aggressive-low-prices/melanie-nallicheri-eqrx/2020-01-13T01:19:45+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Melanie-Nallicheri-EQRX-scaled.jpghttps://timmermanreport.com/everest-base-camp-2021/foundationmedicinelogo/2020-01-13T16:52:55+00:00https://timmermanreport.com/wp-content/uploads/2020/01/foundationmedicinelogo.jpghttps://timmermanreport.com/2020/01/a-new-cholesterol-lowering-drug-at-a-low-price-tim-mayleben-on-the-long-run/tim-mayleben/2020-01-14T02:09:56+00:00https://timmermanreport.com/wp-content/uploads/2020/01/Tim-Mayleben.jpghttps://timmermanreport.com/2020/01/lillys-half-measure-on-insulin-illuminas-up-market-play-the-little-deals-from-sf/schenkeintweet/2020-01-17T00:31:55+00:00https://timmermanreport.com/wp-content/uploads/2020/01/schenkeintweet.jpghttps://timmermanreport.com/team/david-shaywitz/david-shaywitz-at-srk-headshot-day-3/2020-01-17T03:48:37+00:00https://timmermanreport.com/wp-content/uploads/2020/01/David\_Shaywitz\_Notie-e1578579576519.jpghttps://timmermanreport.com/2020/01/much-ado-about-coronavirus-and-23andme-hits-the-wall/coronavirus/2020-01-24T01:43:39+00:00https://timmermanreport.com/wp-content/uploads/2020/01/coronavirus.pnghttps://timmermanreport.com/2015/08/molecular-information-companies-one-way-or-another-find-value-in-genomics/michael-pellini/2020-01-24T03:30:21+00:00https://timmermanreport.com/wp-content/uploads/2015/07/michael-pellini.jpghttps://timmermanreport.com/2020/01/challenging-core-assumptions-tech-backlash-paves-the-way-for-more-thoughtful-healthtech/taleb/2020-01-27T01:04:02+00:00https://timmermanreport.com/wp-content/uploads/2020/01/taleb.pnghttps://timmermanreport.com/2020/02/first-buy-then-invest-novartis-gilead-join-35m-bet-on-vinetis-software/amyduross/2020-02-04T23:30:39+00:00https://timmermanreport.com/wp-content/uploads/2020/02/amyduross.pnghttps://timmermanreport.com/2020/02/putting-the-pieces-together-for-programmable-cell-therapy-jane-grogan-on-the-long-run/janegrogan/2020-02-11T22:47:44+00:00https://timmermanreport.com/wp-content/uploads/2020/02/janegrogan.jpghttps://timmermanreport.com/2020/02/lilly-genentech-alzheimers-drugs-fail-revolutions-big-ipo-an-obesity-drug-disappears/crltweet/2020-02-14T00:17:28+00:00https://timmermanreport.com/wp-content/uploads/2020/02/crltweet.pnghttps://timmermanreport.com/team/jeffrey-berkowitz/jeffberkowitz-headshot/2020-02-16T16:13:19+00:00https://timmermanreport.com/wp-content/uploads/2020/02/JeffBerkowitz-Headshot.jpghttps://timmermanreport.com/2020/02/techlash-offers-health-and-tech-opportunity-to-reset-relationship-rediscover-mutual-respect/davidandamy/2020-02-18T02:04:28+00:00https://timmermanreport.com/wp-content/uploads/2020/02/davidandamy.pnghttps://timmermanreport.com/2020/02/dissecting-biotechs-living-and-walking-dead/asherdead1/2020-02-22T19:34:16+00:00https://timmermanreport.com/wp-content/uploads/2020/02/asherdead1.pnghttps://timmermanreport.com/2020/02/dissecting-biotechs-living-and-walking-dead/paul-godfrey/2020-02-22T19:44:16+00:00https://timmermanreport.com/wp-content/uploads/2020/02/paul-godfrey.jpghttps://timmermanreport.com/2020/02/dissecting-biotechs-living-and-walking-dead/tania-bubela-img-331395875/2020-02-22T19:47:32+00:00https://timmermanreport.com/wp-content/uploads/2020/02/tania-bubela.img\_.-331395875.pnghttps://timmermanreport.com/2017/01/takeda-leans-little-guy-ovid-therapeutics-go-distance-epilepsy-drug/jeremy-levin/2020-02-25T02:04:10+00:00https://timmermanreport.com/wp-content/uploads/2017/01/jeremy-levin.pnghttps://timmermanreport.com/2020/02/gilead-moderna-rise-to-the-occasion-esperion-goes-back-to-back-sangamos-big-neurology-deal/andycorona/2020-02-27T23:46:25+00:00https://timmermanreport.com/wp-content/uploads/2020/02/andycorona.pnghttps://timmermanreport.com/2020/03/covid-19-spreads-in-seattle-gileads-4-9b-cancer-bet-thermo-grabs-qiagen/nurse1/2020-03-06T01:14:36+00:00https://timmermanreport.com/wp-content/uploads/2020/03/nurse1.pnghttps://timmermanreport.com/2020/03/covid-19-spreads-in-seattle-gileads-4-9b-cancer-bet-thermo-grabs-qiagen/nurse2/2020-03-06T01:15:06+00:00https://timmermanreport.com/wp-content/uploads/2020/03/nurse2.pnghttps://timmermanreport.com/2020/03/covid-19-spreads-in-seattle-gileads-4-9b-cancer-bet-thermo-grabs-qiagen/bloom/2020-03-06T01:15:56+00:00https://timmermanreport.com/wp-content/uploads/2020/03/bloom.pnghttps://timmermanreport.com/2020/03/covid-19-spreads-in-seattle-gileads-4-9b-cancer-bet-thermo-grabs-qiagen/levitt/2020-03-06T01:16:24+00:00https://timmermanreport.com/wp-content/uploads/2020/03/levitt.pnghttps://timmermanreport.com/2020/03/living-life-fully-with-stage-4-lung-cancer-isabella-de-le-houssaye-on-the-long-run/isabella/2020-03-09T21:36:31+00:00https://timmermanreport.com/wp-content/uploads/2020/03/isabella-scaled.jpghttps://timmermanreport.com/2020/03/lessons-from-italy-how-the-us-can-respond-to-the-urgent-coronavirus-threat/caseschina/2020-03-10T20:44:14+00:00https://timmermanreport.com/wp-content/uploads/2020/03/caseschina.jpghttps://timmermanreport.com/2020/03/lessons-from-italy-how-the-us-can-respond-to-the-urgent-coronavirus-threat/curve/2020-03-10T20:52:41+00:00https://timmermanreport.com/wp-content/uploads/2020/03/curve.jpghttps://timmermanreport.com/2020/03/covid-19-collective-problem-solving-time/uw1/2020-03-12T23:21:05+00:00https://timmermanreport.com/wp-content/uploads/2020/03/uw1.pnghttps://timmermanreport.com/2020/03/covid-19-collective-problem-solving-time/notflu/2020-03-12T23:21:42+00:00https://timmermanreport.com/wp-content/uploads/2020/03/notflu.pnghttps://timmermanreport.com/2020/03/covid-19-collective-problem-solving-time/flattencurve/2020-03-12T23:22:19+00:00https://timmermanreport.com/wp-content/uploads/2020/03/flattencurve.pnghttps://timmermanreport.com/2020/03/covid-19-collective-problem-solving-time/andyitaly/2020-03-12T23:22:43+00:00https://timmermanreport.com/wp-content/uploads/2020/03/andyitaly.pnghttps://timmermanreport.com/2020/03/solid-tumors-have-eluded-car-t-but-novel-targets-and-techniques-are-at-hand/robertnew/2020-03-17T22:08:30+00:00https://timmermanreport.com/wp-content/uploads/2020/03/RobertNew.jpghttps://timmermanreport.com/2020/03/solid-tumors-have-eluded-car-t-but-novel-targets-and-techniques-are-at-hand/xichen/2020-03-17T22:11:54+00:00https://timmermanreport.com/wp-content/uploads/2020/03/xichen.jpghttps://timmermanreport.com/2020/03/8-days-later-italy-vs-us/ftimage/2020-03-18T15:30:03+00:00https://timmermanreport.com/wp-content/uploads/2020/03/FTimage.jpghttps://timmermanreport.com/2020/03/8-days-later-italy-vs-us/otello3/2020-03-18T15:31:08+00:00https://timmermanreport.com/wp-content/uploads/2020/03/otello3.jpghttps://timmermanreport.com/2020/03/8-days-later-italy-vs-us/otello4/2020-03-18T15:34:47+00:00https://timmermanreport.com/wp-content/uploads/2020/03/otello4.jpghttps://timmermanreport.com/2017/06/watershed-moments-celgene-bristol-myers-squibb-became-deal-winners/jeremy-levin-2/2020-03-19T15:17:11+00:00https://timmermanreport.com/wp-content/uploads/2017/06/jeremy-levin.pnghttps://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/leoracovidtimeline/2020-03-19T21:24:31+00:00https://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/leora5/2020-03-19T21:26:39+00:00https://timmermanreport.com/wp-content/uploads/2020/03/leora5.jpghttps://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/leora6/2020-03-19T21:27:30+00:00https://timmermanreport.com/wp-content/uploads/2020/03/leora6.jpghttps://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/leorah1n1timeline/2020-03-19T21:46:01+00:00https://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/see-enlarged-covid-timeline/2020-03-19T21:50:19+00:00https://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/see-enlarged-h1n1-response-timeline/2020-03-19T21:50:43+00:00https://timmermanreport.com/2020/03/covid-19-response-the-roadmap-not-followed/see-enlarged-h1n1-timeline/2020-03-19T21:55:34+00:00https://timmermanreport.com/2020/03/stay-home-keep-your-physical-distance-engage-with-partners-who-can-help/robperez3/2020-03-20T13:04:57+00:00https://timmermanreport.com/wp-content/uploads/2020/03/robperez3.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/praveen-crop-medium-2/2020-03-20T20:49:09+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Praveen-crop-medium.jpghttps://timmermanreport.com/2020/03/in-times-of-coronavirus-pandemic-it-takes-a-global-village/mark-tebbe/2020-03-20T21:02:17+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Mark-Tebbe.jpghttps://timmermanreport.com/2020/03/in-times-of-coronavirus-pandemic-it-takes-a-global-village/shaktinarayan/2020-03-20T21:03:06+00:00https://timmermanreport.com/wp-content/uploads/2020/03/shaktinarayan.pnghttps://timmermanreport.com/2020/03/staying-mentally-healthy-to-weather-the-covid19-crisis/jefflieberman/2020-03-23T13:31:24+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jefflieberman.jpeghttps://timmermanreport.com/2020/03/staying-mentally-healthy-to-weather-the-covid19-crisis/lsmayer/2020-03-23T13:38:34+00:00https://timmermanreport.com/wp-content/uploads/2020/03/lsmayer.jpghttps://timmermanreport.com/2020/03/what-not-to-do-lessons-from-spains-cavalier-response-to-covid-19/covid19curvemar24/2020-03-24T16:23:07+00:00https://timmermanreport.com/wp-content/uploads/2020/03/covid19curveMar24.pnghttps://timmermanreport.com/2020/03/we-interrupt-this-nightmare-to-bring-you-a-few-giggles/lisa-suennen-headshot-mts/2020-03-26T13:55:18+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Lisa-Suennen-headshot-mts.jpeghttps://timmermanreport.com/2020/03/pharmacy-as-the-biomarker-of-biopharmas-strategic-change-after-coronavirus/jeffberkowitz-headshot-2/2020-03-26T22:00:21+00:00https://timmermanreport.com/wp-content/uploads/2020/03/JeffBerkowitz-Headshot-e1585260062394.jpghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/oecd1/2020-03-26T23:48:11+00:00https://timmermanreport.com/wp-content/uploads/2020/03/oecd1.pnghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/oecd2/2020-03-26T23:48:45+00:00https://timmermanreport.com/wp-content/uploads/2020/03/oecd2.pnghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/oecd3/2020-03-26T23:49:19+00:00https://timmermanreport.com/wp-content/uploads/2020/03/oecd3.pnghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/tracy-geneva-and-luke-4/2020-03-27T00:25:11+00:00https://timmermanreport.com/wp-content/uploads/2018/12/lukeSquare2.jpghttps://timmermanreport.com/2020/03/adjusting-to-telemedicine-a-first-hand-account/jonathanshaywitz/2020-03-27T00:49:40+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jonathanshaywitz-scaled.jpghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/craigs/2020-03-27T08:22:16+00:00https://timmermanreport.com/wp-content/uploads/2020/03/craigs.jpghttps://timmermanreport.com/2020/03/dos-and-donts-of-staying-connected-in-the-time-of-physical-distancing/rainbow/2020-03-27T13:23:48+00:00https://timmermanreport.com/wp-content/uploads/2020/03/rainbow.jpghttps://timmermanreport.com/2020/03/the-coronavirus-tsunami-lyells-492m-megaround-some-deals-you-missed/healthcareworkforce/2020-03-27T13:58:50+00:00https://timmermanreport.com/wp-content/uploads/2020/03/healthcareworkforce.jpghttps://timmermanreport.com/2020/03/singapore-braving-the-second-wave-of-covid19/straits/2020-03-27T16:57:25+00:00https://timmermanreport.com/wp-content/uploads/2020/03/straits.tifhttps://timmermanreport.com/2020/03/singapore-braving-the-second-wave-of-covid19/straittimes/2020-03-27T16:58:18+00:00https://timmermanreport.com/wp-content/uploads/2020/03/straittimes.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/kristin-anderson2/2020-03-27T22:54:12+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kristin-Anderson2.pnghttps://timmermanreport.com/2020/03/look-for-the-helpers-in-the-seattle-scientific-community-and-the-wider-world/helen-chu/2020-03-27T23:18:10+00:00https://timmermanreport.com/wp-content/uploads/2020/03/helen-chu.jpghttps://timmermanreport.com/2020/03/look-for-the-helpers-in-the-seattle-scientific-community-and-the-wider-world/uwvirology/2020-03-27T23:19:46+00:00https://timmermanreport.com/wp-content/uploads/2020/03/uwvirology.jpghttps://timmermanreport.com/2020/03/look-for-the-helpers-in-the-seattle-scientific-community-and-the-wider-world/roychoudhury\_pavitraresize/2020-03-27T23:43:38+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Roychoudhury\_Pavitraresize.jpghttps://timmermanreport.com/2020/03/look-for-the-helpers-in-the-seattle-scientific-community-and-the-wider-world/keith\_jerome/2020-03-27T23:45:41+00:00https://timmermanreport.com/wp-content/uploads/2020/03/Keith\_Jerome.jpghttps://timmermanreport.com/2020/03/knowledge-is-power-dont-give-up-on-diagnostic-tests-for-covid19/mikepellinis32/2020-03-29T00:30:55+00:00https://timmermanreport.com/wp-content/uploads/2020/03/mikepellinis32.pnghttps://timmermanreport.com/2020/03/knowledge-is-power-dont-give-up-on-diagnostic-tests-for-covid19/eabrahams3/2020-03-29T00:32:00+00:00https://timmermanreport.com/wp-content/uploads/2020/03/eabrahams3.jpghttps://timmermanreport.com/2020/01/false-heroes-pharmacy-benefit-managers-and-the-patients-they-prey-on/peterkolchinsky\_rectangle/2020-03-29T17:51:41+00:00https://timmermanreport.com/wp-content/uploads/2020/01/PeterKolchinsky\_RECTANGLE.jpghttps://timmermanreport.com/2019/09/a-nonprofit-that-carried-a-tb-drug-through-the-fda-bruce-carter-on-the-long-run/brucecarter/2020-03-29T22:52:41+00:00https://timmermanreport.com/wp-content/uploads/2019/09/BruceCarter.jpghttps://timmermanreport.com/2020/03/cancer-drugmakers-seek-to-broaden-use-of-tissue-agnostic-therapies/brianalexander\_portrait\_800x800\_1\_/2020-03-30T17:47:47+00:00https://timmermanreport.com/wp-content/uploads/2020/03/BrianAlexander\_portrait\_800x800\_1\_.jpghttps://timmermanreport.com/2020/03/learning-from-china-ramping-up-covid19-tests-to-meet-needs-around-the-world/kheim1/2020-03-30T23:56:20+00:00https://timmermanreport.com/wp-content/uploads/2020/03/kheim1.jpghttps://timmermanreport.com/2020/03/learning-from-china-ramping-up-covid19-tests-to-meet-needs-around-the-world/group-photo-leaving-train-station-wuhan/2020-03-31T00:03:37+00:00https://timmermanreport.com/wp-content/uploads/2020/03/group-photo-leaving-train-station-Wuhan.jpghttps://timmermanreport.com/2020/03/switzerland-what-went-right-and-how-to-better-prepare-for-the-second-wave/alexm/2020-03-31T17:14:51+00:00https://timmermanreport.com/wp-content/uploads/2020/03/alexm.jpghttps://timmermanreport.com/covid-19/covid-19-1330px/2020-03-31T21:37:03+00:00https://timmermanreport.com/wp-content/uploads/2020/03/covid-19-1330px.jpghttps://timmermanreport.com/covid-19/covidbanner/2020-03-31T21:37:20+00:00https://timmermanreport.com/wp-content/uploads/2020/03/covidbanner.jpghttps://timmermanreport.com/2020/03/the-strategy-of-stealth-mode-when-to-stay-hidden-when-to-de-cloak/avak/2020-04-01T00:16:43+00:00https://timmermanreport.com/wp-content/uploads/2020/03/avak.jpghttps://timmermanreport.com/2020/04/thinking-ahead-building-a-broad-arsenal-against-infectious-disease/treatmentdays/2020-04-01T13:37:47+00:00https://timmermanreport.com/wp-content/uploads/2020/04/treatmentdays.pnghttps://timmermanreport.com/2020/04/coronavirus-synthesis-arch-flagship-reload-merck-passes-2-phase-iiis/covid19dashapr2/2020-04-03T02:37:56+00:00https://timmermanreport.com/wp-content/uploads/2020/04/covid19dashapr2.pnghttps://timmermanreport.com/2020/04/loss-and-grief-in-the-time-of-covid-19/shear-hr/2020-04-06T20:02:16+00:00https://timmermanreport.com/wp-content/uploads/2020/04/shear-hr.jpghttps://timmermanreport.com/2020/04/where-the-puck-is-going-serologic-testing-for-sars-cov-2-immunity/mike-koeris-fave1\_small/2020-04-06T21:17:23+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Mike-Koeris-fave1\_small.jpeghttps://timmermanreport.com/2020/04/covid-19-models-what-makes-them-tick/ruthetzioni/2020-04-07T17:07:49+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ruthetzioni.jpghttps://timmermanreport.com/community-action/download-2/2020-04-07T19:14:41+00:00https://timmermanreport.com/wp-content/uploads/2020/04/download.pnghttps://timmermanreport.com/community-action/communitybanner-2/2020-04-07T19:47:03+00:00https://timmermanreport.com/wp-content/uploads/2020/04/communitybanner-%E2%80%93-2.jpghttps://timmermanreport.com/2020/04/rationale-for-testing-anticoagulants-against-covid19/eweiss1/2020-04-07T23:42:12+00:00https://timmermanreport.com/wp-content/uploads/2020/04/eweiss1.jpghttps://timmermanreport.com/2020/04/george-yancopoulos-that-rarest-of-species-a-physician-scientist-still-in-charge-of-a-pharma/giamatti/2020-04-08T01:32:54+00:00https://timmermanreport.com/wp-content/uploads/2020/04/giamatti-scaled.jpghttps://timmermanreport.com/2020/04/facing-the-consequences-of-a-misinformation-pandemic/fordtweet/2020-04-08T20:45:05+00:00https://timmermanreport.com/wp-content/uploads/2020/04/fordtweet.pnghttps://timmermanreport.com/2020/04/gsk-partners-with-vir-on-antibodies-pfizer-with-biontech-on-vaccines-the-testing-fiasco-continues/covidlyapr9/2020-04-10T00:03:22+00:00https://timmermanreport.com/wp-content/uploads/2020/04/covidlyapr9.pnghttps://timmermanreport.com/2020/04/gsk-partners-with-vir-on-antibodies-pfizer-with-biontech-on-vaccines-the-testing-fiasco-continues/megthemedia/2020-04-10T00:04:30+00:00https://timmermanreport.com/wp-content/uploads/2020/04/megthemedia.pnghttps://timmermanreport.com/2020/04/gsk-partners-with-vir-on-antibodies-pfizer-with-biontech-on-vaccines-the-testing-fiasco-continues/andybillmitchell/2020-04-10T00:07:29+00:00https://timmermanreport.com/wp-content/uploads/2020/04/andybillmitchell.pnghttps://timmermanreport.com/2020/04/a-typical-day-for-a-healthcare-investor-and-doctor-peering-into-the-fog/davidsable/2020-04-14T22:13:55+00:00https://timmermanreport.com/wp-content/uploads/2020/04/davidsable-e1586902485803.jpeghttps://timmermanreport.com/2017/04/time-human-knockout-project-advance-drug-discovery/plenge/2020-04-15T19:50:54+00:00https://timmermanreport.com/wp-content/uploads/2017/04/plenge.jpghttps://timmermanreport.com/2020/04/drug-repurposing-to-keep-covid19-patients-out-of-the-icu/rplenge/2020-04-15T19:52:55+00:00https://timmermanreport.com/wp-content/uploads/2020/04/rplenge.pnghttps://timmermanreport.com/2020/04/scaling-up-biotech-drugs-and-vaccines-against-covid19/jim-thomas-2/2020-04-16T18:54:17+00:00https://timmermanreport.com/wp-content/uploads/2020/04/JIm-Thomas.jpghttps://timmermanreport.com/the-long-run/rarecyte\_logo\_darkgray/2020-04-16T20:31:01+00:00https://timmermanreport.com/wp-content/uploads/2020/04/RareCyte\_Logo\_DarkGray.pnghttps://timmermanreport.com/2020/04/serology-testing-keep-an-eye-out-for-quick-and-dirty-tests/viralload/2020-04-16T22:07:13+00:00https://timmermanreport.com/wp-content/uploads/2020/04/viralload.jpghttps://timmermanreport.com/2017/10/vir-biotechnology-shock-awe-startup-bets-infectious-disease-500m/georgescangos/2020-04-17T16:04:36+00:00https://timmermanreport.com/wp-content/uploads/2017/10/GeorgeScangos.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/\_dsc2204/2020-04-17T23:22:47+00:00https://timmermanreport.com/wp-content/uploads/2019/08/DSC2204.jpghttps://timmermanreport.com/2020/04/cultivating-a-tolerance-for-adversity-in-our-teams-and-our-communities/j22/2020-04-17T23:39:20+00:00https://timmermanreport.com/wp-content/uploads/2020/04/j22-scaled.jpghttps://timmermanreport.com/2020/04/cultivating-a-tolerance-for-adversity-in-our-teams-and-our-communities/ericmurphy/2020-04-17T23:53:40+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ericmurphy.pnghttps://timmermanreport.com/2019/09/hot-job-market-creates-challenges-for-companies-opens-doors-for-workers/adamthomas/2020-04-23T00:11:56+00:00https://timmermanreport.com/wp-content/uploads/2019/08/adamthomas.jpghttps://timmermanreport.com/2020/04/massachusetts-biotechs-consider-how-to-return-safely-and-create-a-new-normal/kelley\_boucher/2020-04-23T00:20:36+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Kelley\_Boucher.pnghttps://timmermanreport.com/2020/04/massachusetts-biotechs-consider-how-to-return-safely-and-create-a-new-normal/andy\_dawson\_headshot/2020-04-23T00:22:20+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Andy\_Dawson\_headshot.jpghttps://timmermanreport.com/2020/04/build-back-better/buildbetter/2020-04-23T12:37:06+00:00https://timmermanreport.com/wp-content/uploads/2020/04/buildbetter.pnghttps://timmermanreport.com/2020/04/a-sad-week-of-reckless-leadership/nejmfarce/2020-04-24T17:11:24+00:00https://timmermanreport.com/wp-content/uploads/2020/04/nejmfarce.pnghttps://timmermanreport.com/2020/04/a-sad-week-of-reckless-leadership/someexperts/2020-04-24T17:12:24+00:00https://timmermanreport.com/wp-content/uploads/2020/04/someexperts.pnghttps://timmermanreport.com/2020/04/a-sad-week-of-reckless-leadership/drwoodcock/2020-04-24T17:14:57+00:00https://timmermanreport.com/wp-content/uploads/2020/04/drwoodcock.pnghttps://timmermanreport.com/2020/04/a-sad-week-of-reckless-leadership/jeff-duchin-bio-page/2020-04-24T17:21:06+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Jeff-Duchin-bio-page.pnghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/kuwanaheadshot\_cropped/2020-04-24T19:23:26+00:00https://timmermanreport.com/wp-content/uploads/2020/04/KuwanaHeadshot\_cropped.jpghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/fobpoke\_kpurgentcare\_19april2020/2020-04-24T19:37:27+00:00https://timmermanreport.com/wp-content/uploads/2020/04/FOBPoke\_KPURgentCare\_19April2020-scaled.jpghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/midnight-cookie\_hbv-rn3/2020-04-24T19:37:34+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Midnight-Cookie\_HBV-RN3.jpghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/midnight-cookie\_hbv-staff/2020-04-24T19:37:38+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Midnight-Cookie\_HBV-Staff-scaled.jpghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/samirs\_collage-2020-03-28-00-36-copy/2020-04-24T19:37:44+00:00https://timmermanreport.com/wp-content/uploads/2020/04/SAMIRS\_COLLAGE-2020-03-28-00.36-copy.pnghttps://timmermanreport.com/2020/04/how-a-simple-gesture-morphed-into-a-full-time-effort-to-feed-the-frontline/uwmc-starbucks\_toppot\_27mar2020/2020-04-24T19:37:47+00:00https://timmermanreport.com/wp-content/uploads/2020/04/UWMC-Starbucks\_TopPot\_27Mar2020.jpghttps://timmermanreport.com/2020/04/real-time-tracking-of-viral-outbreaks-emma-hodcroft-on-the-long-run/rarecyte\_logo\_darkgray-2/2020-04-30T14:53:21+00:00https://timmermanreport.com/wp-content/uploads/2020/04/RareCyte\_Logo\_DarkGray-1.pnghttps://timmermanreport.com/2020/04/real-time-tracking-of-viral-outbreaks-emma-hodcroft-on-the-long-run/bilder-oliver-hochstrasser-www-oliverhochstrasser-ch/2020-04-30T14:55:11+00:00https://timmermanreport.com/wp-content/uploads/2020/04/Emma-Hodcroft6363\_2x3-scaled.jpghttps://timmermanreport.com/2020/05/a-time-for-empathy/carolyn/2020-05-01T18:37:53+00:00https://timmermanreport.com/wp-content/uploads/2020/05/carolyn.pnghttps://timmermanreport.com/2020/05/a-time-for-empathy/schenkein-2/2020-05-01T18:38:19+00:00https://timmermanreport.com/wp-content/uploads/2020/05/schenkein.pnghttps://timmermanreport.com/2020/05/if-were-smart-covid19-will-strengthen-our-defense-against-drug-resistant-bugs/atluri-eras-application-photo-002/2020-05-03T00:48:19+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Atluri-ERAS-Application-photo-002.jpghttps://timmermanreport.com/2020/05/if-were-smart-covid19-will-strengthen-our-defense-against-drug-resistant-bugs/pottinger\_paul/2020-05-03T00:51:21+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Pottinger\_Paul-scaled.jpghttps://timmermanreport.com/2020/05/if-were-smart-covid19-will-strengthen-our-defense-against-drug-resistant-bugs/vidya/2020-05-03T01:37:58+00:00https://timmermanreport.com/wp-content/uploads/2020/05/vidya-scaled.jpghttps://timmermanreport.com/2020/05/the-spirit-of-giving-is-more-powerful-than-ever/kellypraveen/2020-05-04T21:32:12+00:00https://timmermanreport.com/wp-content/uploads/2020/05/kellypraveen.jpghttps://timmermanreport.com/2020/05/the-spirit-of-giving-is-more-powerful-than-ever/luke-and-kelly/2020-05-04T21:40:05+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Luke-and-Kelly-scaled.jpghttps://timmermanreport.com/2020/05/beyond-car-t-new-engineered-immune-cell-types-head-to-the-clinic/klichinsky/2020-05-04T22:40:28+00:00https://timmermanreport.com/wp-content/uploads/2020/05/klichinsky.jpghttps://timmermanreport.com/2020/05/beyond-car-t-new-engineered-immune-cell-types-head-to-the-clinic/hastings/2020-05-04T22:41:12+00:00https://timmermanreport.com/wp-content/uploads/2020/05/hastings.jpghttps://timmermanreport.com/2020/05/extending-an-immune-sequencing-platform-against-the-common-foe/crobins\_301\_2019-171x171/2020-05-06T22:30:38+00:00https://timmermanreport.com/wp-content/uploads/2020/05/crobins\_301\_2019-171x171-1.pnghttps://timmermanreport.com/2020/05/extending-an-immune-sequencing-platform-against-the-common-foe/crobins\_301\_2019-171x171-2/2020-05-06T22:30:51+00:00https://timmermanreport.com/wp-content/uploads/2020/05/crobins\_301\_2019-171x171-2.pnghttps://timmermanreport.com/2020/05/keeping-the-faith-and-bracing-for-the-long-slog/pearl/2020-05-08T01:10:33+00:00https://timmermanreport.com/wp-content/uploads/2020/05/pearl.pnghttps://timmermanreport.com/2020/02/as-a-scientist-you-have-a-duty-to-speak-up-as-the-2020-election-nears/jessicasagers/2020-05-13T22:56:17+00:00https://timmermanreport.com/wp-content/uploads/2020/02/JessicaSagers.pnghttps://timmermanreport.com/2020/05/meet-my-friend-who-supported-trump-in-2016/megtweet/2020-05-15T00:54:26+00:00https://timmermanreport.com/wp-content/uploads/2020/05/megtweet.pnghttps://timmermanreport.com/2020/05/meet-my-friend-who-supported-trump-in-2016/millerdragon/2020-05-15T00:54:28+00:00https://timmermanreport.com/wp-content/uploads/2020/05/millerdragon.pnghttps://timmermanreport.com/2020/05/biopharma-gets-serious-in-a-hurry-about-virtual-clinical-trials/breeburks/2020-05-15T20:34:17+00:00https://timmermanreport.com/wp-content/uploads/2020/05/breeburks.jpghttps://timmermanreport.com/2020/05/biopharma-gets-serious-in-a-hurry-about-virtual-clinical-trials/aholland/2020-05-15T20:35:34+00:00https://timmermanreport.com/wp-content/uploads/2020/05/aholland.jpghttps://timmermanreport.com/2020/05/biopharma-gets-serious-in-a-hurry-about-virtual-clinical-trials/dforman/2020-05-15T20:36:41+00:00https://timmermanreport.com/wp-content/uploads/2020/05/dforman.jpghttps://timmermanreport.com/2020/05/stepping-up-ones-game-pandemic-style/ccbingo/2020-05-16T22:00:14+00:00https://timmermanreport.com/wp-content/uploads/2020/05/ccbingo.jpghttps://timmermanreport.com/2020/05/stepping-up-ones-game-pandemic-style/crue/2020-05-16T22:01:27+00:00https://timmermanreport.com/wp-content/uploads/2020/05/crue.pnghttps://timmermanreport.com/2020/05/day-one-taking-a-page-from-rare-disease-playbook-raises-60m-for-kids-with-cancer/dayonetherapeutics\_leadership\_julie/2020-05-20T23:18:59+00:00https://timmermanreport.com/wp-content/uploads/2020/05/DayOneTherapeutics\_Leadership\_julie.jpghttps://timmermanreport.com/2020/05/day-one-taking-a-page-from-rare-disease-playbook-raises-60m-for-kids-with-cancer/dayonetherapeutics\_leadership\_sam/2020-05-20T23:20:19+00:00https://timmermanreport.com/wp-content/uploads/2020/05/DayOneTherapeutics\_Leadership\_sam.jpghttps://timmermanreport.com/2020/05/a-glimmer-of-hope-and-a-premature-victory-dance/tracy-geneva-and-luke-3/2020-05-21T23:42:55+00:00https://timmermanreport.com/wp-content/uploads/2015/01/LukeTimmerman11012014.jpghttps://timmermanreport.com/2020/05/a-glimmer-of-hope-and-a-premature-victory-dance/tracy-geneva-and-luke/2020-05-21T23:43:27+00:00https://timmermanreport.com/wp-content/uploads/2014/12/lukeSquare4.jpghttps://timmermanreport.com/2020/05/finding-a-path-in-biotech-venture-capital-nina-kjellson-on-the-long-run/nkjellson/2020-05-26T23:25:57+00:00https://timmermanreport.com/wp-content/uploads/2020/05/nkjellson.jpghttps://timmermanreport.com/2020/05/the-infodemic-summer/haydon/2020-05-29T00:41:14+00:00https://timmermanreport.com/wp-content/uploads/2020/05/haydon.pnghttps://timmermanreport.com/2020/05/the-infodemic-summer/postman/2020-05-29T14:33:56+00:00https://timmermanreport.com/wp-content/uploads/2020/05/postman-scaled.jpghttps://timmermanreport.com/2020/05/we-need-biopharma-to-dig-deep-and-fight-hard-on-inequality-heres-how/mlksilenceoffriends/2020-06-01T21:24:13+00:00https://timmermanreport.com/wp-content/uploads/2020/05/mlksilenceoffriends.jpghttps://timmermanreport.com/2020/06/scientists-focus-on-the-long-term-lung-complications-in-covid-19-survivors/kjmulam/2020-06-01T22:56:18+00:00https://timmermanreport.com/wp-content/uploads/2020/06/KJmulam.jpghttps://timmermanreport.com/2020/06/scientists-focus-on-the-long-term-lung-complications-in-covid-19-survivors/dausiello/2020-06-01T22:58:25+00:00https://timmermanreport.com/wp-content/uploads/2020/06/dausiello.jpghttps://timmermanreport.com/2020/06/anger-pain-and-even-some-hope/frazier-2/2020-06-05T00:18:05+00:00https://timmermanreport.com/wp-content/uploads/2020/06/frazier.pnghttps://timmermanreport.com/2020/06/anger-pain-and-even-some-hope/ned/2020-06-05T00:18:43+00:00https://timmermanreport.com/wp-content/uploads/2020/06/ned.pnghttps://timmermanreport.com/2020/06/anger-pain-and-even-some-hope/jha/2020-06-05T00:19:17+00:00https://timmermanreport.com/wp-content/uploads/2020/06/jha.pnghttps://timmermanreport.com/2020/06/accent-ceo-shakti-narayan-on-targeting-rna-modifying-proteins-for-cancer/aiserson-headshot/2020-06-05T19:58:49+00:00https://timmermanreport.com/wp-content/uploads/2020/06/AIserson-Headshot.jpghttps://timmermanreport.com/2020/06/accent-ceo-shakti-narayan-on-targeting-rna-modifying-proteins-for-cancer/shakti/2020-06-05T19:59:49+00:00https://timmermanreport.com/wp-content/uploads/2020/06/shakti.pnghttps://timmermanreport.com/2020/06/complexity-in-motion-multi-omics-tools-make-moves-to-unravel-path-from-genotype-to-phenotype/richard-terry-leadership-1000x1024/2020-06-05T21:04:03+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Richard-Terry-Leadership-1000x1024-1.jpghttps://timmermanreport.com/2020/06/complexity-in-motion-multi-omics-tools-make-moves-to-unravel-path-from-genotype-to-phenotype/dr\_parag-mallick-bio-pic-500x500/2020-06-05T21:08:21+00:00https://timmermanreport.com/wp-content/uploads/2020/06/dr\_parag-mallick-bio-pic-500x500-1.jpghttps://timmermanreport.com/2020/06/complexity-in-motion-multi-omics-tools-make-moves-to-unravel-path-from-genotype-to-phenotype/anup-parikh-r2/2020-06-05T21:09:19+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Anup-Parikh-r2.jpghttps://timmermanreport.com/2020/06/atlas-venture-closes-fund-xii-at-400-million-promotes-gladstone-to-partner/gladstone/2020-06-06T16:56:53+00:00https://timmermanreport.com/wp-content/uploads/2020/06/gladstone.jpghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/carolyn\_bio-2/2020-06-09T03:07:48+00:00https://timmermanreport.com/wp-content/uploads/2020/06/carolyn\_bio-1.jpghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/clareozawa/2020-06-09T03:09:30+00:00https://timmermanreport.com/wp-content/uploads/2020/06/clareozawa.jpghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/aetna/2020-06-09T03:10:52+00:00https://timmermanreport.com/wp-content/uploads/2020/06/aetna.jpghttps://timmermanreport.com/2020/06/lets-turn-the-black-nod-into-a-collective-nod/ucianefig1/2020-06-09T14:29:30+00:00https://timmermanreport.com/wp-content/uploads/2020/06/ucianefig1.jpghttps://timmermanreport.com/2020/06/lets-turn-the-black-nod-into-a-collective-nod/ucianefig2/2020-06-09T14:30:09+00:00https://timmermanreport.com/wp-content/uploads/2020/06/ucianefig2.jpghttps://timmermanreport.com/2020/06/making-drugs-at-the-edge-of-reason/vickisato-2/2020-06-10T00:54:51+00:00https://timmermanreport.com/wp-content/uploads/2020/06/vickisato.jpghttps://timmermanreport.com/2020/06/fighting-covid-19-racism-andy-plump-on-the-long-run/plump/2020-06-10T15:24:37+00:00https://timmermanreport.com/wp-content/uploads/2020/06/plump.jpghttps://timmermanreport.com/2020/06/dna-sequencing-startups-aim-to-reduce-cost-increase-meaning-in-the-data/roswell/2020-06-13T01:42:08+00:00https://timmermanreport.com/wp-content/uploads/2020/06/roswell.jpghttps://timmermanreport.com/2020/06/dna-sequencing-startups-aim-to-reduce-cost-increase-meaning-in-the-data/jessesalk/2020-06-13T01:44:45+00:00https://timmermanreport.com/wp-content/uploads/2020/06/jessesalk.jpghttps://timmermanreport.com/2020/06/a-busy-ipo-calendar-forma-repare-progenity-genetron/franklee/2020-06-16T21:36:39+00:00https://timmermanreport.com/wp-content/uploads/2020/06/franklee.jpghttps://timmermanreport.com/2020/06/a-busy-ipo-calendar-forma-repare-progenity-genetron/lloyd-1-768x768/2020-06-16T21:37:46+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Lloyd-1-768x768-1.jpghttps://timmermanreport.com/2020/06/from-heart-to-head-corporations-can-step-up-against-systemic-racism/karl-simpson-bio-headshot2/2020-06-19T21:11:34+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Karl-Simpson-BIO-headshot2.jpghttps://timmermanreport.com/2020/06/bit-bio-cellular-reprogramming-startup-seeks-to-revamp-ipscs-with-50m/kj1/2020-06-24T00:57:05+00:00https://timmermanreport.com/wp-content/uploads/2020/06/kj1.pnghttps://timmermanreport.com/2020/06/bit-bio-cellular-reprogramming-startup-seeks-to-revamp-ipscs-with-50m/elpis\_markk\_500-1/2020-06-24T01:03:18+00:00https://timmermanreport.com/wp-content/uploads/2020/06/Elpis\_MarkK\_500-1.jpghttps://timmermanreport.com/2020/06/the-exponential-curves-re-emerge/cdcjune25/2020-06-25T23:21:29+00:00https://timmermanreport.com/wp-content/uploads/2020/06/cdcJune25.jpghttps://timmermanreport.com/2020/06/leadership-strategy-and-capabilities-how-we-are-losing-the-fight-against-the-virus/jhucovidcases06-26-20/2020-06-26T22:30:16+00:00https://timmermanreport.com/wp-content/uploads/2020/06/jhuCOVIDcases06.26.20.pnghttps://timmermanreport.com/2020/06/leadership-strategy-and-capabilities-how-we-are-losing-the-fight-against-the-virus/ourworlddatajune26/2020-06-27T00:04:31+00:00https://timmermanreport.com/wp-content/uploads/2020/06/ourworlddataJune26-scaled.jpghttps://timmermanreport.com/2020/06/lassen-therapeutics-emerges-from-stealth-with-antibody-to-il-11-receptor/markbarret2/2020-06-27T19:11:28+00:00https://timmermanreport.com/wp-content/uploads/2020/06/MarkBarret2.jpghttps://timmermanreport.com/2020/06/leadership-strategy-and-capabilities-how-we-are-losing-the-fight-against-the-virus/otellomug/2020-06-27T20:08:49+00:00https://timmermanreport.com/wp-content/uploads/2020/06/otellomug.jpghttps://timmermanreport.com/2020/06/qa-with-regeneron-svp-david-weinreich-on-therapeutic-neutralizing-antibodies/david-weinreich/2020-06-28T19:25:53+00:00https://timmermanreport.com/wp-content/uploads/2020/06/David-Weinreich.jpghttps://timmermanreport.com/2020/07/cygnal-therapeutics-zeroes-in-on-unorthodox-peripheral-nervous-system-approach-to-cancer/tcwang/2020-07-01T19:41:03+00:00https://timmermanreport.com/wp-content/uploads/2020/07/tcwang.jpghttps://timmermanreport.com/2020/07/pfizer-biontech-vaccine-shows-life-but-cases-surge-testing-falters-prices-haunt/july1snapshot/2020-07-01T23:56:14+00:00https://timmermanreport.com/wp-content/uploads/2020/07/JUly1snapshot.jpghttps://timmermanreport.com/2020/07/pfizer-biontech-vaccine-shows-life-but-cases-surge-testing-falters-prices-haunt/mitchell/2020-07-01T23:57:15+00:00https://timmermanreport.com/wp-content/uploads/2020/07/mitchell.pnghttps://timmermanreport.com/2020/07/writing-in-the-language-of-dna-kevin-ness-on-the-long-run/kevinness/2020-07-07T01:36:58+00:00https://timmermanreport.com/wp-content/uploads/2020/07/kevinness.jpghttps://timmermanreport.com/2020/07/can-novartis-digitally-transform-clinical-development/vas-narasimhan/2020-07-11T02:55:41+00:00https://timmermanreport.com/wp-content/uploads/2020/07/vas-narasimhan.jpghttps://timmermanreport.com/2020/07/next-gen-synthetic-biology-pushes-further-into-drug-discovery-mrna-and-dna-on-the-desktop/sri/2020-07-15T17:02:23+00:00https://timmermanreport.com/wp-content/uploads/2020/07/sri.jpghttps://timmermanreport.com/2020/07/next-gen-synthetic-biology-pushes-further-into-drug-discovery-mrna-and-dna-on-the-desktop/tim-brears/2020-07-15T17:04:18+00:00https://timmermanreport.com/wp-content/uploads/2020/07/tim-brears.jpghttps://timmermanreport.com/2020/07/next-gen-synthetic-biology-pushes-further-into-drug-discovery-mrna-and-dna-on-the-desktop/becraft/2020-07-15T17:07:10+00:00https://timmermanreport.com/wp-content/uploads/2020/07/becraft.jpghttps://timmermanreport.com/2020/07/standing-with-fauci-positive-moderna-vaccine-data-and-blueprints-megadeal/megken/2020-07-17T00:43:14+00:00https://timmermanreport.com/wp-content/uploads/2020/07/megken.pnghttps://timmermanreport.com/2020/07/karuna-therapeutics-innovates-in-schizophrenia-treatment-with-hybrid-drug/breier\_headshot/2020-07-17T22:32:37+00:00https://timmermanreport.com/wp-content/uploads/2020/07/Breier\_headshot.jpghttps://timmermanreport.com/2020/07/seer-raises-55-million-introduces-novel-proteomic-technology/omid-forkhzad/2020-07-22T03:44:59+00:00https://timmermanreport.com/wp-content/uploads/2020/07/omid-forkhzad.jpghttps://timmermanreport.com/2020/07/seer-raises-55-million-introduces-novel-proteomic-technology/omeado/2020-07-22T03:45:53+00:00https://timmermanreport.com/wp-content/uploads/2020/07/omeado.jpghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig1-2/2020-07-22T17:28:30+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig1.pnghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig2-2/2020-07-22T17:29:14+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig2.pnghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig4/2020-07-22T17:30:49+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig4.pnghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig4-2/2020-07-22T17:31:33+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig4-1.pnghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig3/2020-07-22T17:33:03+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig3.pnghttps://timmermanreport.com/2020/07/adaptive-trials-pioneered-in-the-us-successfully-implemented-in-the-uk-for-covid-19/ucianefig5/2020-07-22T17:37:23+00:00https://timmermanreport.com/wp-content/uploads/2020/07/ucianefig5.jpghttps://timmermanreport.com/2020/07/when-raising-drug-prices-helps-patients/chrismorrison/2020-07-23T19:37:03+00:00https://timmermanreport.com/wp-content/uploads/2020/07/chrismorrison.jpghttps://timmermanreport.com/2020/07/pfizer-secures-2b-for-covid-19-vaccine-biontech-raises-500m-our-test/alit/2020-07-24T00:39:36+00:00https://timmermanreport.com/wp-content/uploads/2020/07/alit.pnghttps://timmermanreport.com/2020/07/pfizer-secures-2b-for-covid-19-vaccine-biontech-raises-500m-our-test/pfevaccine/2020-07-24T00:40:03+00:00https://timmermanreport.com/wp-content/uploads/2020/07/pfevaccine.pnghttps://timmermanreport.com/2020/07/race-and-life-sciences-where-is-the-healing/jamesbaldwin/2020-07-30T18:48:38+00:00https://timmermanreport.com/wp-content/uploads/2020/07/jamesbaldwin.jpghttps://timmermanreport.com/2020/07/jill-hagenkords-rags-to-riches-story-reminds-us-why-we-still-admire-entrepreneurs/jillhagenkord/2020-07-30T21:13:28+00:00https://timmermanreport.com/wp-content/uploads/2020/07/jillhagenkord.jpghttps://timmermanreport.com/2020/08/ohana-biosciences-and-sperm-biology-the-other-half-of-the-fertility-equation/kathleen-gray/2020-07-31T16:14:52+00:00https://timmermanreport.com/wp-content/uploads/2020/07/kathleen-gray.jpghttps://timmermanreport.com/2020/07/closing-medicines-feedback-gap-can-tech-help-integrate-clinical-care-and-clinical-research/adlermilstein/2020-07-31T19:25:29+00:00https://timmermanreport.com/wp-content/uploads/2020/07/adlermilstein.jpghttps://timmermanreport.com/2020/07/closing-medicines-feedback-gap-can-tech-help-integrate-clinical-care-and-clinical-research/mcclellan/2020-07-31T19:27:15+00:00https://timmermanreport.com/wp-content/uploads/2020/07/mcclellan.jpghttps://timmermanreport.com/2020/07/closing-medicines-feedback-gap-can-tech-help-integrate-clinical-care-and-clinical-research/esserman/2020-07-31T19:28:15+00:00https://timmermanreport.com/wp-content/uploads/2020/07/esserman.jpghttps://timmermanreport.com/2020/08/akili-interactive-delivers-prescription-level-treatment-via-video-games/eddiemartucci/2020-08-03T19:22:36+00:00https://timmermanreport.com/wp-content/uploads/2020/08/EddieMartucci.jpghttps://timmermanreport.com/2020/08/akili-interactive-delivers-prescription-level-treatment-via-video-games/adamgazzaley/2020-08-03T19:25:00+00:00https://timmermanreport.com/wp-content/uploads/2020/08/AdamGazzaley.jpghttps://timmermanreport.com/2020/08/generation-bio-blazes-new-trail-in-gene-therapy-with-non-viral-approach/mcdonough/2020-08-04T18:40:41+00:00https://timmermanreport.com/wp-content/uploads/2020/08/mcdonough.jpghttps://timmermanreport.com/2020/08/springworks-faces-key-readout-for-gamma-secretase-eyes-bcma-combo-for-cancer/saqib-islam/2020-08-07T23:29:38+00:00https://timmermanreport.com/wp-content/uploads/2020/08/saqib-islam.pnghttps://timmermanreport.com/2020/08/antibiotic-resistance-looms-large-in-pandemic-crispr-phages-show-promise/erin\_duffy/2020-08-10T22:36:02+00:00https://timmermanreport.com/wp-content/uploads/2020/08/Erin\_Duffy.jpghttps://timmermanreport.com/2020/08/antibiotic-resistance-looms-large-in-pandemic-crispr-phages-show-promise/locusbioteamheadshots-21-2-e1546367110402/2020-08-10T22:37:34+00:00https://timmermanreport.com/wp-content/uploads/2020/08/LocusBioTeamHeadshots-21-2-e1546367110402.jpghttps://timmermanreport.com/2020/08/antibiotic-resistance-looms-large-in-pandemic-crispr-phages-show-promise/christian\_groendahl/2020-08-10T22:39:08+00:00https://timmermanreport.com/wp-content/uploads/2020/08/Christian\_Groendahl.jpghttps://timmermanreport.com/2020/09/mood-disorder-rd-lacking-innovation-turns-to-psychedelics/srini/2020-08-10T22:47:09+00:00https://timmermanreport.com/wp-content/uploads/2020/08/srini.pnghttps://timmermanreport.com/2020/09/mood-disorder-rd-lacking-innovation-turns-to-psychedelics/berra\_yazar-klosinski/2020-08-10T22:49:06+00:00https://timmermanreport.com/wp-content/uploads/2020/08/berra\_yazar-klosinski.pnghttps://timmermanreport.com/2020/08/from-rio-to-rome-rosana-kapeller-on-the-long-run/kapeller/2020-08-11T23:21:37+00:00https://timmermanreport.com/wp-content/uploads/2020/08/kapeller.pnghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1212/2020-08-20T19:11:07+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1212-scaled.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1197/2020-08-20T19:49:35+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1197-scaled.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1198-2/2020-08-20T19:49:50+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1198-scaled.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1204/2020-08-20T19:50:04+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1204-scaled-e1597953210584.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1211/2020-08-20T19:50:16+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1211-scaled-e1597953164283.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1212-2/2020-08-20T19:50:27+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1212-1-scaled.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/img\_1214/2020-08-20T19:50:39+00:00https://timmermanreport.com/wp-content/uploads/2020/08/IMG\_1214-scaled-e1597953252945.jpghttps://timmermanreport.com/2020/08/spiritual-renewal-in-the-north-cascades-and-facing-homelessness/facinghomelessness/2020-08-20T19:57:24+00:00https://timmermanreport.com/wp-content/uploads/2020/08/facinghomelessness.pnghttps://timmermanreport.com/2020/08/an-underappreciated-aspect-of-power-listening/pathtopowerbookshot-e1553888803110/2020-08-27T03:29:54+00:00https://timmermanreport.com/wp-content/uploads/2020/08/pathtopowerbookshot-e1553888803110.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/pearls/2020-08-31T18:52:31+00:00https://timmermanreport.com/wp-content/uploads/2020/08/pearls.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/tracker/2020-08-31T18:53:23+00:00https://timmermanreport.com/wp-content/uploads/2020/08/tracker.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/projections/2020-08-31T18:54:11+00:00https://timmermanreport.com/wp-content/uploads/2020/08/projections.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/masks/2020-08-31T18:55:13+00:00https://timmermanreport.com/wp-content/uploads/2020/08/masks.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/australia/2020-08-31T18:55:57+00:00https://timmermanreport.com/wp-content/uploads/2020/08/australia.pnghttps://timmermanreport.com/2020/08/the-data-are-telling-us-to-prepare-for-a-difficult-fall/aml-21697\_9099266\_mutable\_color/2020-08-31T20:22:50+00:00https://timmermanreport.com/wp-content/uploads/2020/08/AML-21697\_9099266\_mutable\_color.jpghttps://timmermanreport.com/2020/09/beyond-aav-avrobio-and-orchard-take-ex-vivo-approach-to-gene-therapy/geoff-mackay\_1/2020-08-31T23:01:44+00:00https://timmermanreport.com/wp-content/uploads/2020/08/geoff-macKay\_1.pnghttps://timmermanreport.com/2020/09/beyond-aav-avrobio-and-orchard-take-ex-vivo-approach-to-gene-therapy/bobbygaspar/2020-08-31T23:04:03+00:00https://timmermanreport.com/wp-content/uploads/2020/08/bobbygaspar.pnghttps://timmermanreport.com/2020/09/tech-impact-requires-deep-engagement-with-biopharma-lead-users/barbara\_mcclintock\_1902-1992\_shown\_in\_her\_laboratory\_in\_1947/2020-09-02T21:12:39+00:00https://timmermanreport.com/wp-content/uploads/2020/09/Barbara\_McClintock\_1902-1992\_shown\_in\_her\_laboratory\_in\_1947.jpghttps://timmermanreport.com/2016/03/join-tr-stat-conversation-health-science-journalism/luke-timmerman\_avatar\_1446145089/2020-09-03T23:01:23+00:00https://timmermanreport.com/wp-content/uploads/2016/03/Luke-Timmerman\_avatar\_1446145089.jpghttps://timmermanreport.com/2020/09/fda-and-cdc-credibility-tarnished-pfizer-sprints-ahead-with-covid19-vaccine/worldsept3/2020-09-03T23:09:42+00:00https://timmermanreport.com/wp-content/uploads/2020/09/worldsept3.pnghttps://timmermanreport.com/the-long-run/global-partnering-virtual-passpport-ebd-group/2020-09-04T16:24:59+00:00https://timmermanreport.com/wp-content/uploads/2020/09/Global-Partnering-Virtual-Passpport-EBD-Group.pnghttps://timmermanreport.com/2020/09/recursion-pulls-in-239m-for-ai-drug-discovery-bayer-bets-on-fibrosis/juergen/2020-09-08T22:35:43+00:00https://timmermanreport.com/wp-content/uploads/2020/09/juergen.pnghttps://timmermanreport.com/2020/09/recursion-pulls-in-239m-for-ai-drug-discovery-bayer-bets-on-fibrosis/gibson/2020-09-08T22:37:45+00:00https://timmermanreport.com/wp-content/uploads/2020/09/gibson.pnghttps://timmermanreport.com/2020/09/industry-and-academia-take-a-stand-for-science/fauci-advisory-council/2020-09-11T00:46:20+00:00https://timmermanreport.com/wp-content/uploads/2020/09/fauci-advisory-council.jpghttps://timmermanreport.com/2019/08/an-unforgettable-experience-the-kilimanjaro-climb-to-fight-cancer-yearbook/spencer-guthrie-headshot/2020-09-14T03:38:13+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Spencer-Guthrie-headshot.jpghttps://timmermanreport.com/2020/09/attralus-secures-25m-series-a-to-diagnose-and-treat-amyloidosis/richard/2020-09-14T03:39:18+00:00https://timmermanreport.com/wp-content/uploads/2020/09/richard-scaled.jpghttps://timmermanreport.com/2020/09/attralus-secures-25m-series-a-to-diagnose-and-treat-amyloidosis/s\_guthrie-headshot/2020-09-14T16:13:29+00:00https://timmermanreport.com/wp-content/uploads/2020/09/S\_Guthrie-headshot-scaled.jpghttps://timmermanreport.com/2020/09/america-the-engine-of-biomedical-discovery-should-be-trumps-most-favored-nation/tomculman/2020-09-15T18:05:24+00:00https://timmermanreport.com/wp-content/uploads/2020/09/TomCulman.jpghttps://timmermanreport.com/2020/09/america-the-engine-of-biomedical-discovery-should-be-trumps-most-favored-nation/jfkwhp-st-387-19-62/2020-09-15T18:20:26+00:00https://timmermanreport.com/wp-content/uploads/2020/09/JFKWHP-ST-387-19-62.jpghttps://timmermanreport.com/2020/09/graphite-bio-secures-45m-series-a-to-advance-targeted-gene-editing-therapy/joshlehrer/2020-09-16T01:52:00+00:00https://timmermanreport.com/wp-content/uploads/2020/09/joshlehrer.jpghttps://timmermanreport.com/2020/09/graphite-bio-secures-45m-series-a-to-advance-targeted-gene-editing-therapy/porteus\_matthew/2020-09-16T01:54:01+00:00https://timmermanreport.com/wp-content/uploads/2020/09/Porteus\_Matthew.jpghttps://timmermanreport.com/2020/09/moderna-and-pfizers-vaccine-transparency-gileads-megadeal-and-a-tribute-to-bill-sr/loncarbillion/2020-09-18T00:38:06+00:00https://timmermanreport.com/wp-content/uploads/2020/09/loncarbillion.pnghttps://timmermanreport.com/2020/09/moderna-and-pfizers-vaccine-transparency-gileads-megadeal-and-a-tribute-to-bill-sr/topolprotocol/2020-09-18T00:38:28+00:00https://timmermanreport.com/wp-content/uploads/2020/09/topolprotocol.pnghttps://timmermanreport.com/2020/09/moderna-and-pfizers-vaccine-transparency-gileads-megadeal-and-a-tribute-to-bill-sr/20200915-billsrtribute-tgn\_assets-002-homepage\_hero-001/2020-09-18T00:45:50+00:00https://timmermanreport.com/wp-content/uploads/2020/09/20200915-BillSrTribute-TGN\_Assets-002-Homepage\_Hero-001.jpghttps://timmermanreport.com/2020/09/how-lunch-with-bill-gates-sr-changed-my-life/gatessr/2020-09-23T13:35:28+00:00https://timmermanreport.com/wp-content/uploads/2020/09/gatessr.jpghttps://timmermanreport.com/2020/09/small-molecules-against-rna-targets-jennifer-petter-on-the-long-run/jenniferpetter/2020-09-29T00:19:05+00:00https://timmermanreport.com/wp-content/uploads/2020/09/jenniferpetter.pnghttps://timmermanreport.com/2020/09/covid-19-diagnostic-testing-needs-to-be-open-not-closed/alex-dickinson/2020-09-29T20:53:25+00:00https://timmermanreport.com/wp-content/uploads/2020/09/Alex-Dickinson.jpghttps://timmermanreport.com/2020/10/fda-commissioners-speak-out-an-antibiotic-incentive-proposal-and-a-drug-price-grilling/porter1/2020-10-02T00:31:01+00:00https://timmermanreport.com/wp-content/uploads/2020/10/porter1.pnghttps://timmermanreport.com/2020/10/fda-commissioners-speak-out-an-antibiotic-incentive-proposal-and-a-drug-price-grilling/porter2/2020-10-02T00:31:24+00:00https://timmermanreport.com/wp-content/uploads/2020/10/porter2.pnghttps://timmermanreport.com/2017/02/now-ever-need-personalized-medicine-immuno-oncology/sw-lower-res/2020-10-07T00:31:34+00:00https://timmermanreport.com/wp-content/uploads/2017/01/SW-Lower-Res.jpghttps://timmermanreport.com/2020/10/seeing-covid-19-in-context-applying-spatial-biology-to-the-lungs/sarahwarrensquare/2020-10-07T00:34:01+00:00https://timmermanreport.com/wp-content/uploads/2020/10/sarahwarrensquare.pnghttps://timmermanreport.com/2020/10/seeing-covid-19-in-context-applying-spatial-biology-to-the-lungs/jason-reeves-headshot-2/2020-10-07T00:34:53+00:00https://timmermanreport.com/wp-content/uploads/2020/10/Jason-Reeves-Headshot-1.jpghttps://timmermanreport.com/2020/10/seeing-covid-19-in-context-applying-spatial-biology-to-the-lungs/jason-reeves-headshot/2020-10-07T00:35:41+00:00https://timmermanreport.com/wp-content/uploads/2020/10/Jason-Reeves-Headshot.jpghttps://timmermanreport.com/2020/10/a-historic-nobel-for-crispr-pfizer-sticks-up-for-fda-a-cdc-legend-speaks/front1-2/2020-10-09T00:50:28+00:00https://timmermanreport.com/wp-content/uploads/2020/10/front1.pnghttps://timmermanreport.com/2020/10/a-historic-nobel-for-crispr-pfizer-sticks-up-for-fda-a-cdc-legend-speaks/front2-2/2020-10-09T00:51:06+00:00https://timmermanreport.com/wp-content/uploads/2020/10/front2.pnghttps://timmermanreport.com/2020/10/a-historic-nobel-for-crispr-pfizer-sticks-up-for-fda-a-cdc-legend-speaks/front4/2020-10-09T00:51:31+00:00https://timmermanreport.com/wp-content/uploads/2020/10/front4.pnghttps://timmermanreport.com/2020/10/a-historic-nobel-for-crispr-pfizer-sticks-up-for-fda-a-cdc-legend-speaks/front3-2/2020-10-09T00:52:02+00:00https://timmermanreport.com/wp-content/uploads/2020/10/front3.pnghttps://timmermanreport.com/2020/07/cygnal-therapeutics-zeroes-in-on-unorthodox-peripheral-nervous-system-approach-to-cancer/pearl-2/2020-10-13T00:53:46+00:00https://timmermanreport.com/wp-content/uploads/2020/07/pearl.jpghttps://timmermanreport.com/2020/10/an-especially-inspiring-nobel-prize-and-a-sign-of-more-work-to-do/jenadair/2020-10-13T19:49:33+00:00https://timmermanreport.com/wp-content/uploads/2020/10/jenadair-scaled.jpghttps://timmermanreport.com/2020/10/corporate-leaders-face-pressure-from-investors-regulators-to-act-on-diversity/cambriaallen/2020-10-13T21:16:38+00:00https://timmermanreport.com/wp-content/uploads/2020/10/cambriaallen.pnghttps://timmermanreport.com/2020/10/rayzebio-snags-45m-to-reimagine-targeted-radiotherapies-for-cancer/song/2020-10-14T00:59:47+00:00https://timmermanreport.com/wp-content/uploads/2020/10/song.jpghttps://timmermanreport.com/2020/10/rayzebio-snags-45m-to-reimagine-targeted-radiotherapies-for-cancer/versant\_team\_jerrel/2020-10-14T01:11:09+00:00https://timmermanreport.com/wp-content/uploads/2020/10/Versant\_Team\_Jerrel.jpghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/distrust1/2020-10-23T00:29:37+00:00https://timmermanreport.com/wp-content/uploads/2020/10/distrust1.pnghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/distrust2/2020-10-23T00:30:00+00:00https://timmermanreport.com/wp-content/uploads/2020/10/distrust2.pnghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/distrust3/2020-10-23T00:30:17+00:00https://timmermanreport.com/wp-content/uploads/2020/10/distrust3.pnghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/distrust4/2020-10-23T00:30:33+00:00https://timmermanreport.com/wp-content/uploads/2020/10/distrust4.pnghttps://timmermanreport.com/2020/10/remdesivirs-fda-approval-moderna-fully-enrolls-fda-wrestles-with-trust/bach/2020-10-23T00:33:34+00:00https://timmermanreport.com/wp-content/uploads/2020/10/bach.pnghttps://timmermanreport.com/2020/10/machine-learning-for-drug-discovery-daphne-koller-on-the-long-run/insitro-daphne-koller2x/2020-10-26T23:19:07+00:00https://timmermanreport.com/wp-content/uploads/2020/10/insitro-daphne-koller2x.jpghttps://timmermanreport.com/2020/10/what-happened-in-switzerland/swiss1/2020-10-28T23:37:58+00:00https://timmermanreport.com/wp-content/uploads/2020/10/swiss1.pnghttps://timmermanreport.com/2020/10/what-happened-in-switzerland/swiss2/2020-10-28T23:39:00+00:00https://timmermanreport.com/wp-content/uploads/2020/10/swiss2.pnghttps://timmermanreport.com/2020/10/what-happened-in-switzerland/swiss3/2020-10-28T23:40:03+00:00https://timmermanreport.com/wp-content/uploads/2020/10/swiss3.pnghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/saria\_photo/2020-11-01T22:12:41+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Saria\_photo-scaled.jpghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/zak-091817\_data\_science\_040-300x350/2020-11-01T22:13:51+00:00https://timmermanreport.com/wp-content/uploads/2020/11/zak-091817\_data\_science\_040-300x350-1.jpghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/marz/2020-11-01T22:15:52+00:00https://timmermanreport.com/wp-content/uploads/2020/11/marz.pnghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/rudin/2020-11-01T22:18:02+00:00https://timmermanreport.com/wp-content/uploads/2020/11/rudin.jpghttps://timmermanreport.com/2020/11/rebuffed-as-overlords-ai-experts-return-in-peace-seeking-partnership-with-clinicians/ken\_ehlert/2020-11-01T23:10:28+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Ken\_Ehlert.pnghttps://timmermanreport.com/2020/11/targeted-protein-degraders-pull-in-millions-of-dollars-in-the-wake-of-new-hope/theresagaffney/2020-11-03T22:15:35+00:00https://timmermanreport.com/wp-content/uploads/2020/11/theresagaffney-scaled-e1604441689266.jpghttps://timmermanreport.com/2020/11/targeted-protein-degraders-pull-in-millions-of-dollars-in-the-wake-of-new-hope/markrolfe/2020-11-03T22:19:03+00:00https://timmermanreport.com/wp-content/uploads/2020/11/markrolfe.pnghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/carolyn\_bio/2020-11-03T22:19:38+00:00https://timmermanreport.com/wp-content/uploads/2020/06/carolyn\_bio.jpghttps://timmermanreport.com/2020/11/targeted-protein-degraders-pull-in-millions-of-dollars-in-the-wake-of-new-hope/markuswarmuth/2020-11-03T22:21:39+00:00https://timmermanreport.com/wp-content/uploads/2020/11/markuswarmuth.pnghttps://timmermanreport.com/2020/11/merck-buys-velosbio-biogens-alzheimers-surprise-a-reflection-from-wisconsin/biib/2020-11-06T00:27:01+00:00https://timmermanreport.com/wp-content/uploads/2020/11/biib.pnghttps://timmermanreport.com/2020/11/biotech-companies-acting-on-promises-to-increase-racial-diversity/minita/2020-11-10T14:28:48+00:00https://timmermanreport.com/wp-content/uploads/2020/11/minita.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/billnewell/2020-11-10T14:29:27+00:00https://timmermanreport.com/wp-content/uploads/2018/12/billnewell.jpghttps://timmermanreport.com/2020/11/biotech-companies-acting-on-promises-to-increase-racial-diversity/rene-russo-color/2020-11-10T14:30:20+00:00https://timmermanreport.com/wp-content/uploads/2020/11/rene-russo-color.pnghttps://timmermanreport.com/2020/11/pfizer-biontechs-watershed-moment-lilly-antibody-gets-eua-the-rebuilding-begins/wedding/2020-11-13T01:49:00+00:00https://timmermanreport.com/wp-content/uploads/2020/11/wedding.pnghttps://timmermanreport.com/2020/11/pfizer-biontechs-watershed-moment-lilly-antibody-gets-eua-the-rebuilding-begins/atul/2020-11-13T01:49:29+00:00https://timmermanreport.com/wp-content/uploads/2020/11/atul.pnghttps://timmermanreport.com/2020/11/pfizer-biontechs-watershed-moment-lilly-antibody-gets-eua-the-rebuilding-begins/cases/2020-11-13T01:49:48+00:00https://timmermanreport.com/wp-content/uploads/2020/11/cases.pnghttps://timmermanreport.com/2020/11/a-new-model-for-vaccine-communications-grounded-in-science-and-empathy/mk\_headshot\_2019/2020-11-23T19:27:48+00:00https://timmermanreport.com/wp-content/uploads/2020/11/MK\_headshot\_2019.pnghttps://timmermanreport.com/2020/11/a-new-model-for-vaccine-communications-grounded-in-science-and-empathy/head\_shot\_high\_res\_32/2020-11-23T19:33:55+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Head\_Shot\_High\_Res\_328229.jpghttps://timmermanreport.com/2020/11/medicines-based-on-unusual-genetic-traits-andrew-farnum-on-the-long-run/farnum/2020-11-24T00:01:06+00:00https://timmermanreport.com/wp-content/uploads/2020/11/farnum-e1606176095863.pnghttps://timmermanreport.com/2020/11/getting-married-in-2020-one-of-many-difficult-family-decisions-in-the-pandemic/carolyn-and-matt/2020-11-24T16:30:30+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Carolyn-and-Matt.jpghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/huckman/2020-11-25T16:23:07+00:00https://timmermanreport.com/wp-content/uploads/2020/11/huckman.jpghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/firstshot/2020-11-25T16:24:55+00:00https://timmermanreport.com/wp-content/uploads/2020/11/firstshot-scaled.jpghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/secondshot/2020-11-25T16:25:27+00:00https://timmermanreport.com/wp-content/uploads/2020/11/secondshot-scaled.jpghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/mhuckman/2020-11-25T16:47:38+00:00https://timmermanreport.com/wp-content/uploads/2020/11/MHuckman.jpghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/mikehuckman/2020-11-25T16:49:55+00:00https://timmermanreport.com/wp-content/uploads/2020/11/mikehuckman.pnghttps://timmermanreport.com/2020/11/i-used-to-report-on-clinical-trials-now-im-in-one-heres-why-i-volunteered/mikehuckman1/2020-11-25T16:51:55+00:00https://timmermanreport.com/wp-content/uploads/2020/11/mikehuckman1.pnghttps://timmermanreport.com/2020/12/covid-19-drives-new-push-for-crispr-based-home-diagnostics/fvinluan\_headshot/2020-11-25T19:44:27+00:00https://timmermanreport.com/wp-content/uploads/2020/11/fvinluan\_headshot.jpghttps://timmermanreport.com/2020/12/covid-19-drives-new-push-for-crispr-based-home-diagnostics/rahul-480v4/2020-11-25T19:55:27+00:00https://timmermanreport.com/wp-content/uploads/2020/11/rahul-480v4.jpghttps://timmermanreport.com/2020/12/covid-19-drives-new-push-for-crispr-based-home-diagnostics/janicechen/2020-11-25T19:58:36+00:00https://timmermanreport.com/wp-content/uploads/2020/11/janicechen.jpghttps://timmermanreport.com/2020/12/covid-19-drives-new-push-for-crispr-based-home-diagnostics/gerald-j-kost/2020-11-25T20:03:10+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Gerald-J.-Kost.jpghttps://timmermanreport.com/2020/11/5am-atlas-join-40m-bet-on-kinaset-a-pan-jak-inhibitor-for-severe-asthma/clarke/2020-11-27T18:54:52+00:00https://timmermanreport.com/wp-content/uploads/2020/11/clarke.jpghttps://timmermanreport.com/2020/11/5am-atlas-join-40m-bet-on-kinaset-a-pan-jak-inhibitor-for-severe-asthma/jamil-square-e1522187161557/2020-11-27T23:13:24+00:00https://timmermanreport.com/wp-content/uploads/2020/11/Jamil-square-e1522187161557.jpghttps://timmermanreport.com/2020/11/the-weather-outside-is-frightful-and-thats-just-the-half-of-it/mascara/2020-11-30T17:54:06+00:00https://timmermanreport.com/wp-content/uploads/2020/11/mascara.jpghttps://timmermanreport.com/2020/11/the-weather-outside-is-frightful-and-thats-just-the-half-of-it/fomo/2020-11-30T17:54:28+00:00https://timmermanreport.com/wp-content/uploads/2020/11/fomo.pnghttps://timmermanreport.com/2020/11/the-weather-outside-is-frightful-and-thats-just-the-half-of-it/stomp/2020-11-30T17:55:30+00:00https://timmermanreport.com/wp-content/uploads/2020/11/stomp.jpghttps://timmermanreport.com/2020/11/the-weather-outside-is-frightful-and-thats-just-the-half-of-it/dembones/2020-11-30T17:55:46+00:00https://timmermanreport.com/wp-content/uploads/2020/11/dembones.pnghttps://timmermanreport.com/2020/12/vaccine-scarcity-buckle-up-for-debate-in-the-coming-months/acip/2020-12-02T04:30:21+00:00https://timmermanreport.com/wp-content/uploads/2020/12/acip.pnghttps://timmermanreport.com/2020/12/genesis-technology-stanford-spinout-for-ai-drug-discovery-captures-52m-series-a/evan-p-500/2020-12-02T04:42:33+00:00https://timmermanreport.com/wp-content/uploads/2020/12/evan-p-500-e1606884134151.pnghttps://timmermanreport.com/2020/12/genesis-technology-stanford-spinout-for-ai-drug-discovery-captures-52m-series-a/peppi\_prasit/2020-12-02T04:43:50+00:00https://timmermanreport.com/wp-content/uploads/2020/12/peppi\_prasit.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_02/2020-12-02T23:05:12+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_02.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_12/2020-12-02T23:05:13+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_12.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_10/2020-12-02T23:05:13+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_10.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_08/2020-12-02T23:05:13+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_08.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_06/2020-12-02T23:05:13+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_06.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_04/2020-12-02T23:05:13+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_04.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_20/2020-12-02T23:05:14+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_20.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_18/2020-12-02T23:05:14+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_18.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_16/2020-12-02T23:05:14+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_16.jpghttps://timmermanreport.com/individual-subscriptions/testimonial\_14/2020-12-02T23:05:14+00:00https://timmermanreport.com/wp-content/uploads/2020/02/testimonial\_14.jpghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/dec3-1/2020-12-04T01:59:24+00:00https://timmermanreport.com/wp-content/uploads/2020/12/dec3.1.pnghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/dec3-2/2020-12-04T01:59:44+00:00https://timmermanreport.com/wp-content/uploads/2020/12/dec3.2.pnghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/dec3-3/2020-12-04T02:00:00+00:00https://timmermanreport.com/wp-content/uploads/2020/12/dec3.3.pnghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/dec3-4/2020-12-04T02:00:18+00:00https://timmermanreport.com/wp-content/uploads/2020/12/dec3.4.pnghttps://timmermanreport.com/2020/12/azs-muddy-result-regeneron-cocktail-okd-and-biogen-sage-bet-big-on-depression/dec3-5/2020-12-04T02:00:32+00:00https://timmermanreport.com/wp-content/uploads/2020/12/dec3.5.pnghttps://timmermanreport.com/2020/12/this-covid-19-long-hauler-is-still-trying-to-recover/blairschoeb/2020-12-04T22:05:59+00:00https://timmermanreport.com/wp-content/uploads/2020/12/blairschoeb.pnghttps://timmermanreport.com/2020/12/vaccine-communication-another-opportunity-for-biopharma-to-lead/kyle1/2020-12-11T00:14:19+00:00https://timmermanreport.com/wp-content/uploads/2020/12/kyle1.pnghttps://timmermanreport.com/2020/12/pfizer-biontech-vaccine-gets-fda-advisory-ok-now-comes-more-hard-work/nurse/2020-12-11T01:52:11+00:00https://timmermanreport.com/wp-content/uploads/2020/12/nurse.pnghttps://timmermanreport.com/2020/12/the-vaccine-is-coming-and-scientists-need-to-keep-the-focus-on-equity/michele-andrsik/2020-12-11T20:05:22+00:00https://timmermanreport.com/wp-content/uploads/2020/12/michele-andrsik.jpghttps://timmermanreport.com/2020/12/the-us-is-teeming-with-spacs-why-is-the-uk-at-zero/uciane1/2020-12-14T01:11:28+00:00https://timmermanreport.com/wp-content/uploads/2020/12/uciane1.pnghttps://timmermanreport.com/2020/12/seeking-impact-serviers-david-lee-on-the-long-run-podcast/davidlee/2020-12-14T22:45:44+00:00https://timmermanreport.com/wp-content/uploads/2020/12/davidlee.jpghttps://timmermanreport.com/2020/12/startup-profiles-exosite-drug-discovery-efficient-gene-therapy-for-the-eye/bruce/2020-12-16T00:09:51+00:00https://timmermanreport.com/wp-content/uploads/2020/12/bruce.jpghttps://timmermanreport.com/2020/12/startup-profiles-exosite-drug-discovery-efficient-gene-therapy-for-the-eye/liu\_1/2020-12-16T00:11:10+00:00https://timmermanreport.com/wp-content/uploads/2020/12/liu\_1.jpghttps://timmermanreport.com/2020/12/startup-profiles-exosite-drug-discovery-efficient-gene-therapy-for-the-eye/sarahbhagat-3/2020-12-16T00:13:25+00:00https://timmermanreport.com/wp-content/uploads/2020/12/SarahBhagat-3.jpghttps://timmermanreport.com/2020/03/doctor-mother-ceo-balancing-competing-needs-and-opting-for-the-front-lines/amandacristini/2020-12-17T15:23:04+00:00https://timmermanreport.com/wp-content/uploads/2020/03/amandacristini.jpghttps://timmermanreport.com/2020/12/a-triumph-of-the-scientific-enterprise-industry-academia-and-government/modernatweet/2020-12-18T00:42:36+00:00https://timmermanreport.com/wp-content/uploads/2020/12/modernatweet.pnghttps://timmermanreport.com/2020/12/more-than-words-taking-steps-together-towards-greater-health-equity/nina1/2020-12-18T23:30:19+00:00https://timmermanreport.com/wp-content/uploads/2020/12/nina1.pnghttps://timmermanreport.com/2020/12/more-than-words-taking-steps-together-towards-greater-health-equity/healthequity1/2020-12-18T23:40:57+00:00https://timmermanreport.com/wp-content/uploads/2020/12/healthequity1.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/xkcd/2020-12-19T17:58:13+00:00https://timmermanreport.com/wp-content/uploads/2020/12/xkcd.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/xkcd1/2020-12-19T17:59:53+00:00https://timmermanreport.com/wp-content/uploads/2020/12/xkcd1.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/xkcd2/2020-12-19T18:04:01+00:00https://timmermanreport.com/wp-content/uploads/2020/12/xkcd2.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/xkcd3/2020-12-19T18:04:32+00:00https://timmermanreport.com/wp-content/uploads/2020/12/xkcd3.jpghttps://timmermanreport.com/2020/12/there-is-light-at-the-end-of-the-tunnel-yes-but-its-a-long-tunnel/xkcd4/2020-12-19T18:05:06+00:00https://timmermanreport.com/wp-content/uploads/2020/12/xkcd4.jpghttps://timmermanreport.com/2020/12/celsius-servier-forge-single-cell-analysis-partnership-for-colorectal-cancer/tariq-kassum-celsius/2020-12-20T18:42:22+00:00https://timmermanreport.com/wp-content/uploads/2020/12/Tariq-Kassum-Celsius.jpghttps://timmermanreport.com/2020/12/science-in-the-face-of-fear-vaccine-hesitancy-and-public-trust/kmcurves/2020-12-20T22:33:48+00:00https://timmermanreport.com/wp-content/uploads/2020/12/kmcurves.pnghttps://timmermanreport.com/2021/01/startup-profiles-senti-and-myeloid-raise-cash-to-push-cell-therapy-frontiers/timlu/2021-01-06T01:58:59+00:00https://timmermanreport.com/wp-content/uploads/2021/01/timlu.pnghttps://timmermanreport.com/2021/01/startup-profiles-senti-and-myeloid-raise-cash-to-push-cell-therapy-frontiers/getts/2021-01-06T02:01:57+00:00https://timmermanreport.com/wp-content/uploads/2021/01/getts.jpghttps://timmermanreport.com/2015/05/more-than-moderna-whos-who-in-mrna-therapeutics/sbancel-moderna-2/2021-01-07T00:54:03+00:00https://timmermanreport.com/wp-content/uploads/2015/05/SBancel-moderna-2.jpghttps://timmermanreport.com/2021/01/fungus-based-startup-lifemine-fetches-50m-arsenal-attracts-bms-cell-therapy/drazan/2021-01-07T02:38:00+00:00https://timmermanreport.com/wp-content/uploads/2021/01/drazan.pnghttps://timmermanreport.com/2021/01/biotech-has-never-been-more-radiant-even-in-this-dark-moment/megjan7/2021-01-08T04:58:19+00:00https://timmermanreport.com/wp-content/uploads/2021/01/megjan7.pnghttps://timmermanreport.com/2021/01/biotech-has-never-been-more-radiant-even-in-this-dark-moment/trevortweet/2021-01-08T05:28:59+00:00https://timmermanreport.com/wp-content/uploads/2021/01/trevortweet.pnghttps://timmermanreport.com/2021/01/biotech-has-never-been-more-radiant-even-in-this-dark-moment/pavitra/2021-01-08T05:29:16+00:00https://timmermanreport.com/wp-content/uploads/2021/01/pavitra.pnghttps://timmermanreport.com/2021/01/cell-gene-therapy-boom-sparks-investment-in-biologics-manufacturing/rasession/2021-01-13T00:43:21+00:00https://timmermanreport.com/wp-content/uploads/2021/01/rasession.pnghttps://timmermanreport.com/2021/01/cell-gene-therapy-boom-sparks-investment-in-biologics-manufacturing/pcagnoni/2021-01-13T00:46:03+00:00https://timmermanreport.com/wp-content/uploads/2021/01/pcagnoni.pnghttps://timmermanreport.com/2021/01/cell-gene-therapy-boom-sparks-investment-in-biologics-manufacturing/fabian/2021-01-13T00:47:35+00:00https://timmermanreport.com/wp-content/uploads/2021/01/fabian.pnghttps://timmermanreport.com/2021/01/cell-gene-therapy-boom-sparks-investment-in-biologics-manufacturing/armon/2021-01-13T00:48:54+00:00https://timmermanreport.com/wp-content/uploads/2021/01/armon.jpghttps://timmermanreport.com/2021/01/how-worried-should-we-be-about-emerging-strains-of-sars-cov-2/maraaspinall/2021-01-13T23:10:13+00:00https://timmermanreport.com/wp-content/uploads/2021/01/maraaspinall.pnghttps://timmermanreport.com/2021/01/how-worried-should-we-be-about-emerging-strains-of-sars-cov-2/viralspike/2021-01-13T23:47:18+00:00https://timmermanreport.com/wp-content/uploads/2021/01/viralspike.pnghttps://timmermanreport.com/2021/01/how-worried-should-we-be-about-emerging-strains-of-sars-cov-2/newvariant/2021-01-13T23:48:29+00:00https://timmermanreport.com/wp-content/uploads/2021/01/newvariant.pnghttps://timmermanreport.com/2021/01/a-vision-for-an-mhealth-driven-biopharma-future/boboverell/2021-01-15T17:59:28+00:00https://timmermanreport.com/wp-content/uploads/2021/01/boboverell.jpghttps://timmermanreport.com/2021/01/a-vision-for-an-mhealth-driven-biopharma-future/overell/2021-01-16T19:02:59+00:00https://timmermanreport.com/wp-content/uploads/2021/01/overell.jpghttps://timmermanreport.com/2021/01/two-doses-or-one-lets-stick-to-the-data/beyrer/2021-01-17T20:38:59+00:00https://timmermanreport.com/wp-content/uploads/2021/01/beyrer.jpghttps://timmermanreport.com/2021/01/gene-editing-for-transplants-and-cell-therapy-luhan-yang-on-the-long-run/luhanyang-2/2021-01-20T00:15:12+00:00https://timmermanreport.com/wp-content/uploads/2021/01/luhanyang.jpghttps://timmermanreport.com/about-luke-timmerman/collinsplenary-3/2021-01-22T00:45:08+00:00https://timmermanreport.com/wp-content/uploads/2014/12/collinsplenary-1.jpghttps://timmermanreport.com/2021/01/a-bold-idea-for-the-nih/stlouis/2021-01-22T00:46:21+00:00https://timmermanreport.com/wp-content/uploads/2021/01/stlouis.pnghttps://timmermanreport.com/2021/01/a-bold-idea-for-the-nih/topoljan21/2021-01-22T00:47:21+00:00https://timmermanreport.com/wp-content/uploads/2021/01/topoljan21.pnghttps://timmermanreport.com/2021/01/a-bold-idea-for-the-nih/megjan21/2021-01-22T00:52:29+00:00https://timmermanreport.com/wp-content/uploads/2021/01/megjan21.pnghttps://timmermanreport.com/2021/01/a-bold-idea-for-the-nih/collins-2/2021-01-22T00:54:09+00:00https://timmermanreport.com/wp-content/uploads/2021/01/collins.pnghttps://timmermanreport.com/2021/01/ukko-gets-bayers-backing-for-an-ai-approach-to-food-allergies/ukko-2/2021-01-27T00:50:12+00:00https://timmermanreport.com/wp-content/uploads/2021/01/Ukko-CEO-Anat-Binur.jpghttps://timmermanreport.com/2021/01/ideas-for-an-fda-reboot/virbio/2021-01-29T01:28:41+00:00https://timmermanreport.com/wp-content/uploads/2021/01/virbio.pnghttps://timmermanreport.com/2020/05/coronavirus-vaccine-strategy-larry-corey-on-the-long-run/larry-corey/2021-02-01T02:56:25+00:00https://timmermanreport.com/wp-content/uploads/2020/05/Larry-Corey-e1610917745413.jpghttps://timmermanreport.com/2021/02/2021-the-rise-of-the-variants/otellofeb1/2021-02-02T00:34:11+00:00https://timmermanreport.com/wp-content/uploads/2021/02/otellofeb1.jpghttps://timmermanreport.com/2021/02/2021-the-rise-of-the-variants/otellofeb1-2/2021-02-02T01:16:03+00:00https://timmermanreport.com/wp-content/uploads/2021/02/otellofeb1.2.jpghttps://timmermanreport.com/2021/02/the-insurrectionist-and-the-visionary/confederate-flag/2021-02-05T00:37:24+00:00https://timmermanreport.com/wp-content/uploads/2021/02/confederate-flag.jpghttps://timmermanreport.com/2021/02/the-insurrectionist-and-the-visionary/morrillactmap/2021-02-05T00:44:06+00:00https://timmermanreport.com/wp-content/uploads/2021/02/morrillactmap.pnghttps://timmermanreport.com/2021/02/the-insurrectionist-and-the-visionary/porter/2021-02-05T00:46:21+00:00https://timmermanreport.com/wp-content/uploads/2021/02/porter.pnghttps://timmermanreport.com/2021/02/the-insurrectionist-and-the-visionary/porter-2/2021-02-05T00:47:00+00:00https://timmermanreport.com/wp-content/uploads/2021/02/porter-1.pnghttps://timmermanreport.com/the-long-run/synthego/2021-02-05T19:36:23+00:00https://timmermanreport.com/wp-content/uploads/2021/02/synthego-e1612816479377.jpghttps://timmermanreport.com/2021/02/a-single-shot-for-heart-disease-sekar-kathiresan-on-the-long-run/sek/2021-02-08T20:03:12+00:00https://timmermanreport.com/wp-content/uploads/2021/02/sek.jpghttps://timmermanreport.com/2021/02/a-2b-ipo-bonanza-fda-clears-juno-car-t-and-avrobio-gene-therapy-dazzles/bobjuno/2021-02-08T22:53:15+00:00https://timmermanreport.com/wp-content/uploads/2021/02/bobjuno.pnghttps://timmermanreport.com/2021/02/a-2b-ipo-bonanza-fda-clears-juno-car-t-and-avrobio-gene-therapy-dazzles/katie/2021-02-08T22:54:57+00:00https://timmermanreport.com/wp-content/uploads/2021/02/katie.pnghttps://timmermanreport.com/2021/02/no-longer-an-afterthought-day-one-raises-130m-for-childhood-cancer-therapies/dayonetherapeutics\_jeremy-1/2021-02-09T23:20:42+00:00https://timmermanreport.com/wp-content/uploads/2021/02/DayOneTherapeutics\_Jeremy-1.jpghttps://timmermanreport.com/2021/02/ensoma-gets-70m-to-enable-off-the-shelf-accessible-cell-therapies/sarah-de-crescenzo/2021-02-11T01:07:38+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Sarah-de-Crescenzo.jpghttps://timmermanreport.com/2021/02/ensoma-gets-70m-to-enable-off-the-shelf-accessible-cell-therapies/hans-peter-kiem/2021-02-11T04:50:09+00:00https://timmermanreport.com/wp-content/uploads/2021/02/hans-peter-kiem.jpghttps://timmermanreport.com/2021/02/ensoma-gets-70m-to-enable-off-the-shelf-accessible-cell-therapies/paula/2021-02-11T04:51:14+00:00https://timmermanreport.com/wp-content/uploads/2021/02/paula.jpghttps://timmermanreport.com/2021/02/long-covids-insidious-toll-novos-victory-against-obesity-gileads-stumble-in-ipf/kff1/2021-02-12T00:37:45+00:00https://timmermanreport.com/wp-content/uploads/2021/02/kff1.pnghttps://timmermanreport.com/2021/02/long-covids-insidious-toll-novos-victory-against-obesity-gileads-stumble-in-ipf/kff2/2021-02-12T00:38:17+00:00https://timmermanreport.com/wp-content/uploads/2021/02/kff2.pnghttps://timmermanreport.com/2021/02/long-covids-insidious-toll-novos-victory-against-obesity-gileads-stumble-in-ipf/sek2-2/2021-02-12T00:38:44+00:00https://timmermanreport.com/wp-content/uploads/2021/02/sek2.pnghttps://timmermanreport.com/2021/02/long-covids-insidious-toll-novos-victory-against-obesity-gileads-stumble-in-ipf/cdc3/2021-02-12T00:39:08+00:00https://timmermanreport.com/wp-content/uploads/2021/02/cdc3.pnghttps://timmermanreport.com/2021/02/centessa-rolls-up-10-medicxi-startups-gets-250m-to-scale-up-virtual-model/untitled-9522-49/2021-02-15T21:47:59+00:00https://timmermanreport.com/wp-content/uploads/2021/02/untitled-9522-49-scaled.jpghttps://timmermanreport.com/2021/02/increasing-vaccine-confidence-with-the-tools-that-got-us-this-far/covpnteam/2021-02-17T01:40:23+00:00https://timmermanreport.com/wp-content/uploads/2021/02/covpnteam.jpghttps://timmermanreport.com/2021/02/public-health-focused-adjuvant-capital-backed-by-merck-gates-raises-300m/adjuvant/2021-02-17T23:10:56+00:00https://timmermanreport.com/wp-content/uploads/2021/02/adjuvant.jpghttps://timmermanreport.com/2021/02/public-health-focused-adjuvant-capital-backed-by-merck-gates-raises-300m/anikagupta/2021-02-17T23:13:13+00:00https://timmermanreport.com/wp-content/uploads/2021/02/anikagupta.pnghttps://timmermanreport.com/2021/02/biotechs-blue-collar-needs-centessas-roll-up-and-adjuvants-fund-for-public-health/pavitra-2/2021-02-19T04:00:17+00:00https://timmermanreport.com/wp-content/uploads/2021/02/pavitra.pnghttps://timmermanreport.com/2021/02/biotechs-blue-collar-needs-centessas-roll-up-and-adjuvants-fund-for-public-health/bluebirdstock/2021-02-19T13:42:34+00:00https://timmermanreport.com/wp-content/uploads/2021/02/bluebirdstock.pnghttps://timmermanreport.com/2021/02/big-news-for-obesity-and-heart-failure-thats-been-underappreciated/alex1/2021-02-20T19:21:42+00:00https://timmermanreport.com/wp-content/uploads/2021/02/alex1.pnghttps://timmermanreport.com/2021/02/big-news-for-obesity-and-heart-failure-thats-been-underappreciated/alex2/2021-02-20T19:22:16+00:00https://timmermanreport.com/wp-content/uploads/2021/02/alex2.pnghttps://timmermanreport.com/2021/02/big-news-for-obesity-and-heart-failure-thats-been-underappreciated/alex3/2021-02-20T19:22:55+00:00https://timmermanreport.com/wp-content/uploads/2021/02/alex3.pnghttps://timmermanreport.com/2021/02/alta-reloads-astrazeneca-loses-cancer-indication-sanofi-gsk-vaccine-reboots/celine1/2021-02-23T02:20:22+00:00https://timmermanreport.com/wp-content/uploads/2021/02/celine1.pnghttps://timmermanreport.com/2021/02/alta-reloads-astrazeneca-loses-cancer-indication-sanofi-gsk-vaccine-reboots/andy2-2/2021-02-23T02:20:53+00:00https://timmermanreport.com/wp-content/uploads/2021/02/andy2.pnghttps://timmermanreport.com/2021/02/orna-therapeutics-a-circular-rna-bet-raises-80m-to-overcome-classic-rna-challenges/tom-v2-284-384-1/2021-02-24T03:23:47+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Tom-v2-284-384-1.jpghttps://timmermanreport.com/2021/02/no-more-waiting-for-central-lab-results-truvian-raises-105m/headshot-samuel-kitara/2021-02-24T03:28:48+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Headshot-Samuel-Kitara.jpeghttps://timmermanreport.com/2021/02/no-more-waiting-for-central-lab-results-truvian-raises-105m/hawkins/2021-02-24T03:30:50+00:00https://timmermanreport.com/wp-content/uploads/2021/02/hawkins.jpghttps://timmermanreport.com/2021/02/pfizer-biontech-ace-real-world-test-jj-faces-fda-scrutiny-merck-pays-up/sek3/2021-02-26T00:34:34+00:00https://timmermanreport.com/wp-content/uploads/2021/02/sek3.pnghttps://timmermanreport.com/2021/02/pfizer-biontech-ace-real-world-test-jj-faces-fda-scrutiny-merck-pays-up/carl/2021-02-26T00:37:30+00:00https://timmermanreport.com/wp-content/uploads/2021/02/carl.pnghttps://timmermanreport.com/2021/03/tenaya-grabs-106m-for-gene-therapy-regenerative-medicines-for-the-heart/faraz-ali/2021-02-28T22:04:17+00:00https://timmermanreport.com/wp-content/uploads/2021/02/faraz-ali.pnghttps://timmermanreport.com/2021/03/tenaya-grabs-106m-for-gene-therapy-regenerative-medicines-for-the-heart/goeddel1/2021-02-28T22:05:46+00:00https://timmermanreport.com/wp-content/uploads/2021/02/Goeddel1.jpghttps://timmermanreport.com/2021/03/investing-in-manufacturing-mental-health-more-bob-nelsen-on-the-long-run/nelsen/2021-03-01T22:48:10+00:00https://timmermanreport.com/wp-content/uploads/2021/03/nelsen.pnghttps://timmermanreport.com/2021/03/jj-vaccine-okd-morphic-nails-integrin-target-az-grabs-1b-for-moderna-shares/brad/2021-03-02T01:53:35+00:00https://timmermanreport.com/wp-content/uploads/2021/03/brad.pnghttps://timmermanreport.com/2021/03/jj-vaccine-okd-morphic-nails-integrin-target-az-grabs-1b-for-moderna-shares/griffin/2021-03-02T01:55:22+00:00https://timmermanreport.com/wp-content/uploads/2021/03/griffin.pnghttps://timmermanreport.com/2017/02/canadian-biotech-breakaway/olympus-digital-camera/2021-03-02T21:07:45+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AM-head-shot.jpghttps://timmermanreport.com/2021/03/bring-on-the-ai-derived-antibodies-aulos-envisions-way-to-seize-il-2-opportunity/ehlers/2021-03-02T21:16:23+00:00https://timmermanreport.com/wp-content/uploads/2021/03/ehlers.jpghttps://timmermanreport.com/2021/01/ukko-gets-bayers-backing-for-an-ai-approach-to-food-allergies/ukko/2021-03-02T21:19:34+00:00https://timmermanreport.com/wp-content/uploads/2021/01/Ukko-Chairman-and-Co-Founder-Yanay-Ofran.jpghttps://timmermanreport.com/2021/03/jj-vaccine-one-dose-delivers-strong-immune-response-and-protection/jj1/2021-03-03T16:26:01+00:00https://timmermanreport.com/wp-content/uploads/2021/03/jj1.pnghttps://timmermanreport.com/2021/03/jj-vaccine-one-dose-delivers-strong-immune-response-and-protection/jj2/2021-03-03T16:26:03+00:00https://timmermanreport.com/wp-content/uploads/2021/03/jj2.pnghttps://timmermanreport.com/2021/03/mental-health-a-new-frontier-for-biotech/da-wallach-headshot/2021-03-04T23:43:08+00:00https://timmermanreport.com/wp-content/uploads/2021/03/DA-Wallach-Headshot.jpghttps://timmermanreport.com/2021/03/mental-health-a-new-frontier-for-biotech/harmit/2021-03-04T23:46:11+00:00https://timmermanreport.com/wp-content/uploads/2021/03/harmit.pnghttps://timmermanreport.com/2021/03/science-policy-chat-join-rep-jake-auchincloss-and-me-on-clubhouse-mar-10/330px-jake\_auchincloss\_117th\_congress\_portrait/2021-03-06T21:46:21+00:00https://timmermanreport.com/wp-content/uploads/2021/03/330px-Jake\_Auchincloss\_117th\_Congress\_portrait.jpghttps://timmermanreport.com/2021/03/the-rise-in-asian-american-hate-crimes-a-biopharma-perspective-and-call-for-action/kwok/2021-03-08T18:44:47+00:00https://timmermanreport.com/wp-content/uploads/2021/03/kwok.jpghttps://timmermanreport.com/2021/03/once-vaccinated-what-to-do-with-masks/fludeaths/2021-03-10T14:06:42+00:00https://timmermanreport.com/wp-content/uploads/2021/03/fludeaths.pnghttps://timmermanreport.com/2021/03/novavax-shines-vir-antibody-stays-in-the-game-and-cdc-lightens-up/topolmar11/2021-03-12T00:29:07+00:00https://timmermanreport.com/wp-content/uploads/2021/03/topolmar11.pnghttps://timmermanreport.com/2021/03/novavax-shines-vir-antibody-stays-in-the-game-and-cdc-lightens-up/bradonblue/2021-03-12T00:29:40+00:00https://timmermanreport.com/wp-content/uploads/2021/03/bradonblue.pnghttps://timmermanreport.com/2021/03/novavax-shines-vir-antibody-stays-in-the-game-and-cdc-lightens-up/quench/2021-03-12T00:30:52+00:00https://timmermanreport.com/wp-content/uploads/2021/03/quench.pnghttps://timmermanreport.com/2021/03/azs-vaccine-mess-rubius-infiltrates-solid-tumors-insitros-400m-haul/ourworld/2021-03-16T16:21:56+00:00https://timmermanreport.com/wp-content/uploads/2021/03/ourworld.pnghttps://timmermanreport.com/2021/03/azs-vaccine-mess-rubius-infiltrates-solid-tumors-insitros-400m-haul/rubius/2021-03-16T16:22:31+00:00https://timmermanreport.com/wp-content/uploads/2021/03/rubius.pnghttps://timmermanreport.com/2021/03/burnout-alarms-are-ringing-people-need-a-break/rosanapaintings/2021-03-18T23:45:59+00:00https://timmermanreport.com/wp-content/uploads/2021/03/rosanapaintings.pnghttps://timmermanreport.com/2021/03/burnout-alarms-are-ringing-people-need-a-break/angie\_you2/2021-03-18T23:47:07+00:00https://timmermanreport.com/wp-content/uploads/2021/03/angie\_you2.jpghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/bijan-salehizadeh2x/2021-03-18T23:48:16+00:00https://timmermanreport.com/wp-content/uploads/2015/09/bijan-salehizadeh@2x.jpghttps://timmermanreport.com/2021/03/az-says-its-vaccine-is-ok-rebuilding-trust-will-take-a-while/outbreak/2021-03-22T23:54:23+00:00https://timmermanreport.com/wp-content/uploads/2021/03/outbreak.pnghttps://timmermanreport.com/2021/03/az-says-its-vaccine-is-ok-rebuilding-trust-will-take-a-while/sek-2/2021-03-22T23:54:56+00:00https://timmermanreport.com/wp-content/uploads/2021/03/sek.pnghttps://timmermanreport.com/2021/03/crossing-the-blood-brain-barrier-interview-with-denalis-ryan-watts/ryanwatts/2021-03-24T19:52:15+00:00https://timmermanreport.com/wp-content/uploads/2021/03/ryanwatts.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/ed64d40b-aff3-458d-b946-7ba1dd6092f9/2021-03-25T00:18:46+00:00https://timmermanreport.com/wp-content/uploads/2021/03/ed64d40b-aff3-458d-b946-7ba1dd6092f9.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/3bf0b7cd-7dcc-4b69-947f-b7d69733dcc0/2021-03-25T00:18:49+00:00https://timmermanreport.com/wp-content/uploads/2021/03/3bf0b7cd-7dcc-4b69-947f-b7d69733dcc0.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/a1d21eb2-3596-40c9-b004-b37b0ba9f487/2021-03-25T00:18:50+00:00https://timmermanreport.com/wp-content/uploads/2021/03/a1d21eb2-3596-40c9-b004-b37b0ba9f487.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/7c029ae2-0205-4a86-bf17-185d8d77488b/2021-03-25T00:18:52+00:00https://timmermanreport.com/wp-content/uploads/2021/03/7c029ae2-0205-4a86-bf17-185d8d77488b.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/autumn-foliage-white-mountains-new-hampshire/2021-03-25T00:21:55+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Autumn-foliage-White-Mountains-New-Hampshire.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/attachment/10677/2021-03-25T00:28:43+00:00https://timmermanreport.com/wp-content/uploads/2021/03/10677.jpghttps://timmermanreport.com/2021/03/eliem-therapeutics-debuts-with-80m-to-tackle-chronic-pain-depression/bob-azelby/2021-03-25T00:58:19+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Bob-Azelby.jpghttps://timmermanreport.com/2021/03/eliem-therapeutics-debuts-with-80m-to-tackle-chronic-pain-depression/valerie-morisset/2021-03-25T00:59:07+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Valerie-Morisset.jpghttps://timmermanreport.com/2021/03/a-glimpse-into-a-price-controlled-future/bruce-2/2021-03-26T00:35:05+00:00https://timmermanreport.com/wp-content/uploads/2021/03/bruce.pnghttps://timmermanreport.com/2021/03/a-glimpse-into-a-price-controlled-future/brad-2/2021-03-26T00:35:57+00:00https://timmermanreport.com/wp-content/uploads/2021/03/brad-1.pnghttps://timmermanreport.com/2021/03/a-glimpse-into-a-price-controlled-future/jebkeiper-web/2021-03-26T00:38:25+00:00https://timmermanreport.com/wp-content/uploads/2021/03/JebKeiper-web.pnghttps://timmermanreport.com/2021/03/a-glimpse-into-a-price-controlled-future/sara/2021-03-26T00:39:24+00:00https://timmermanreport.com/wp-content/uploads/2021/03/sara.jpghttps://timmermanreport.com/2021/03/digital-health-from-pharma-tofitness/sgsb-0349-jeffrey\_pfefferrt/2021-03-27T20:25:57+00:00https://timmermanreport.com/wp-content/uploads/2021/03/SGSB-0349-Jeffrey\_PfefferRT.jpghttps://timmermanreport.com/2021/03/digital-health-from-pharma-tofitness/erik\_compressed/2021-03-27T20:28:19+00:00https://timmermanreport.com/wp-content/uploads/2021/03/erik\_compressed-scaled.jpghttps://timmermanreport.com/2021/03/digital-health-from-pharma-tofitness/weber-2/2021-03-27T20:31:12+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Weber.jpghttps://timmermanreport.com/2021/03/needed-planet-fitness-for-the-digital-world/pete/2021-03-28T17:57:21+00:00https://timmermanreport.com/wp-content/uploads/2021/03/pete.pnghttps://timmermanreport.com/2021/03/better-faster-cheaper-dna-synthesis-at-scale-emily-leproust-the-long-run/emily-leproust-hz/2021-03-29T21:20:25+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Emily-Leproust-HZ-scaled.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/lifesciencecares/2021-03-30T00:24:02+00:00https://timmermanreport.com/wp-content/uploads/2021/03/lifesciencecares.pnghttps://timmermanreport.com/2021/03/amgen-acquires-rodeo-lean-startup-with-dual-mechanism-for-crohns-colitis/markowitz/2021-03-30T13:56:49+00:00https://timmermanreport.com/wp-content/uploads/2021/03/Markowitz.jpghttps://timmermanreport.com/2021/03/asian-americans-in-biotech-breaking-the-silence/nancyh\_31r-website/2021-03-31T20:23:50+00:00https://timmermanreport.com/wp-content/uploads/2021/03/NancyH\_31r-website.jpghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/crotty/2021-04-02T00:14:50+00:00https://timmermanreport.com/wp-content/uploads/2021/04/crotty.pnghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/juurlink/2021-04-02T00:15:25+00:00https://timmermanreport.com/wp-content/uploads/2021/04/juurlink.pnghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/norbert/2021-04-02T00:16:45+00:00https://timmermanreport.com/wp-content/uploads/2021/04/norbert.pnghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/mina/2021-04-02T00:17:20+00:00https://timmermanreport.com/wp-content/uploads/2021/04/mina.pnghttps://timmermanreport.com/2021/04/pfizers-vaccine-passes-kid-test-jjs-costly-error-and-ftc-challenges-illumina-grail/frank/2021-04-02T00:18:02+00:00https://timmermanreport.com/wp-content/uploads/2021/04/frank.pnghttps://timmermanreport.com/2021/04/building-an-easy-on-ramp-for-consumer-fitness/headshot-avatar-wharton-web-page-129x133/2021-04-03T02:18:04+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Headshot-Avatar-Wharton-Web-Page-129x133-1.jpghttps://timmermanreport.com/2021/04/building-an-easy-on-ramp-for-consumer-fitness/mehta/2021-04-03T02:21:12+00:00https://timmermanreport.com/wp-content/uploads/2021/04/mehta.pnghttps://timmermanreport.com/2021/04/covid-19-testing-going-to-the-dogs/genie-joseph-headshot-cropped/2021-04-05T20:24:23+00:00https://timmermanreport.com/wp-content/uploads/2021/04/genie-joseph-headshot-cropped.jpghttps://timmermanreport.com/2021/04/compassionate-use-policy-has-everything-we-need-except-policy-and-compassion/daniel-mcintyre/2021-04-05T22:22:24+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Daniel-McIntyre.jpghttps://timmermanreport.com/2021/04/the-glory-of-john-martin-an-understated-leader-who-built-a-biotech-powerhouse/chris-g-final-400px/2021-04-06T00:19:32+00:00https://timmermanreport.com/wp-content/uploads/2021/04/chris-g-final-400px.jpghttps://timmermanreport.com/2021/04/the-glory-of-john-martin-an-understated-leader-who-built-a-biotech-powerhouse/john-martin/2021-04-06T00:23:05+00:00https://timmermanreport.com/wp-content/uploads/2021/04/john-martin.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/timmermantraverselogo/2021-04-08T16:45:24+00:00https://timmermanreport.com/wp-content/uploads/2021/04/timmermantraverselogo.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/svb-logo-box-rgb/2021-04-08T16:46:47+00:00https://timmermanreport.com/wp-content/uploads/2021/04/svb-logo-box-rgb.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/print-2/2021-04-08T16:47:40+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Faber-Logo.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/5am\_rgb\_color\_blu-01/2021-04-08T16:48:03+00:00https://timmermanreport.com/wp-content/uploads/2021/04/5am\_RGB\_COLOR\_BLU-01.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/atlas-logo-2015-icon-type/2021-04-08T16:48:20+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Atlas-Logo-2015-Icon-Type.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/baincapital\_life-sciences\_h\_rgb/2021-04-08T16:48:37+00:00https://timmermanreport.com/wp-content/uploads/2021/04/BainCapital\_Life-Sciences\_H\_rgb.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/cbre/2021-04-08T16:49:41+00:00https://timmermanreport.com/wp-content/uploads/2021/04/cbre.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/dicerna/2021-04-08T16:49:55+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Dicerna.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/king-st/2021-04-08T16:50:12+00:00https://timmermanreport.com/wp-content/uploads/2021/04/King-St.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/massbiologo\_color/2021-04-08T16:50:28+00:00https://timmermanreport.com/wp-content/uploads/2021/04/MassBioLogo\_Color.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/qiming/2021-04-08T16:51:40+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Qiming.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/primary-cropped/2021-04-08T16:51:56+00:00https://timmermanreport.com/wp-content/uploads/2021/04/PRIMARY-CROPPED-e1617928610495.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/browne-consulting-group/2021-04-08T16:52:21+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Browne-Consulting-Group-scaled.jpghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/foley-hoag/2021-04-08T16:53:04+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Foley-Hoag.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/lightstonepng/2021-04-08T16:54:11+00:00https://timmermanreport.com/wp-content/uploads/2021/04/lightstonepng.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/crlpng/2021-04-08T16:54:56+00:00https://timmermanreport.com/wp-content/uploads/2021/04/crlpng.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/racap\_id\_blue\_notag/2021-04-08T20:59:01+00:00https://timmermanreport.com/wp-content/uploads/2021/04/RACap\_ID\_Blue\_NoTag.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/sr-one/2021-04-08T21:00:30+00:00https://timmermanreport.com/wp-content/uploads/2021/04/sr-one.pnghttps://timmermanreport.com/2021/04/timmerman-traverse-for-lsc-a-biotech-community-drive-to-fight-poverty/1ab-green-1/2021-04-08T22:11:00+00:00https://timmermanreport.com/wp-content/uploads/2021/04/1AB-Green-1.jpghttps://timmermanreport.com/2021/04/partnering-in-a-world-of-biotech-abundance-james-sabry-on-the-long-run/ec-sabry-2018\_370px/2021-04-17T15:59:52+00:00https://timmermanreport.com/wp-content/uploads/2021/04/ec-sabry-2018\_370px.jpghttps://timmermanreport.com/readers-saying/bob-more/2021-04-21T13:16:04+00:00https://timmermanreport.com/wp-content/uploads/2021/04/bob-more.pnghttps://timmermanreport.com/2021/04/liberating-founders-and-investors-from-narrative-bias/alit-2/2021-04-26T15:34:25+00:00https://timmermanreport.com/wp-content/uploads/2021/04/alit.pnghttps://timmermanreport.com/2021/04/building-momentum-and-leverage-how-pandion-ended-up-acquired-by-merck/pandion\_ceo\_rahul\_kakkar\_md/2021-04-26T17:28:52+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Pandion\_CEO\_Rahul\_Kakkar\_MD.jpghttps://timmermanreport.com/2021/04/boundless-bio-pushing-frontiers-with-ecdna-cancer-therapy-raises-105m/zachary-hornby/2021-04-28T01:23:36+00:00https://timmermanreport.com/wp-content/uploads/2021/04/Zachary-Hornby.jpghttps://timmermanreport.com/2021/04/boundless-bio-pushing-frontiers-with-ecdna-cancer-therapy-raises-105m/jason/2021-04-28T01:25:02+00:00https://timmermanreport.com/wp-content/uploads/2021/04/jason.jpghttps://timmermanreport.com/2020/06/versant-bets-50m-on-lycia-to-make-protein-degraders-against-extracellular-targets/clareozawa-2/2021-04-29T00:42:00+00:00https://timmermanreport.com/wp-content/uploads/2020/06/clareozawa-1.jpghttps://timmermanreport.com/2021/04/abbvie-bets-90m-on-capsida-approach-to-aav-gene-therapy-delivery/beth-wlb-web/2021-04-29T00:43:33+00:00https://timmermanreport.com/wp-content/uploads/2021/04/beth-wlb-web.jpghttps://timmermanreport.com/2019/05/third-rock-and-friends-bet-110m-on-thrive-a-hopkins-born-cancer-screening-startup/clengauer/2021-04-29T13:36:35+00:00https://timmermanreport.com/wp-content/uploads/2019/05/clengauer.jpghttps://timmermanreport.com/2020/03/agbt-2020-recap-partying-like-its-1999-for-good-reason/deannainscripta\_20190426123759/2021-04-29T13:37:46+00:00https://timmermanreport.com/wp-content/uploads/2020/02/DeannaInscripta\_20190426123759-scaled.jpghttps://timmermanreport.com/2021/05/single-cell-analysis-comes-of-age-lighting-the-way-for-precision-therapies/kamkolkar/2021-04-29T13:40:28+00:00https://timmermanreport.com/wp-content/uploads/2021/04/kamkolkar.pnghttps://timmermanreport.com/2021/05/single-cell-analysis-comes-of-age-lighting-the-way-for-precision-therapies/joevictor/2021-04-29T13:42:31+00:00https://timmermanreport.com/wp-content/uploads/2021/04/joevictor.jpghttps://timmermanreport.com/2021/05/single-cell-analysis-comes-of-age-lighting-the-way-for-precision-therapies/aphilippakis-1\_134715/2021-04-29T14:05:07+00:00https://timmermanreport.com/wp-content/uploads/2021/04/APhilippakis-1\_134715.jpghttps://timmermanreport.com/2021/05/single-cell-analysis-comes-of-age-lighting-the-way-for-precision-therapies/aphilippakis-1\_134715-2/2021-04-29T14:05:56+00:00https://timmermanreport.com/wp-content/uploads/2021/04/APhilippakis-1\_134715-1.jpghttps://timmermanreport.com/2021/04/jj-back-after-pause-sanofi-aids-moderna-and-a-flood-of-women-join-biotech-boards/brad1-2/2021-04-29T23:52:37+00:00https://timmermanreport.com/wp-content/uploads/2021/04/brad1.pnghttps://timmermanreport.com/2021/04/jj-back-after-pause-sanofi-aids-moderna-and-a-flood-of-women-join-biotech-boards/brad2-2/2021-04-29T23:52:39+00:00https://timmermanreport.com/wp-content/uploads/2021/04/brad2.pnghttps://timmermanreport.com/2021/04/jj-back-after-pause-sanofi-aids-moderna-and-a-flood-of-women-join-biotech-boards/brad2-3/2021-04-29T23:53:23+00:00https://timmermanreport.com/wp-content/uploads/2021/04/brad2-1.pnghttps://timmermanreport.com/2021/04/jj-back-after-pause-sanofi-aids-moderna-and-a-flood-of-women-join-biotech-boards/brightangelapr24small/2021-04-29T23:54:37+00:00https://timmermanreport.com/wp-content/uploads/2021/04/BrightAngelApr24small.jpghttps://timmermanreport.com/2021/05/rt-pcr-tests-for-covid-19-have-quantitative-power-lets-start-using-it/mara1/2021-05-03T22:33:34+00:00https://timmermanreport.com/wp-content/uploads/2021/05/mara1.pnghttps://timmermanreport.com/2021/05/rt-pcr-tests-for-covid-19-have-quantitative-power-lets-start-using-it/mara1-2/2021-05-03T22:34:02+00:00https://timmermanreport.com/wp-content/uploads/2021/05/mara1-1.pnghttps://timmermanreport.com/2021/05/rt-pcr-tests-for-covid-19-have-quantitative-power-lets-start-using-it/mara2/2021-05-03T22:35:47+00:00https://timmermanreport.com/wp-content/uploads/2021/05/mara2.pnghttps://timmermanreport.com/2021/05/startup-profiles-perlmutter-bets-on-super-microscopy-foresites-precision-immunology/tjian/2021-05-05T02:01:13+00:00https://timmermanreport.com/wp-content/uploads/2021/05/tjian.jpghttps://timmermanreport.com/2021/05/startup-profiles-perlmutter-bets-on-super-microscopy-foresites-precision-immunology/june/2021-05-05T02:01:39+00:00https://timmermanreport.com/wp-content/uploads/2021/05/june.jpghttps://timmermanreport.com/2021/05/motivating-fitness-with-immersive-experience-rather-than-competition/danliebermanheadshot/2021-05-06T04:22:10+00:00https://timmermanreport.com/wp-content/uploads/2021/05/danliebermanheadshot.pnghttps://timmermanreport.com/2021/05/biden-threatens-patents-vaccines-shine-biogens-pricing-predicament/raj/2021-05-06T23:51:03+00:00https://timmermanreport.com/wp-content/uploads/2021/05/raj.pnghttps://timmermanreport.com/2021/05/biden-threatens-patents-vaccines-shine-biogens-pricing-predicament/trade/2021-05-06T23:51:24+00:00https://timmermanreport.com/wp-content/uploads/2021/05/trade.pnghttps://timmermanreport.com/2021/05/appia-bio-seeks-off-the-shelf-cancer-therapy-with-rare-inkt-cells/zoesteinsnyder/2021-05-10T17:39:59+00:00https://timmermanreport.com/wp-content/uploads/2021/05/zoesteinsnyder.pnghttps://timmermanreport.com/2021/05/appia-bio-seeks-off-the-shelf-cancer-therapy-with-rare-inkt-cells/kang1/2021-05-10T17:44:14+00:00https://timmermanreport.com/wp-content/uploads/2021/05/Kang1.jpghttps://timmermanreport.com/2021/05/appia-bio-seeks-off-the-shelf-cancer-therapy-with-rare-inkt-cells/yangl/2021-05-10T17:46:48+00:00https://timmermanreport.com/wp-content/uploads/2021/05/YangL.jpghttps://timmermanreport.com/2021/05/pfizer-advances-to-adolescents-xontogenys-new-fund-rekindling-curiosity/goldstein1/2021-05-14T00:16:46+00:00https://timmermanreport.com/wp-content/uploads/2021/05/Goldstein1.jpghttps://timmermanreport.com/2021/05/pfizer-advances-to-adolescents-xontogenys-new-fund-rekindling-curiosity/rajsingapore/2021-05-14T00:18:05+00:00https://timmermanreport.com/wp-content/uploads/2021/05/rajsingapore.pnghttps://timmermanreport.com/2021/05/pfizer-advances-to-adolescents-xontogenys-new-fund-rekindling-curiosity/economist/2021-05-14T00:18:46+00:00https://timmermanreport.com/wp-content/uploads/2021/05/economist.pnghttps://timmermanreport.com/2021/05/vedere-ii-after-novartis-acquisition-snags-77m-for-gene-therapy-to-restore-vision/c\_moyazeni-1/2021-05-18T01:40:37+00:00https://timmermanreport.com/wp-content/uploads/2021/05/c\_moyazeni-1.jpghttps://timmermanreport.com/2021/05/vedere-ii-after-novartis-acquisition-snags-77m-for-gene-therapy-to-restore-vision/cyrus/2021-05-18T13:33:46+00:00https://timmermanreport.com/wp-content/uploads/2021/05/cyrus.pnghttps://timmermanreport.com/2021/05/sqz-biotech-shortens-cell-therapy-manufacturing-time-demonstrates-safety/sharei/2021-05-19T20:40:02+00:00https://timmermanreport.com/wp-content/uploads/2021/05/sharei.pnghttps://timmermanreport.com/2021/05/gsk-persists-with-vaccines-asco-abstracts-biogen-gene-therapy-fizzles/katie-2/2021-05-21T00:15:07+00:00https://timmermanreport.com/wp-content/uploads/2021/05/katie.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/dchang/2021-05-27T00:07:35+00:00https://timmermanreport.com/wp-content/uploads/2021/05/dchang.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/ahuang/2021-05-27T00:08:52+00:00https://timmermanreport.com/wp-content/uploads/2021/05/ahuang.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/samk/2021-05-27T00:11:41+00:00https://timmermanreport.com/wp-content/uploads/2021/05/samk.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/tachiy/2021-05-27T00:15:02+00:00https://timmermanreport.com/wp-content/uploads/2021/05/tachiy.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/eridai-2/2021-05-27T00:17:22+00:00https://timmermanreport.com/wp-content/uploads/2021/05/eridai-1.pnghttps://timmermanreport.com/2021/05/from-fitness-to-flourish-expanding-the-scope-of-digital-exercise/wellbeing/2021-05-27T19:54:27+00:00https://timmermanreport.com/wp-content/uploads/2021/05/wellbeing.pnghttps://timmermanreport.com/2021/05/gsk-vir-win-antibody-ok-sanofi-gsk-moves-to-phase-iii-a-day-one-ipo/suesutter/2021-05-28T02:22:59+00:00https://timmermanreport.com/wp-content/uploads/2021/05/suesutter.pnghttps://timmermanreport.com/2021/06/the-promise-and-challenge-of-deriving-meaningful-clinical-insights-from-wearables/jessilynn-dunn/2021-05-31T19:39:33+00:00https://timmermanreport.com/wp-content/uploads/2021/05/jessilynn-dunn.jpghttps://timmermanreport.com/2021/06/the-promise-and-challenge-of-deriving-meaningful-clinical-insights-from-wearables/mike-snyder\_web300/2021-05-31T19:41:28+00:00https://timmermanreport.com/wp-content/uploads/2021/05/mike-snyder\_web300.jpghttps://timmermanreport.com/2021/06/stablix-seeking-to-stabilize-instead-of-degrade-proteins-raises-63m/versant\_team\_carlo/2021-06-02T19:01:32+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Versant\_Team\_Carlo.jpghttps://timmermanreport.com/2021/06/stablix-seeking-to-stabilize-instead-of-degrade-proteins-raises-63m/colecraft/2021-06-02T19:02:32+00:00https://timmermanreport.com/wp-content/uploads/2021/06/colecraft.jpghttps://timmermanreport.com/2021/06/amgens-kras-triumph-eric-lander-in-the-saddle-and-eqrx-takes-aim-at-pd-l1/dwb/2021-06-04T00:36:53+00:00https://timmermanreport.com/wp-content/uploads/2021/06/dwb.pnghttps://timmermanreport.com/2021/06/amgens-kras-triumph-eric-lander-in-the-saddle-and-eqrx-takes-aim-at-pd-l1/boothmorph/2021-06-04T00:37:25+00:00https://timmermanreport.com/wp-content/uploads/2021/06/boothmorph.pnghttps://timmermanreport.com/2021/06/bright-peak-therapeutics-raises-107m-to-advance-cytokine-engineering/fredwiklund1/2021-06-09T19:25:30+00:00https://timmermanreport.com/wp-content/uploads/2021/06/fredwiklund1.pnghttps://timmermanreport.com/2021/06/t-cell-diagnostic-tests-covid-19-pushed-us-and-we-can-see-where-this-leads/chadrobins/2021-06-10T01:37:28+00:00https://timmermanreport.com/wp-content/uploads/2021/06/chadrobins.pnghttps://timmermanreport.com/2021/06/biogens-alzheimers-controversy-cytokine-startups-reload-and-vaccines-beat-variants/makris/2021-06-10T23:21:50+00:00https://timmermanreport.com/wp-content/uploads/2021/06/makris.pnghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/torres/2021-06-12T21:48:22+00:00https://timmermanreport.com/wp-content/uploads/2021/06/torres.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/paul-s-sm/2021-06-12T21:49:17+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Paul-S.-sm.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/paul/2021-06-12T21:50:31+00:00https://timmermanreport.com/wp-content/uploads/2021/06/paul.pnghttps://timmermanreport.com/2020/09/small-molecules-against-rna-targets-jennifer-petter-on-the-long-run/jpetter/2021-06-12T21:51:39+00:00https://timmermanreport.com/wp-content/uploads/2020/09/jpetter-scaled.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/corinne-le-goff/2021-06-12T21:52:45+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Corinne-Le-Goff.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/moore/2021-06-12T21:53:29+00:00https://timmermanreport.com/wp-content/uploads/2021/06/moore.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/erichuang/2021-06-12T21:54:28+00:00https://timmermanreport.com/wp-content/uploads/2021/06/erichuang.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/paolo/2021-06-12T21:54:58+00:00https://timmermanreport.com/wp-content/uploads/2021/06/paolo.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/jesusgomez/2021-06-12T21:55:43+00:00https://timmermanreport.com/wp-content/uploads/2021/06/jesusgomez.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/fust/2021-06-12T21:56:27+00:00https://timmermanreport.com/wp-content/uploads/2021/06/fust.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/fust-2/2021-06-12T21:56:55+00:00https://timmermanreport.com/wp-content/uploads/2021/06/fust-1.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/funnell/2021-06-12T21:58:30+00:00https://timmermanreport.com/wp-content/uploads/2021/06/funnell.pnghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/laurent/2021-06-12T21:59:34+00:00https://timmermanreport.com/wp-content/uploads/2021/06/laurent.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/leone/2021-06-12T21:59:57+00:00https://timmermanreport.com/wp-content/uploads/2021/06/leone.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/david-square-2-e1524497396520/2021-06-12T22:01:29+00:00https://timmermanreport.com/wp-content/uploads/2021/06/david-square-2-e1524497396520.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/carolyn-2/2021-06-12T22:01:47+00:00https://timmermanreport.com/wp-content/uploads/2021/06/carolyn.jpghttps://timmermanreport.com/2021/06/biotech-pride-19-industry-leaders-who-identify-as-lgbtq/isabel-aznarez/2021-06-12T22:02:16+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Isabel-Aznarez.jpghttps://timmermanreport.com/2021/06/after-devastating-new-study-is-there-a-future-for-workplace-wellness-and-has-peloton-figured-it-out/profiles\_mapp\_faculty\_martyseligman/2021-06-15T16:36:00+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Profiles\_MAPP\_Faculty\_MartySeligman.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/kelly-chibale2/2021-06-16T21:36:07+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Kelly-Chibale2.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/330px-kizzmekia\_corbett\_portrait/2021-06-16T21:39:04+00:00https://timmermanreport.com/wp-content/uploads/2021/06/330px-Kizzmekia\_Corbett\_portrait-e1623879579991.jpghttps://timmermanreport.com/2020/12/startup-profiles-exosite-drug-discovery-efficient-gene-therapy-for-the-eye/jackie-grant\_large\_52425c438f53f4d02eb7eba32b8b5077/2021-06-16T21:42:07+00:00https://timmermanreport.com/wp-content/uploads/2020/12/Jackie-Grant\_large\_52425c438f53f4d02eb7eba32b8b5077.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/williamhobbs/2021-06-16T21:44:23+00:00https://timmermanreport.com/wp-content/uploads/2021/06/williamhobbs.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/enoch/2021-06-16T21:45:21+00:00https://timmermanreport.com/wp-content/uploads/2021/06/enoch.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/mola/2021-06-16T21:47:35+00:00https://timmermanreport.com/wp-content/uploads/2021/06/mola.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/peter/2021-06-16T21:52:27+00:00https://timmermanreport.com/wp-content/uploads/2021/06/peter.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/cameron/2021-06-16T21:53:16+00:00https://timmermanreport.com/wp-content/uploads/2021/06/cameron.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/derrell/2021-06-16T21:53:57+00:00https://timmermanreport.com/wp-content/uploads/2021/06/derrell.jpghttps://timmermanreport.com/2021/06/on-juneteenth-honoring-22-black-biotech-leaders/rasession-2/2021-06-16T21:55:07+00:00https://timmermanreport.com/wp-content/uploads/2021/06/rasession.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/timmerman-web-graphic-2/2021-06-21T20:03:03+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Timmerman-Web-Graphic-2.pnghttps://timmermanreport.com/2021/06/third-rock-led-abata-secures-95m-for-t-reg-cell-therapy-against-ms/samantha-singer\_abata/2021-06-22T21:36:44+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Samantha-Singer\_Abata-scaled.jpghttps://timmermanreport.com/2021/06/third-rock-led-abata-secures-95m-for-t-reg-cell-therapy-against-ms/richard-ransohoff\_abata/2021-06-22T21:38:05+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Richard-Ransohoff\_Abata.jpghttps://timmermanreport.com/2021/06/f-prime-leads-60m-bet-on-adela-scanning-the-methylome-for-early-signs-of-cancer/baldoni/2021-06-22T23:56:26+00:00https://timmermanreport.com/wp-content/uploads/2021/06/baldoni.pnghttps://timmermanreport.com/2021/06/f-prime-leads-60m-bet-on-adela-scanning-the-methylome-for-early-signs-of-cancer/decarvalho/2021-06-23T00:05:45+00:00https://timmermanreport.com/wp-content/uploads/2021/06/decarvalho.jpghttps://timmermanreport.com/2021/06/f-prime-leads-60m-bet-on-adela-scanning-the-methylome-for-early-signs-of-cancer/bratman/2021-06-23T00:06:28+00:00https://timmermanreport.com/wp-content/uploads/2021/06/bratman.jpghttps://timmermanreport.com/2021/06/eqrx-exscientia-team-up-to-accelerate-rd-for-lower-priced-better-drugs/andrew-hopkins/2021-06-24T01:43:36+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Andrew-Hopkins.jpghttps://timmermanreport.com/2021/06/the-other-half-decentralized-research-is-the-path-to-all-inclusive-medicine/sanskriti-thakur-medable-cgo-2021/2021-06-24T19:22:43+00:00https://timmermanreport.com/wp-content/uploads/2021/06/Sanskriti-Thakur-Medable-CGO-2021.jpghttps://timmermanreport.com/2021/06/lander-pushes-arpa-h-lilly-follows-fast-in-alzheimers-wyden-moderates-on-price/senate-commerce-science-and-transportation-committee-hearing/2021-06-25T00:21:01+00:00https://timmermanreport.com/wp-content/uploads/2021/06/eric-lander-commerce-committee-hearing-crop.jpghttps://timmermanreport.com/2021/06/lander-pushes-arpa-h-lilly-follows-fast-in-alzheimers-wyden-moderates-on-price/llybiib/2021-06-25T00:22:17+00:00https://timmermanreport.com/wp-content/uploads/2021/06/llybiib.pnghttps://timmermanreport.com/2021/06/lander-pushes-arpa-h-lilly-follows-fast-in-alzheimers-wyden-moderates-on-price/skorneybrian/2021-06-25T00:38:03+00:00https://timmermanreport.com/wp-content/uploads/2021/06/skorneybrian.jpghttps://timmermanreport.com/2021/06/lab-supply-shortages-persist-slowing-down-everyday-experiments/eppendorf/2021-06-28T21:55:09+00:00https://timmermanreport.com/wp-content/uploads/2021/06/eppendorf.pnghttps://timmermanreport.com/2021/06/lab-supply-shortages-persist-slowing-down-everyday-experiments/suzieruskin/2021-06-28T21:58:05+00:00https://timmermanreport.com/wp-content/uploads/2021/06/suzieruskin.pnghttps://timmermanreport.com/2021/06/lab-supply-shortages-persist-slowing-down-everyday-experiments/manabe/2021-06-29T00:23:58+00:00https://timmermanreport.com/wp-content/uploads/2021/06/manabe.jpghttps://timmermanreport.com/2021/06/lab-supply-shortages-persist-slowing-down-everyday-experiments/jcheah/2021-06-29T14:36:55+00:00https://timmermanreport.com/wp-content/uploads/2021/06/jcheah.pnghttps://timmermanreport.com/in-the-news/tradeoffslogo/2021-06-30T17:01:10+00:00https://timmermanreport.com/wp-content/uploads/2021/06/tradeoffslogo.pnghttps://timmermanreport.com/2021/07/biogens-perilous-path-intellias-in-vivo-milestone-holiday-financings/secretary-xavier-becerra/2021-07-01T23:34:37+00:00https://timmermanreport.com/wp-content/uploads/2021/07/secretary-xavier-becerra.jpghttps://timmermanreport.com/2018/06/impact-on-the-world-in-more-ways-than-one-tony-coles-on-the-long-run-podcast/tonycoles/2021-07-01T23:36:46+00:00https://timmermanreport.com/wp-content/uploads/2018/06/tonycoles.jpghttps://timmermanreport.com/2021/07/verge-genomics-secures-25m-from-lilly-to-validate-new-als-drug-targets/jane/2021-07-07T21:02:36+00:00https://timmermanreport.com/wp-content/uploads/2021/07/jane-e1625691740287.jpghttps://timmermanreport.com/2021/07/verge-genomics-secures-25m-from-lilly-to-validate-new-als-drug-targets/alice-zhang-headshot-high-res/2021-07-07T21:03:30+00:00https://timmermanreport.com/wp-content/uploads/2021/07/Alice-Zhang-Headshot-high-res-e1625691792560.pnghttps://timmermanreport.com/2021/07/one-and-done-gene-editing-a-feature-or-flaw/simeon/2021-07-12T18:58:56+00:00https://timmermanreport.com/wp-content/uploads/2021/07/simeon.pnghttps://timmermanreport.com/2021/07/payers-revolt-against-biogens-aduhelm-fda-credibility-crisis-and-a-prime-financing/rnjuly13/2021-07-15T23:50:58+00:00https://timmermanreport.com/wp-content/uploads/2021/07/rnjuly13.pnghttps://timmermanreport.com/2021/07/payers-revolt-against-biogens-aduhelm-fda-credibility-crisis-and-a-prime-financing/cdc/2021-07-15T23:51:32+00:00https://timmermanreport.com/wp-content/uploads/2021/07/cdc.pnghttps://timmermanreport.com/2021/07/payers-revolt-against-biogens-aduhelm-fda-credibility-crisis-and-a-prime-financing/brilliant/2021-07-15T23:54:20+00:00https://timmermanreport.com/wp-content/uploads/2021/07/brilliant.pnghttps://timmermanreport.com/2021/07/from-deltato-omega/otellojuly192021/2021-07-19T15:47:48+00:00https://timmermanreport.com/wp-content/uploads/2021/07/OtelloJuly192021.pnghttps://timmermanreport.com/2021/07/investing-at-the-nexus-of-biology-technology-jenny-rooke-on-the-long-run/jenny/2021-07-19T17:13:42+00:00https://timmermanreport.com/wp-content/uploads/2021/07/Jenny.jpghttps://timmermanreport.com/2021/07/investing-at-the-nexus-of-biology-technology-jenny-rooke-on-the-long-run/dna-script-logo/2021-07-19T17:16:32+00:00https://timmermanreport.com/wp-content/uploads/2021/07/DNA-Script-Logo.pnghttps://timmermanreport.com/2021/07/biogens-bumbling-defense-delta-on-the-move-pacbios-power-play/sekvaccine/2021-07-22T23:25:47+00:00https://timmermanreport.com/wp-content/uploads/2021/07/sekvaccine.pnghttps://timmermanreport.com/2021/07/biogens-bumbling-defense-delta-on-the-move-pacbios-power-play/dickinson/2021-07-22T23:26:38+00:00https://timmermanreport.com/wp-content/uploads/2021/07/dickinson.pnghttps://timmermanreport.com/2021/08/kidney-companies-taking-pages-from-the-oncology-playbook-with-precision-medicine/tony\_558x392/2021-07-24T16:19:31+00:00https://timmermanreport.com/wp-content/uploads/2021/07/Tony\_558x392.pnghttps://timmermanreport.com/2021/08/kidney-companies-taking-pages-from-the-oncology-playbook-with-precision-medicine/blaine/2021-07-24T16:20:54+00:00https://timmermanreport.com/wp-content/uploads/2021/07/blaine.pnghttps://timmermanreport.com/2021/08/all-inclusive-medicine-needs-more-diverse-genomic-data/onlunye/2021-07-26T20:25:14+00:00https://timmermanreport.com/wp-content/uploads/2021/07/onlunye.jpghttps://timmermanreport.com/2021/08/all-inclusive-medicine-needs-more-diverse-genomic-data/lappalainen-portrait-300/2021-07-26T20:33:00+00:00https://timmermanreport.com/wp-content/uploads/2021/07/Lappalainen-Portrait-300.jpghttps://timmermanreport.com/2021/08/all-inclusive-medicine-needs-more-diverse-genomic-data/varmus-1014x487/2021-07-26T20:40:19+00:00https://timmermanreport.com/wp-content/uploads/2021/07/varmus-1014x487-1.jpghttps://timmermanreport.com/2021/01/the-politics-of-speaking-up/phastings/2021-07-26T21:13:33+00:00https://timmermanreport.com/wp-content/uploads/2021/01/phastings.jpghttps://timmermanreport.com/2021/07/career-arc-of-a-biotech-leader-sue-desmond-hellmann-on-the-long-run/sue-desmond-hellmann/2021-07-26T22:21:21+00:00https://timmermanreport.com/wp-content/uploads/2021/07/sue-desmond-hellmann.jpghttps://timmermanreport.com/2021/07/fda-rejections-midsummer-ipos-amgens-bispecific-buy/hill/2021-07-29T23:23:12+00:00https://timmermanreport.com/wp-content/uploads/2021/07/hill.pnghttps://timmermanreport.com/2021/08/tachi-yamada-physician-scientist-biopharma-industry-leader-dies-at-76/topper/2021-08-05T01:57:16+00:00https://timmermanreport.com/wp-content/uploads/2021/08/topper.jpghttps://timmermanreport.com/2021/08/tachi-yamada-physician-scientist-biopharma-industry-leader-dies-at-76/goldsmith-image\_3x/2021-08-05T01:58:05+00:00https://timmermanreport.com/wp-content/uploads/2021/08/goldsmith-image\_3x.pnghttps://timmermanreport.com/the-long-run/tfs-logo/2021-08-05T17:26:10+00:00https://timmermanreport.com/wp-content/uploads/2021/08/TFS-LOGO.pnghttps://timmermanreport.com/2021/08/bayer-snaps-up-vividion-sanofi-grabs-translate-bio-and-rip-tachi-yamada/topol/2021-08-06T00:52:54+00:00https://timmermanreport.com/wp-content/uploads/2021/08/topol.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/timmerman-web-graphic-sponsors/2021-08-19T16:10:07+00:00https://timmermanreport.com/wp-content/uploads/2021/08/Timmerman-Web-Graphic-Sponsors.pnghttps://timmermanreport.com/2021/08/spiritual-renewal-through-giving-back-and-experiencing-nature/bakerglacier/2021-08-20T16:29:05+00:00https://timmermanreport.com/wp-content/uploads/2021/08/bakerglacier.pnghttps://timmermanreport.com/2021/08/spiritual-renewal-through-giving-back-and-experiencing-nature/bakerglacier-2/2021-08-20T16:29:20+00:00https://timmermanreport.com/wp-content/uploads/2021/08/bakerglacier-1.pnghttps://timmermanreport.com/2021/08/spiritual-renewal-through-giving-back-and-experiencing-nature/bakersummit/2021-08-20T16:31:31+00:00https://timmermanreport.com/wp-content/uploads/2021/08/bakersummit.pnghttps://timmermanreport.com/2021/08/spiritual-renewal-through-giving-back-and-experiencing-nature/bakersmall/2021-08-20T18:00:40+00:00https://timmermanreport.com/wp-content/uploads/2021/08/bakersmall.jpghttps://timmermanreport.com/2021/08/computation-is-the-backstage-enabler-in-gene-editing/mandanaarbab/2021-08-20T19:46:56+00:00https://timmermanreport.com/wp-content/uploads/2021/08/mandanaarbab.jpghttps://timmermanreport.com/2021/08/computation-is-the-backstage-enabler-in-gene-editing/lucasharrington/2021-08-20T19:49:03+00:00https://timmermanreport.com/wp-content/uploads/2021/08/lucasharrington.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/1-2/2021-08-25T19:17:06+00:00https://timmermanreport.com/wp-content/uploads/2021/08/1.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/attachment/2/2021-08-25T19:17:26+00:00https://timmermanreport.com/wp-content/uploads/2021/08/2.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/attachment/3/2021-08-25T19:17:42+00:00https://timmermanreport.com/wp-content/uploads/2021/08/3.pnghttps://timmermanreport.com/2021/08/meet-the-climb-to-fight-cancer-postdoctoral-fellow-aleena-arakaki/aleenaarakaki/2021-08-25T21:53:01+00:00https://timmermanreport.com/wp-content/uploads/2021/08/aleenaarakaki.jpghttps://timmermanreport.com/2021/08/meet-the-climb-to-fight-cancer-postdoctoral-fellow-aleena-arakaki/kiliteamfellowship/2021-08-25T22:04:06+00:00https://timmermanreport.com/wp-content/uploads/2021/08/kiliteamfellowship.pnghttps://timmermanreport.com/2021/08/meet-the-climb-to-fight-cancer-postdoctoral-fellow-aleena-arakaki/kili/2021-08-25T23:46:39+00:00https://timmermanreport.com/wp-content/uploads/2021/08/kili.pnghttps://timmermanreport.com/2021/08/pfizer-biontech-vaccine-approved-lilly-works-with-lycia-we-wait-for-jj/tests/2021-08-26T20:44:56+00:00https://timmermanreport.com/wp-content/uploads/2021/08/tests.pnghttps://timmermanreport.com/2021/08/pfizer-biontech-vaccine-approved-lilly-works-with-lycia-we-wait-for-jj/chinaresearch/2021-08-26T20:45:18+00:00https://timmermanreport.com/wp-content/uploads/2021/08/chinaresearch.pnghttps://timmermanreport.com/2021/08/pfizer-biontech-vaccine-approved-lilly-works-with-lycia-we-wait-for-jj/cohen/2021-08-26T20:54:19+00:00https://timmermanreport.com/wp-content/uploads/2021/08/cohen.pnghttps://timmermanreport.com/2021/08/atlas-medicxi-invest-70m-in-antibody-for-obesity-licensed-from-novartis/klickstein/2021-08-30T23:34:39+00:00https://timmermanreport.com/wp-content/uploads/2021/08/klickstein.jpghttps://timmermanreport.com/2021/09/uk-gamechanger-for-heart-disease-jj-hiv-vaccine-fails-purdue-goes-kaput/onno/2021-09-02T23:17:43+00:00https://timmermanreport.com/wp-content/uploads/2021/09/onno.pnghttps://timmermanreport.com/2021/09/base-editing-for-therapeutics-john-evans-on-the-long-run/tfs-logo-2/2021-09-03T17:38:02+00:00https://timmermanreport.com/wp-content/uploads/2021/09/TFS-LOGO.pnghttps://timmermanreport.com/2021/09/versant-orbimed-invest-50m-in-startup-inserting-genes-in-the-liver/wilson-2/2021-09-08T02:14:51+00:00https://timmermanreport.com/wp-content/uploads/2021/09/wilson.jpghttps://timmermanreport.com/2021/09/hero-narratives-inspire-entrepreneurs-but-obscure-uncomfortable-trade-offs/reid107823-600x801/2021-09-08T17:18:25+00:00https://timmermanreport.com/wp-content/uploads/2021/09/reid107823-600x801-1.jpghttps://timmermanreport.com/timmerman-traverse-for-lsc/1-4/2021-09-08T17:22:18+00:00https://timmermanreport.com/wp-content/uploads/2021/09/1.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/2-2/2021-09-08T17:22:43+00:00https://timmermanreport.com/wp-content/uploads/2021/09/2.pnghttps://timmermanreport.com/timmerman-traverse-for-lsc/3-2/2021-09-08T17:23:06+00:00https://timmermanreport.com/wp-content/uploads/2021/09/3.pnghttps://timmermanreport.com/2021/09/knowledge-is-power-the-covid-testing-opportunity-mara-aspinall-on-the-long-run/ansr-logo-no-tag-1900px-png-1/2021-09-13T01:03:09+00:00https://timmermanreport.com/wp-content/uploads/2021/09/ANSR-logo-no-tag-1900px-PNG-1.pnghttps://timmermanreport.com/2021/09/what-should-i-read-a-few-suggestions-for-biotech-pros/brian-christian-photo-by-eileen-meny-crop-3/2021-09-20T18:37:59+00:00https://timmermanreport.com/wp-content/uploads/2021/09/brian-christian-photo-by-eileen-meny-crop-3.jpghttps://timmermanreport.com/2021/09/what-should-i-read-a-few-suggestions-for-biotech-pros/scott\_gottlieb\_2/2021-09-20T18:40:02+00:00https://timmermanreport.com/wp-content/uploads/2021/09/scott\_gottlieb\_2.pnghttps://timmermanreport.com/2019/04/foundation-flatiron-cross-the-genotype-phenotype-chasm-show-clinical-cancer-genome-database-at-work/flatiron\_vineeta\_agarwala/2021-09-20T19:02:44+00:00https://timmermanreport.com/wp-content/uploads/2019/04/flatiron\_vineeta\_agarwala.jpghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/madisonhut/2021-09-20T19:07:10+00:00https://timmermanreport.com/wp-content/uploads/2021/09/madisonhut.pnghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/reidhuber/2021-09-20T23:37:13+00:00https://timmermanreport.com/wp-content/uploads/2021/09/reidhuber.pnghttps://timmermanreport.com/2021/09/a-magical-time-in-the-presidential-range-giving-back-to-community/alice/2021-09-21T00:56:01+00:00https://timmermanreport.com/wp-content/uploads/2021/09/ALICE.jpghttps://timmermanreport.com/2021/09/jj-bounces-back-illumina-grail-scrutiny-azs-her-2-adc-triumph/alex/2021-09-23T22:56:44+00:00https://timmermanreport.com/wp-content/uploads/2021/09/alex.pnghttps://timmermanreport.com/2021/09/jj-bounces-back-illumina-grail-scrutiny-azs-her-2-adc-triumph/attnbiogen/2021-09-23T22:57:11+00:00https://timmermanreport.com/wp-content/uploads/2021/09/attnbiogen.pnghttps://timmermanreport.com/2021/09/sequencing-genomes-of-indigenous-populations-keolu-fox-on-the-long-run/keolufox1/2021-09-27T16:50:40+00:00https://timmermanreport.com/wp-content/uploads/2021/09/keolufox1.jpghttps://timmermanreport.com/2021/09/sequencing-genomes-of-indigenous-populations-keolu-fox-on-the-long-run/ansr-logo-no-tag-1900px-png-1-2/2021-09-27T16:51:09+00:00https://timmermanreport.com/wp-content/uploads/2021/09/ANSR-logo-no-tag-1900px-PNG-1-1.pnghttps://timmermanreport.com/2021/09/sequencing-genomes-of-indigenous-populations-keolu-fox-on-the-long-run/tfs-logo-3/2021-09-27T16:52:25+00:00https://timmermanreport.com/wp-content/uploads/2021/09/TFS-LOGO-1.pnghttps://timmermanreport.com/2021/09/expansion-snags-80m-to-make-small-molecules-against-rna-targets/300x300\_matthew\_disney/2021-09-28T23:36:11+00:00https://timmermanreport.com/wp-content/uploads/2021/09/300x300\_matthew\_disney.jpghttps://timmermanreport.com/2021/09/expansion-snags-80m-to-make-small-molecules-against-rna-targets/renato/2021-09-28T23:39:07+00:00https://timmermanreport.com/wp-content/uploads/2021/09/renato.pnghttps://timmermanreport.com/2021/09/merck-buys-acceleron-regeneron-antibody-saves-lives-moderna-invests-in-cambridge/maccheever/2021-09-30T23:33:05+00:00https://timmermanreport.com/wp-content/uploads/2021/09/maccheever.jpeghttps://timmermanreport.com/2021/10/pharmas-digital-transformation-enduring-challenges-sustained-hopes-and-a-progress-report-from-lillys-ceo/davericks/2021-10-04T16:14:14+00:00https://timmermanreport.com/wp-content/uploads/2021/10/davericks.jpghttps://timmermanreport.com/2021/10/exo-pockets-78m-to-make-small-molecules-against-exosite-targets/thilo/2021-10-04T20:32:42+00:00https://timmermanreport.com/wp-content/uploads/2021/10/thilo.pnghttps://timmermanreport.com/2021/10/exo-pockets-78m-to-make-small-molecules-against-exosite-targets/bakersmall-2/2021-10-04T20:48:50+00:00https://timmermanreport.com/wp-content/uploads/2021/10/bakersmall.jpghttps://timmermanreport.com/2021/10/exo-pockets-78m-to-make-small-molecules-against-exosite-targets/300x300\_ardem\_patapoutian/2021-10-04T20:52:55+00:00https://timmermanreport.com/wp-content/uploads/2021/10/300x300\_ardem\_patapoutian.jpghttps://timmermanreport.com/2021/10/exo-pockets-78m-to-make-small-molecules-against-exosite-targets/ardemnobelday/2021-10-04T21:06:28+00:00https://timmermanreport.com/wp-content/uploads/2021/10/ardemNobelDay.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/eridai/2021-10-05T22:59:28+00:00https://timmermanreport.com/wp-content/uploads/2021/05/eridai.pnghttps://timmermanreport.com/2021/10/rna-2-0-startups-take-aim-at-improved-delivery-target-specificity/yusuf/2021-10-05T23:01:55+00:00https://timmermanreport.com/wp-content/uploads/2021/10/yusuf.jpghttps://timmermanreport.com/2021/10/rna-2-0-startups-take-aim-at-improved-delivery-target-specificity/becraft-2/2021-10-05T23:21:45+00:00https://timmermanreport.com/wp-content/uploads/2021/10/becraft.jpeghttps://timmermanreport.com/2021/10/rna-2-0-startups-take-aim-at-improved-delivery-target-specificity/becraft1/2021-10-05T23:22:57+00:00https://timmermanreport.com/wp-content/uploads/2021/10/becraft1.pnghttps://timmermanreport.com/2021/10/rna-2-0-startups-take-aim-at-improved-delivery-target-specificity/founder-nathaniel/2021-10-05T23:24:04+00:00https://timmermanreport.com/wp-content/uploads/2021/10/founder-nathaniel.pnghttps://timmermanreport.com/2021/10/neumora-secures-500m-amgen-deal-in-quest-for-precision-neuroscience-rd/kburow/2021-10-06T22:45:58+00:00https://timmermanreport.com/wp-content/uploads/2021/10/kburow.pnghttps://timmermanreport.com/2021/10/reimagining-dna-sequencing-with-long-reads-christian-henry-on-the-long-run/henry\_bod/2021-10-13T02:16:11+00:00https://timmermanreport.com/wp-content/uploads/2021/10/Henry\_BoD.pnghttps://timmermanreport.com/2021/10/califf-back-at-fda-modernas-booster-slam-dunk-the-vaccine-equity-debate/gounder/2021-10-14T23:23:49+00:00https://timmermanreport.com/wp-content/uploads/2021/10/gounder.pnghttps://timmermanreport.com/2021/10/califf-back-at-fda-modernas-booster-slam-dunk-the-vaccine-equity-debate/ourworlddata/2021-10-14T23:25:15+00:00https://timmermanreport.com/wp-content/uploads/2021/10/ourworlddata.pnghttps://timmermanreport.com/2021/10/dna-script-snags-165m-to-build-up-benchtop-dna-synthesis-market-technology/sylvain/2021-10-25T23:04:47+00:00https://timmermanreport.com/wp-content/uploads/2021/10/sylvain.jpghttps://timmermanreport.com/2021/10/pfizer-vaccine-okd-for-kids-merck-ensures-global-access-and-maraganore-passes-torch/shareofpeople/2021-10-29T02:42:35+00:00https://timmermanreport.com/wp-content/uploads/2021/10/shareofpeople.pnghttps://timmermanreport.com/about-luke-timmerman/milkenglobal2021/2021-10-29T20:07:14+00:00https://timmermanreport.com/wp-content/uploads/2021/10/Milkenglobal2021-scaled.jpghttps://timmermanreport.com/2021/11/cf-foundation-invests-up-to-110m-in-flagship-unit-to-combine-technologies/paulbiondi/2021-11-03T01:35:15+00:00https://timmermanreport.com/wp-content/uploads/2021/11/paulbiondi.pnghttps://timmermanreport.com/2021/11/the-vaccine-pile-up-regeneron-crushes-it-cf-foundation-bets-on-flagship-combos/walensky/2021-11-05T00:50:12+00:00https://timmermanreport.com/wp-content/uploads/2021/11/walensky.pnghttps://timmermanreport.com/the-long-run/absci-namelogo1/2021-11-05T20:41:49+00:00https://timmermanreport.com/wp-content/uploads/2021/11/Absci-NameLogo1.pnghttps://timmermanreport.com/2021/11/uks-100k-genomes-study-ends-diagnostic-odyssey-for-some-with-rare-diseases/richardscott/2021-11-09T22:52:08+00:00https://timmermanreport.com/wp-content/uploads/2021/11/richardscott.pnghttps://timmermanreport.com/2021/11/uks-100k-genomes-study-ends-diagnostic-odyssey-for-some-with-rare-diseases/heidirehm\_413x315/2021-11-09T22:53:04+00:00https://timmermanreport.com/wp-content/uploads/2021/11/HeidiRehm\_413x315.jpghttps://timmermanreport.com/2021/11/motivating-a-modicum-of-exercise-the-healthtech-opportunity/aarti/2021-11-14T21:29:05+00:00https://timmermanreport.com/wp-content/uploads/2021/11/aarti.jpghttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/lt1/2021-11-15T00:35:46+00:00https://timmermanreport.com/wp-content/uploads/2020/01/LT1.jpghttps://timmermanreport.com/2018/07/nine-observations-on-leadership-and-teamwork-from-mt-everest/attachment/11/2021-11-15T00:41:22+00:00https://timmermanreport.com/wp-content/uploads/2018/07/11.jpghttps://timmermanreport.com/2021/11/chroma-medicine-secures-125m-to-edit-the-epigenome/vic1-1/2021-11-17T00:35:12+00:00https://timmermanreport.com/wp-content/uploads/2021/11/vic1.1.jpghttps://timmermanreport.com/2021/11/chroma-medicine-secures-125m-to-edit-the-epigenome/cath-1-1/2021-11-17T00:36:34+00:00https://timmermanreport.com/wp-content/uploads/2021/11/cath.1.1.jpghttps://timmermanreport.com/2021/11/precision-healths-next-great-challenge-behavior-change/priti/2021-11-18T18:24:57+00:00https://timmermanreport.com/wp-content/uploads/2021/11/priti.jpghttps://timmermanreport.com/2021/11/precision-healths-next-great-challenge-behavior-change/jessietenenbaum2/2021-11-18T18:28:26+00:00https://timmermanreport.com/wp-content/uploads/2021/11/jessietenenbaum2.jpghttps://timmermanreport.com/2021/11/precision-healths-next-great-challenge-behavior-change/johnquackenbush/2021-11-18T18:30:14+00:00https://timmermanreport.com/wp-content/uploads/2021/11/johnquackenbush.pnghttps://timmermanreport.com/2021/11/in-rna-therapeutics-are-circles-better-than-lines/awessel/2021-11-19T23:03:22+00:00https://timmermanreport.com/wp-content/uploads/2021/11/awessel.jpghttps://timmermanreport.com/2021/11/in-rna-therapeutics-are-circles-better-than-lines/diegomiralles/2021-11-19T23:05:43+00:00https://timmermanreport.com/wp-content/uploads/2021/11/diegomiralles.pnghttps://timmermanreport.com/2021/11/in-rna-therapeutics-are-circles-better-than-lines/tbarnes/2021-11-19T23:06:52+00:00https://timmermanreport.com/wp-content/uploads/2021/11/tbarnes.pnghttps://timmermanreport.com/2021/11/obesity-is-rising-can-health-coaches-tech-drive-durable-behavior-change/obesitychart/2021-11-26T17:57:18+00:00https://timmermanreport.com/wp-content/uploads/2021/11/obesitychart.pnghttps://timmermanreport.com/2021/11/omicron-variant-the-latest-twist-in-the-pandemic/omicron/2021-11-26T20:19:53+00:00https://timmermanreport.com/wp-content/uploads/2021/11/omicron.pnghttps://timmermanreport.com/2021/11/omicron-variant-the-latest-twist-in-the-pandemic/ftomicron/2021-11-26T20:27:09+00:00https://timmermanreport.com/wp-content/uploads/2021/11/ftomicron.pnghttps://timmermanreport.com/2021/11/obesity-is-rising-can-health-coaches-tech-drive-durable-behavior-change/fcs\_ama\_shoot\_1\_3\_0/2021-11-27T21:57:22+00:00https://timmermanreport.com/wp-content/uploads/2021/11/fcs\_ama\_shoot\_1\_3\_0.jpghttps://timmermanreport.com/2021/11/obesity-is-rising-can-health-coaches-tech-drive-durable-behavior-change/herman\_pontzer/2021-11-27T21:59:39+00:00https://timmermanreport.com/wp-content/uploads/2021/11/herman\_pontzer.jpghttps://timmermanreport.com/2021/11/obesity-is-rising-can-health-coaches-tech-drive-durable-behavior-change/john-berardi/2021-11-27T22:09:02+00:00https://timmermanreport.com/wp-content/uploads/2021/11/john-berardi.pnghttps://timmermanreport.com/2021/12/apollo-health-ventures-gets-180m-to-invest-in-extending-human-healthspan/nils/2021-12-01T02:07:21+00:00https://timmermanreport.com/wp-content/uploads/2021/11/nils.jpghttps://timmermanreport.com/2021/12/corporate-health-and-wellness-has-new-urgency-and-vision/perma/2021-12-06T13:39:00+00:00https://timmermanreport.com/wp-content/uploads/2021/12/perma.pnghttps://timmermanreport.com/2021/12/targeted-small-molecule-protein-degraders-nello-mainolfi-on-the-long-run/nello-2-1024x684/2021-12-06T23:33:04+00:00https://timmermanreport.com/wp-content/uploads/2021/12/nello-2-1024x684-1.jpghttps://timmermanreport.com/2021/12/newpath-partners-secures-350m-for-startups-working-on-hard-science-problems/tomcahill/2021-12-07T23:17:48+00:00https://timmermanreport.com/wp-content/uploads/2021/12/tomcahill.jpghttps://timmermanreport.com/2021/12/sqz-shows-promise-with-hpv-cancer-vaccine-in-early-solid-tumor-clinical-trial/poonam2/2021-12-08T22:27:45+00:00https://timmermanreport.com/wp-content/uploads/2021/12/poonam2.jpghttps://timmermanreport.com/2021/12/three-core-questions-underlying-durable-behavior-change/bk\_55\_esther\_dyson/2021-12-09T03:29:44+00:00https://timmermanreport.com/wp-content/uploads/2021/12/bk\_55\_esther\_dyson.jpghttps://timmermanreport.com/2021/12/three-core-questions-underlying-durable-behavior-change/sam-promo-photo-cropped/2021-12-09T03:31:29+00:00https://timmermanreport.com/wp-content/uploads/2021/12/Sam-Promo-Photo-Cropped.jpghttps://timmermanreport.com/2021/12/a-missed-opportunity-for-grownups/kids/2021-12-10T02:22:11+00:00https://timmermanreport.com/wp-content/uploads/2021/12/kids.pnghttps://timmermanreport.com/2021/12/the-other-side-of-the-story-vaccines-must-produce-both-antibodies-and-t-cell-immunity/harlan-2/2021-12-14T19:07:32+00:00https://timmermanreport.com/wp-content/uploads/2021/12/harlan.jpghttps://timmermanreport.com/2021/12/the-other-side-of-the-story-vaccines-must-produce-both-antibodies-and-t-cell-immunity/adaptiveomicron/2021-12-14T19:08:43+00:00https://timmermanreport.com/wp-content/uploads/2021/12/adaptiveomicron.pnghttps://timmermanreport.com/2021/12/the-long-war/pearls-before-swine/2021-12-15T14:45:43+00:00https://timmermanreport.com/wp-content/uploads/2021/12/pandemicover.tifhttps://timmermanreport.com/2021/12/the-long-war/pearls-before-swine-2/2021-12-15T14:47:24+00:00https://timmermanreport.com/wp-content/uploads/2021/12/pandemicover-1.tifhttps://timmermanreport.com/2021/12/the-long-war/pearls-2/2021-12-15T14:48:24+00:00https://timmermanreport.com/wp-content/uploads/2021/12/pearls.gifhttps://timmermanreport.com/2021/12/the-long-war/pearls-3/2021-12-15T14:49:27+00:00https://timmermanreport.com/wp-content/uploads/2021/12/pearls-1.gifhttps://timmermanreport.com/2021/12/jpm-goes-virtual-pfizer-acquires-arena-arc-reimagines-the-scientific-enterprise/adagio/2021-12-17T02:02:38+00:00https://timmermanreport.com/wp-content/uploads/2021/12/adagio.pnghttps://timmermanreport.com/2021/12/jpm-goes-virtual-pfizer-acquires-arena-arc-reimagines-the-scientific-enterprise/collins-3/2021-12-17T02:03:04+00:00https://timmermanreport.com/wp-content/uploads/2021/12/collins.pnghttps://timmermanreport.com/2021/12/jpm-goes-virtual-pfizer-acquires-arena-arc-reimagines-the-scientific-enterprise/levy/2021-12-17T02:03:28+00:00https://timmermanreport.com/wp-content/uploads/2021/12/levy.pnghttps://timmermanreport.com/2021/12/physician-scientist-biotech-vc-vineeta-agarwala-on-the-long-run/vineetaagarwala-400x400/2021-12-20T22:33:21+00:00https://timmermanreport.com/wp-content/uploads/2021/12/VineetaAgarwala-400x400-1.jpghttps://timmermanreport.com/2021/12/controlling-covid-in-2022-masks-treatments-and-fast-frequent-testing/singapore/2021-12-21T00:35:18+00:00https://timmermanreport.com/wp-content/uploads/2021/12/singapore.pnghttps://timmermanreport.com/2021/12/controlling-covid-in-2022-masks-treatments-and-fast-frequent-testing/nonvaccinated/2021-12-21T00:38:26+00:00https://timmermanreport.com/wp-content/uploads/2021/12/nonvaccinated.pnghttps://timmermanreport.com/2021/12/controlling-covid-in-2022-masks-treatments-and-fast-frequent-testing/quilty/2021-12-21T00:40:51+00:00https://timmermanreport.com/wp-content/uploads/2021/12/quilty.pnghttps://timmermanreport.com/2021/12/pfizer-merck-get-covid-drugs-okd-sanofi-buys-amunix-and-a-new-pcsk9-contender/itcould1/2021-12-23T17:09:25+00:00https://timmermanreport.com/wp-content/uploads/2021/12/itcould1.jpghttps://timmermanreport.com/2021/12/pfizer-merck-get-covid-drugs-okd-sanofi-buys-amunix-and-a-new-pcsk9-contender/angie/2021-12-23T17:10:37+00:00https://timmermanreport.com/wp-content/uploads/2021/12/angie.pnghttps://timmermanreport.com/2021/12/pfizer-merck-get-covid-drugs-okd-sanofi-buys-amunix-and-a-new-pcsk9-contender/megzients/2021-12-23T17:11:25+00:00https://timmermanreport.com/wp-content/uploads/2021/12/megzients.pnghttps://timmermanreport.com/2021/12/pfizer-merck-get-covid-drugs-okd-sanofi-buys-amunix-and-a-new-pcsk9-contender/boosters/2021-12-23T17:12:07+00:00https://timmermanreport.com/wp-content/uploads/2021/12/boosters.pnghttps://timmermanreport.com/2021/12/improving-health-and-wellness-in-2022/stulberg1/2021-12-23T17:20:17+00:00https://timmermanreport.com/wp-content/uploads/2021/12/stulberg1.jpghttps://timmermanreport.com/2021/12/improving-health-and-wellness-in-2022/kindwellhealth/2021-12-23T17:22:31+00:00https://timmermanreport.com/wp-content/uploads/2021/12/kindwellhealth.pnghttps://timmermanreport.com/2022/01/rna-editing-looks-to-find-its-place-in-the-gene-editing-world/burns/2022-01-04T19:27:30+00:00https://timmermanreport.com/wp-content/uploads/2022/01/burns.pnghttps://timmermanreport.com/2022/01/rna-editing-looks-to-find-its-place-in-the-gene-editing-world/mali/2022-01-04T19:29:02+00:00https://timmermanreport.com/wp-content/uploads/2022/01/mali.jpeghttps://timmermanreport.com/2022/01/rna-editing-looks-to-find-its-place-in-the-gene-editing-world/aiyar/2022-01-04T19:33:25+00:00https://timmermanreport.com/wp-content/uploads/2022/01/aiyar.jpghttps://timmermanreport.com/2022/01/the-omicron-wave-a-review-of-the-research-on-spread-and-severity/tehbest/2022-01-06T19:34:32+00:00https://timmermanreport.com/wp-content/uploads/2022/01/tehbest.pnghttps://timmermanreport.com/2022/01/the-omicron-wave-a-review-of-the-research-on-spread-and-severity/ukhsa/2022-01-06T19:36:16+00:00https://timmermanreport.com/wp-content/uploads/2022/01/ukhsa.pnghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/carl\_sagan\_planetary\_society\_cropped/2022-01-07T02:19:51+00:00https://timmermanreport.com/wp-content/uploads/2022/01/Carl\_Sagan\_Planetary\_Society\_cropped.pnghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/mara/2022-01-07T02:21:21+00:00https://timmermanreport.com/wp-content/uploads/2022/01/mara.pnghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/nickerson/2022-01-07T02:23:50+00:00https://timmermanreport.com/wp-content/uploads/2022/01/nickerson.jpghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/nickerson-2/2022-01-07T02:24:39+00:00https://timmermanreport.com/wp-content/uploads/2022/01/nickerson-1.jpghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/vaccines/2022-01-07T02:24:53+00:00https://timmermanreport.com/wp-content/uploads/2022/01/vaccines.pnghttps://timmermanreport.com/2022/01/biotechs-candle-burns-bright-in-the-dark/2022drugs/2022-01-07T02:25:55+00:00https://timmermanreport.com/wp-content/uploads/2022/01/2022drugs.pnghttps://timmermanreport.com/2022/01/beware-of-the-expert-fallacy-but-dont-fall-into-the-cynicism-trap/angeladuckworthphoto/2022-01-09T22:32:05+00:00https://timmermanreport.com/wp-content/uploads/2022/01/AngelaDuckworthPhoto.jpghttps://timmermanreport.com/2022/01/beware-of-the-expert-fallacy-but-dont-fall-into-the-cynicism-trap/jamil-zaki-square0/2022-01-09T22:34:15+00:00https://timmermanreport.com/wp-content/uploads/2022/01/jamil-zaki-square0.jpghttps://timmermanreport.com/2022/01/antibody-engineering-company-building-bassil-dahiyat-on-the-long-run/bassil-2/2022-01-11T20:50:28+00:00https://timmermanreport.com/wp-content/uploads/2022/01/bassil.pnghttps://timmermanreport.com/2022/01/the-biogen-debacle-continues/kaye/2022-01-14T01:25:12+00:00https://timmermanreport.com/wp-content/uploads/2022/01/kaye.pnghttps://timmermanreport.com/2022/01/the-biogen-debacle-continues/sara-2/2022-01-14T01:26:50+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sara.pnghttps://timmermanreport.com/2022/01/the-biogen-debacle-continues/alex-2/2022-01-14T01:27:11+00:00https://timmermanreport.com/wp-content/uploads/2022/01/alex.pnghttps://timmermanreport.com/2022/01/the-biogen-debacle-continues/jha-2/2022-01-14T01:28:10+00:00https://timmermanreport.com/wp-content/uploads/2022/01/jha.pnghttps://timmermanreport.com/2022/01/the-biogen-debacle-continues/allen/2022-01-14T01:28:22+00:00https://timmermanreport.com/wp-content/uploads/2022/01/allen.pnghttps://timmermanreport.com/everest-base-camp-2021/k2-logo-1/2022-01-14T16:37:20+00:00https://timmermanreport.com/wp-content/uploads/2022/01/K2-Logo-1.pnghttps://timmermanreport.com/everest-base-camp-2021/sofinnovainvestments/2022-01-19T17:51:59+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sofinnovainvestments.pnghttps://timmermanreport.com/2022/01/immpact-bio-with-bispecific-car-t-showing-durable-crs-raises-111m-series-b/sumant/2022-01-20T01:04:58+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sumant.jpghttps://timmermanreport.com/2022/01/behind-the-scenes-of-bd-brad-prosek-on-getting-to-know-an-unconventional-acquirer/bd-secrets-v1/2022-01-20T15:52:34+00:00https://timmermanreport.com/wp-content/uploads/2022/01/BD-Secrets-v1.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1king/2022-01-21T01:11:42+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1king.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1hana/2022-01-21T01:11:58+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1hana.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1jain/2022-01-21T01:12:15+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1jain.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1edelstein/2022-01-21T01:13:16+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1edelstein.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1bob/2022-01-21T01:13:35+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1bob.pnghttps://timmermanreport.com/2022/01/reflecting-on-mlk-and-science-in-society/1career/2022-01-21T01:13:49+00:00https://timmermanreport.com/wp-content/uploads/2022/01/1career.pnghttps://timmermanreport.com/2022/01/kyverna-gets-85m-to-take-car-t-cells-for-autoimmunity-to-the-clinic/borie/2022-01-25T22:10:56+00:00https://timmermanreport.com/wp-content/uploads/2022/01/borie.pnghttps://timmermanreport.com/2022/01/a-small-step-on-drug-pricing/ethan/2022-01-28T00:27:37+00:00https://timmermanreport.com/wp-content/uploads/2022/01/ethan.pnghttps://timmermanreport.com/2022/01/sridhar-iyengar-on-figuring-out-the-key-element-to-success-customer-needs/the-shiftv2-0/2022-01-28T23:00:16+00:00https://timmermanreport.com/wp-content/uploads/2022/01/The-shiftv2.0.pnghttps://timmermanreport.com/2022/01/sridhar-iyengar-on-figuring-out-the-key-element-to-success-customer-needs/sri-2/2022-01-28T23:01:34+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sri.jpghttps://timmermanreport.com/2022/01/gandeeva-raises-40m-for-fast-cryo-em-enabled-drug-discovery/sriram/2022-01-30T00:45:09+00:00https://timmermanreport.com/wp-content/uploads/2022/01/sriram.jpghttps://timmermanreport.com/2017/09/socializing-hours-biotech-runs-open/struex/2022-02-02T22:08:27+00:00https://timmermanreport.com/wp-content/uploads/2017/09/struex.jpghttps://timmermanreport.com/2021/10/califf-back-at-fda-modernas-booster-slam-dunk-the-vaccine-equity-debate/califf/2022-02-04T01:18:06+00:00https://timmermanreport.com/wp-content/uploads/2021/10/califf.jpghttps://timmermanreport.com/2022/02/the-world-is-still-waiting-for-novavax/ft/2022-02-04T01:19:50+00:00https://timmermanreport.com/wp-content/uploads/2022/02/ft.pnghttps://timmermanreport.com/2022/02/the-world-is-still-waiting-for-novavax/shirley/2022-02-04T01:20:35+00:00https://timmermanreport.com/wp-content/uploads/2022/02/shirley.pnghttps://timmermanreport.com/2022/02/the-world-is-still-waiting-for-novavax/leana/2022-02-04T01:20:53+00:00https://timmermanreport.com/wp-content/uploads/2022/02/leana.pnghttps://timmermanreport.com/2022/02/behind-the-scenes-of-bd-maude-tessier-on-a-megamerger-curveball/maudet/2022-02-04T21:03:22+00:00https://timmermanreport.com/wp-content/uploads/2022/02/maudet.pnghttps://timmermanreport.com/2021/08/better-cancer-drugs-for-kids-julie-grant-and-sam-blackman-on-the-long-run/juliegrant/2022-02-05T20:39:18+00:00https://timmermanreport.com/wp-content/uploads/2021/08/juliegrant.pnghttps://timmermanreport.com/2022/02/the-cancer-moonshot-relaunched/julie2/2022-02-05T20:55:38+00:00https://timmermanreport.com/wp-content/uploads/2022/02/julie2.tifhttps://timmermanreport.com/2022/02/the-cancer-moonshot-relaunched/julie1/2022-02-05T20:58:41+00:00https://timmermanreport.com/wp-content/uploads/2022/02/julie1.jpghttps://timmermanreport.com/2022/02/the-cancer-moonshot-relaunched/julie4/2022-02-05T21:50:17+00:00https://timmermanreport.com/wp-content/uploads/2022/02/julie4-e1644097743167.jpghttps://timmermanreport.com/2022/02/going-private-the-public-bear-market-will-soon-hit-private-companies/googlefinance/2022-02-08T17:53:11+00:00https://timmermanreport.com/wp-content/uploads/2022/02/googlefinance.pnghttps://timmermanreport.com/2022/02/seismic-gets-101m-to-use-machine-learning-for-autoimmune-drug-discovery/jo-viney/2022-02-08T23:09:46+00:00https://timmermanreport.com/wp-content/uploads/2022/02/Jo-Viney.jpghttps://timmermanreport.com/2022/02/biotechs-future-off-the-beaten-path/chen/2022-02-11T00:47:16+00:00https://timmermanreport.com/wp-content/uploads/2022/02/chen.pnghttps://timmermanreport.com/everest-base-camp-2021/wsgr/2022-02-17T01:42:46+00:00https://timmermanreport.com/wp-content/uploads/2022/02/wsgr.pnghttps://timmermanreport.com/everest-base-camp-2021/simcha/2022-02-17T01:45:40+00:00https://timmermanreport.com/wp-content/uploads/2022/02/simcha.pnghttps://timmermanreport.com/2022/02/the-unsung-community-heroes-who-make-biotech-thrive/jimellis/2022-02-18T02:25:30+00:00https://timmermanreport.com/wp-content/uploads/2022/02/jimellis.pnghttps://timmermanreport.com/2022/02/the-unsung-community-heroes-who-make-biotech-thrive/rusty/2022-02-18T02:34:52+00:00https://timmermanreport.com/wp-content/uploads/2022/02/rusty.pnghttps://timmermanreport.com/2022/02/the-unsung-community-heroes-who-make-biotech-thrive/natalie/2022-02-18T02:36:28+00:00https://timmermanreport.com/wp-content/uploads/2022/02/natalie.jpghttps://timmermanreport.com/2022/02/the-unsung-community-heroes-who-make-biotech-thrive/biotechpeoplemountains/2022-02-18T02:48:52+00:00https://timmermanreport.com/wp-content/uploads/2022/02/BiotechPeopleMountains.jpghttps://timmermanreport.com/2022/04/samantha-truex-on-how-getting-market-feedback-turned-into-ma-for-padlock/padlockbms/2022-02-18T19:07:39+00:00https://timmermanreport.com/wp-content/uploads/2022/04/padlockbms.pnghttps://timmermanreport.com/everest-base-camp-2021/parexel-logo-color-rgb-png\_screen-use/2022-02-22T00:20:59+00:00https://timmermanreport.com/wp-content/uploads/2022/02/Parexel-Logo-Color-RGB-PNG\_screen-use.pnghttps://timmermanreport.com/2022/03/rondo-raises-67m-to-make-bispecific-t-cell-engagers-for-solid-tumors/rondo1/2022-03-02T02:13:42+00:00https://timmermanreport.com/wp-content/uploads/2022/03/rondo1.jpghttps://timmermanreport.com/2022/03/biotech-takes-a-stand/topol1/2022-03-04T01:08:53+00:00https://timmermanreport.com/wp-content/uploads/2022/03/topol1.pnghttps://timmermanreport.com/2022/03/peacetime-vs-wartime-ceo-a-useful-lens-for-transformative-leaders/benhorowitz-400x400/2022-03-07T13:46:47+00:00https://timmermanreport.com/wp-content/uploads/2022/03/BenHorowitz-400x400-1.jpghttps://timmermanreport.com/2022/03/sars-cov-2-where-did-it-come-from-and-where-does-it-go-next/mara1-3/2022-03-07T15:24:59+00:00https://timmermanreport.com/wp-content/uploads/2022/03/mara1.pnghttps://timmermanreport.com/2022/03/sars-cov-2-where-did-it-come-from-and-where-does-it-go-next/mara2-2/2022-03-07T15:25:52+00:00https://timmermanreport.com/wp-content/uploads/2022/03/mara2.pnghttps://timmermanreport.com/2022/03/sars-cov-2-where-did-it-come-from-and-where-does-it-go-next/mara3/2022-03-07T15:26:37+00:00https://timmermanreport.com/wp-content/uploads/2022/03/mara3.pnghttps://timmermanreport.com/2022/03/sars-cov-2-where-did-it-come-from-and-where-does-it-go-next/mara4/2022-03-07T15:27:50+00:00https://timmermanreport.com/wp-content/uploads/2022/03/mara4.pnghttps://timmermanreport.com/2022/03/sars-cov-2-where-did-it-come-from-and-where-does-it-go-next/mara5/2022-03-07T15:28:39+00:00https://timmermanreport.com/wp-content/uploads/2022/03/mara5.pnghttps://timmermanreport.com/2022/03/the-globally-integrated-biotech-is-down-but-not-out/andrey/2022-03-07T16:49:55+00:00https://timmermanreport.com/wp-content/uploads/2022/03/andrey.jpg